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1. Introduction 
 
„It is not the strongest of the species that survives, nor the most intelligent, but rather the 
one most adaptable to change.“ 
            Clarrence Darrow, 1988 
 
Bacteria, unicellular and rather simple organisms, are the most abundant life form on earth. It 
is estimated that 4 – 6 x1030 individual bacterial cells can be found on earth, representing the 
largest pool of nitrogen and phosphate and the second largest pool of carbon stored in all 
organisms (Whitman et al., 1998). Bacteria can be found ubiquitously in all possible 
environments. During evolution, they have developed a large metabolic diversity to adapt to 
even extreme conditions, often making them the dominant species in these ecological niches. 
Even though being highly adapted to their favoured habitats, all bacteria have to face changes 
in their environment and rely on sensory and regulatory mechanisms to cope with these 
changes. Studying these mechanisms on the molecular level is of growing importance. It 
allows understanding how pathogenic bacteria adapt to their hosts, to develop new drugs, 
molecular tools for research and to control biosynthesis in biotechnical processes. Most 
important, recent findings suggest that many regulatory mechanisms are conserved in all three 
domains of life. Therefore studying regulatory mechanisms in bacteria provides an insight 
into possible mechanisms in higher organisms, yet in systems of lower complexity.  
This work focuses on sensory and regulatory mechanisms in one of the simplest organisms 
known, the human pathogen Mycoplasma pneumoniae.  
 
 
1.1 Signal transduction in bacteria 
Bacteria have developed a broad variety of mechanisms to react to changes in their 
environment. All mechanisms have in common that an external stimulus is sensed and 
transduced into a cellular response, either adjustments of enzymatic or physiological activity 
or alteration of gene expression, aiming to adapt to these new conditions. The stimuli sensed, 
as well as the output responses, can both be specific or general. As an example, the zinc up-
take repressor Zur in the soil bacterium Bacillus subtilis specifically senses intracellular Zn2+ 
concentrations and mediates specific responses towards zinc starvation, whereas the 
expression and activity of general stress-response sigma factor SigS in Escherichia coli is 
triggered by various signals (Gaballa and Helmann, 1998; Hengge-Aronis, 2002). Cellular 
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responses can appear in all stages of bacterial gene expression (see Fig. 1.1 for an overview of 
most common mechanisms of regulation). Furthermore, sensing and transduction systems are 
often coupled to allow fast responses. Since discussing bacterial sensing systems would go 
beyond the scope of this work, only the most common regulatory mechanisms in bacteria are 
described in the next chapters. 
 
Fig. 1.1: Regulatory mechanism in bacteria 
Examples of the most common mechanisms how bacteria regulate gene expression are given in the figure above.  
 
 
1.1.1 Transcription regulation in bacteria 
Regulation of transcription is the most prevalent mechanism to respond to environmental 
changes in bacteria. It allows adjusting gene expression without unnecessarily wasting energy 
and other resources. Transcription can be regulated by several different mechanisms and often 
genes are targets of more then one regulatory event. 
In most bacteria the largest regulons, i.e. groups of genes that are under control of the same 
regulator, are those that are transcribed under the control of specific sigma factors. Sigma 
factors are proteins that initiate transcription by recruiting RNA polymerase to promoters of 
genes. They consist of one, in exceptional cases two proteins (Gruber and Gross, 2003; Paget 
and Helmann, 2003; MacLellan et al., 2009) with two conserved helix-turn-helix motifs that 
recognize and bind to specific promoter sequences (Gruber and Gross, 2003). Often sigma 
factors themselves are targets of regulatory events, either on the level of expression like         
B. subtilis SigD (Mirel et al., 2000), or by inactivation through interactions with so called 
anti-sigma factors. Such anti-sigma factors can either be proteins like FlgM in the case of      
B. subtilis SigD, or other molecules like 6S RNA in E. coli (Fredrick and Helmann, 1996; 
Trotochaud and Wassarman, 2004). Besides sigma and anti-sigma factors, other proteins or 
molecules can also trigger the affinity of RNA polymerase towards specific promoters. 
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Examples for this are the transcription regulator Spx present in the Firmicutes, or the 
alarmone (p)ppGpp (both discussed later) that interact with the RNA polymerase and, by this, 
mediate transcription regulation.  
Transcription regulators are responsible for the majority of transcription regulatory events. 
These regulators are proteins with DNA binding domains such as helix-turn-helix motifs 
(Brennan and Matthews, 1989) or zinc-finger domains that bind near the regulated promoters. 
Transcription regulators can be divided into three groups: activators, repressors and 
pleiotropic regulators that can act both as repressor or activator. Activators can act by several 
different mechanisms. However, the majority of these proteins bind to operator sequences 
upstream of their target promoters. Binding to their operator either results in changes of the 
topology of the DNA, allowing RNA polymerase to bind to the promoter, or to additional, cis-
acting elements. Other activators are affecting the half-lives of open promoter complexes, 
thereby abetting transcription initiation. Although transcription activators that bind 
downstream of the +1 site of transcription have been found (Sperandio et al., 2000; Munson 
and Scott, 2000), they are more likely an exception from the classical activating mechanisms 
of this group of proteins. In contrast to activators, repressors are DNA binding proteins that 
bind directly to the promoter or in the leader region between the promoter and the start codon 
of their target gene. When binding to the promoter region, repressors either cover the +1 site, 
the -10 or -35 regions, thereby preventing sigma binding or melting of DNA to start 
transcription. Repressors that bind to the leader sequence of their target gene block the active 
RNA polymerase, thereby leading to a break-off of transcription, a mechanism refered to as 
´roadblock´ (Kim et al., 2002; Choi and Saier, 2005). Finally, pleiotropic regulators such as 
the carbon catabolite control protein CcpA in the Firmicutes are DNA binding proteins that 
act both as activators or repressors, depending on their binding site in respect of the controlled 
gene (Blencke et al., 2003). Moreover, DNA binding of several competing regulators to a 
common operator can affect their activity by antagonizing effects, as shown for the lev operon 
in B. subtilis (Martin-Verstraete et al., 1995). Apart from these specialized proteins whose 
only function is to sense environmental changes and to respond by governing transcription, 
other proteins like B. subtilis RocG can moonlight as transcription regulators (Commichau et 
al., 2007). Based on their bi-functional role as enzymes and transcription regulators, these 
proteins are referred to as ´trigger enzymes´. 
RNA switches are cis-acting regulatory RNA elements that control transcription or translation 
by anti-termination. They are located in the 5´leader sequence of transcripts and form a 
terminator structure in the absence of their effector, leading to transcription breakup. If the 
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effector is present, it binds to the transcription terminator leading to structural changes and 
continuing transcription. Several molecules have been described as riboswitch effectors, 
including tRNA, proteins, and metabolites. In addition, riboswitches that do not require 
effector binding but other stimuli, like the temperature sensitive riboswitch upstream of 
Listeria monocytogenes prfA, have been discovered (Johansson et al., 2002). Recent studies 
found that at least 1.6% of all genes in B. subtilis and 1.4% of all genes in L. monocytogenes 
are controlled by riboswitches, highlighting the importance of these elements in bacterial 
transcription regulation (Irnov et al., 2006; Toledo-Arana et al., 2009).  
 
 
1.1.2 Post-transcriptional regulation in bacteria 
For a long period, post-transcriptional regulations where thought to occur only by RNA 
processing or degradation. However, during the last years, another widely distributed 
mechanism of post-transcriptional control has been discovered involving small, non-coding 
RNAs (sRNA). These sRNAs can be grouped in two categories, according to their mechanism 
of regulation: (I) small, trans-acting antisense sRNAs that bind to their target mRNA by base 
pairing and (II) sRNAs that interact with proteins, thereby triggering their activity. An 
example of group (II) is E. coli 6S RNA, described previously. sRNAs of group (I) can either 
effect translation initiation by masking or exposing the Shine-Dalgarno sequence of its target 
mRNAs (e.g. B. subtilis SR1) or by altering the stability of their targets as for Staphylococcus 
aureus RNAIII (Heidrich et al., 2006; Huntzinger et al., 2005). Moreover, recent publications 
showed that also small mRNAs could function as regulatory RNAs, and that titration effects 
trigger regulatory effects of sRNA with multiple targets (Mangold et al., 2004; Gimpel et al., 
2010; Figueroa-Bossi et al., 2009; Overgaard et al., 2009). Full operational capability of 
sRNAs in Gram-negative bacteria requires the activity of the RNA chaperone Hfq that 
stabilizes these sRNAs or mediates duplex formation of sRNA and its target mRNA (Soper et 
al., 2010). Even though an Hfq ortholog is present in most Gram-positive bacteria, it is not 
required for stabilisation of sRNA and its function is so far unknown (Heidrich et al., 2006). 
Gene expression can also be regulated by transcript stability. As described previously, 
stability of RNA can be affected by interactions with other RNA molecules or proteins. In 
addition to this, some RNAs are targets of specific ribonucleases. For example, the gapA 
operon of B. subtilis is transcribed as a polycistronic RNA of six genes and post-
transcriptionally processed by endoribonuclease RNaseY, leading to the formation of two 
mature mRNA fragments with different stability (Ludwig et al., 2001; Commichau et al., 
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2009). The stability of the shorter, gapA harbouring mRNA is triggered by a small peptide 
coded on sRNA S1 by an unknown mechanism (Gimpel et al., 2010). 
3´polyadenylation of transcripts is a third mechanism to regulate transcript stability in 
bacteria. In contrast to eukaryotes, 3´polyadenylation was found to lead to quicker RNA 
degradation in bacteria instead of stabilizing transcripts (Marujo et al., 2000). In E. coli, 
transcripts of over 90% of open reading frames where shown to be polyadenylated during 
exponential growth, and recent publications describe a poly(A) dependent mechanism of glmS 
regulation in this bacterium, suggesting a common role of polyadenylation in regulating gene 
expression in E. coli (Mohanty and Kushner, 2006; Joanny et al., 2007). Whereas poly(A) 
polymerase I (PAP I) and, to a lesser extend, polynucleotide phosphorylase (PNPase) have 
been found to be responsible for polyadenylation of transcripts in E. coli, synthesis of poly(A) 
tails in  B. subtilis depends on the activity of a so far unknown enzyme (O´Hara et al., 1995; 
Campos-Guillén et al., 2005). Moreover, the role of polyadenylation in RNA stability and 
regulation in Gram-positive bacteria has not been studied so far. 
 
 
1.1.3 Post-translational regulation in bacteria 
Post-translational regulations in bacteria occur mainly by three mechanisms: protein 
modification, protein degradation or by interaction with proteins or other molecules. Protein 
modifications can either take place by protein processing, rather rarely in bacteria, or by the 
addition of chemical groups to certain amino acid residues of the protein. A lot of different 
chemical post-translational protein modifications have been described in bacteria, including 
phosphorylation, acetylation, methylation, uridylylation/adenylation and glycolysation 
(Cozzone, 1998; Wang et al., 2010; Amaro and Jerez, 1984; Edwards and Merrick, 1995; 
Abu-Qarn et al., 2008). These chemical modifications are either directly involved in 
regulatory events or in signal transduction by triggering enzymatic activity (Wang et al., 
2010), mediating interactions with proteins or other molecules such as RNA (Deutscher et al., 
1995; Lindner et al., 1999) or affecting the stability of their target proteins (Schmidl et al., 
2010). Post-translational regulations in a quantitative manner can also occur by targeted 
degradation of proteins. For example, the Clp protease complex in B. subtilis was shown to 
preferably degrade proteins involved in central metabolism in response to glucose starvation, 
thereby down regulating these pathways (Gerth et al., 2008). This protease complex is also 
responsible for the instability of transcription regulator Spx in this bacterium, as will be 
discussed later. 
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1.2 The Mollicutes and the organism Mycoplasma pneumoniae 
Although a multitude of distinct bacteria have been studied to date, the common model 
organisms for Gram-positive and Gram-negative bacteria are the soil bacterium B. subtilis and 
the enterobacterium E. coli, respectively. Even though being studied for more than seventy 
years, only recent publications in the field of synthetic biology have attracted wide attention 
to the Mollicutes and their subgroup, the Mycoplasmas. In the next two chapters, the 
Mollicutes in general and the organism M. pneumoniae in particular will be described. 
 
 
1.2.1 The class Mollicutes  
The class Mollicutes forms a subgroup within the phylum of the Firmicutes, Gram-positive 
bacteria with a low GC content (Ciccarelli et al., 2006). The name Mollicutes is derived from 
the Latin words mollis, meaning “soft” and cutis, meaning “skin”, in reference to the fact that 
members of this subgroup lack a cell wall (Gibbons and Murray, 1987). To date, this group 
consists of the genera Mycoplasma, Acholeplasma, Spiroplasma, Mesoplasma, Hemoplasma, 
Phytoplasma and Ureaplasma. 16S rRNA analysis has shown that the Mollicutes arose by 
degenerative evolution from a clostridial ancestor, common to the branches Bacillus and 
Lactobacillus (Woese et al., 1979). Phylogenetic studies on the amino acid sequences of the 
widely distributed enzyme phosphoglycerate kinase (Pgk) within these groups could also 
reveal a closer relationship of the Mollicutes to the Streptococcus/Lactobacillus branch of 
Firmicutes, suggesting a shared ancestor rather with this subgroup than with the groups 
Bacillus and Clostridium (Neimark, 1979; Wolf et al., 2004). 
As a result of their reductive evolution, all Mollicutes possess highly reduced genomes, 
ranging from 1.5 Mbp in Acholeplasma laidlawii to 0.58 Mbp in Mycoplasma genitalium, the 
bacterium containing the smallest genome able to grow independent of a host (NCBI; Fraser 
et al., 1995). These reduced genomes are also reflected by their lifestyle: all members of this 
group are adapted to live as parasites in close association with eukaryotic cells (Ochman and 
Davalos, 2006) and to date, some members like the Phytoplasma can still not be grown in 
vitro. Their small genomes make the Mollicutes, especially the Mycoplasmas an important 
model organism of the comparatively young sciences of synthetic biology and systems 
biology. M. genitalium was used to study the minimal genetic requirements of an independent 
living cell, and recent publications aimed, for the first time, to completely understand a 
minimal organism by intensively studying the transcriptome, metabolome and interactome of            
M. pneumoniae (Hutchison et al., 1999; Glass et al., 2006; Güell et al., 2009; Kühner et al., 
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2009; Yus et al., 2009; Suthers et al. 2009). Furthermore, M. genitalium, Mycoplasma 
mycoides LC and Mycoplasma capricolum where used as model organisms to develop 
methods to synthesize, assemble and transplant whole bacterial genomes, important steps on 
the way to create artificially designed microorganisms (Lartigue et al., 2007; Gibson et al., 
2008; Lartigue et al., 2009; Bender et al., 2010; Gibson et al., 2010). 
 
 
 
Fig. 1.2: Phylogeny of the Mollicutes 
Unrooted phylogenetic tree of the Firmicutes with special emphasis to the Mollicutes. The tree is based on a 
concatenated alignment of 31 universal protein families. Image taken from Stülke et al., 2009. 
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1.2.2 Virulence of Mollicutes  
As mentioned above, all members of the Mollicutes are parasites of eukaryotic hosts. Apart 
from harming their hosts by cadging their nutrients, a small set of other mechanisms that lead 
to pathogenicity has been described. Hydrogen peroxide is the primary virulence factor in      
M. pulmonis, M. mycoides and M. pneumoniae (Cohen and Somerson, 1967; Brennan and 
Feinstein, 1968; Cherry and Taylor-Robinson, 1970). In M. pneumoniae and M. mycoides, 
hydrogen peroxide originates as a by-product from glycerol metabolism, where glycerol-3-
phosphate is converted to dihydroxyacetone phosphate (DHAP) by glycerol-3-phosphate 
dehydrogenase, GlpD (Pilo et al., 2005; Hames et al., 2009). Recent studies showed that 
physical contact between these two Mycoplasma species and their host cells is required to 
establish cytotoxicity, suggesting a model in which hydrogen peroxide is directly injected into 
the host cells rather than just being secreted (Bischof et al., 2008; Schmidl et al., 2010). In 
addition to hydrogen peroxide, putative cytotoxins have been described in M. pneumoniae and 
M. penetrans. The M. pneumoniae CARDS toxin resembles the major cytotoxin of Bordatella 
pertussis in domains and enzymatic activity and was shown to cause pertussis-like symptoms 
in baboon and mouse infection models (Kannan and Baseman, 2006; Hardy et al., 2009). The 
related toxin of M. penetrans is an ADP-ribosylating enzyme, but its role in virulence has not 
been determined so far (Johnson et al., 2009). Despite these two toxins, the lack of obvious 
virulence factors in the Mollicutes reflects their evolution as parasites rather than 
opportunistic pathogens: To date, Mycoplasma alligatoris was reported to be the only 
member of the Mollicutes being lethal for its host, the american alligator (Brown et al., 2001).  
Some mechanisms to escape their host’s immune responses are found in the Mollicutes. 
Antigen variation is described for lipoproteins and adhesins of M. pneumoniae, M. pulmonis 
and several other Mycoplasmas (Watson et al., 1988, Kenri et al., 1999). In addition, several 
Mycoplasma species are able to invade and to grow within non-phagocytic cells in vitro 
(Taylor-Robinson et al., 1991; Jensen et al., 1994, Winner et al., 2000, Yavlovich et al., 
2004). This behaviour could help these bacteria to hide from their host´s defence systems. 
However, it is not clear if intracellular growth does also occur during infection in vivo. 
Transmission of bacterial cells to a new host occurs either by direct contact of infected with 
uninfected hosts or by aerosols. In addition, several Mollicutes have developed specific 
strategies to infect new hosts. M. genitalium is  able to attach to human spermatozoa and   M. 
hominis invades Trichimonas vaginalis, both using these mobile eukaryotic cells as a shuttle 
between two hosts (Svenstrup et al., 2003; Vancini et al., 2008). Other Mollicutes, such as 
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Phytoplasma or phytopathogenic Spiroplasma depend on insect shuttle vectors for 
transmission (Bové et al., 2003).  
 
 
1.2.3 The organism M. pneumoniae 
M. pneumoniae is a human pathogen and the causative organism of atypical pneumonia and 
tracheobronchitis in children and old or immune-suppressed adults (Chanock et al., 1963). It 
was first isolated in1944 from the sputum from a patient suffering on pneumonia-like 
symptons, at the time misinterpreted as a virus and only later characterized as a pleuro-
pneumonia-like organism (PPLO) (Meiklejohn et al., 1944; Chanock et al., 1962). Almost 20 
years after its first description, the name M. pneumoniae was proposed (Chanock, 1963).  
M. pneumoniae has a bipolar cell shape consisting of the so called tip structure or attachment 
organelle, the major cell body and the trailing filament on the opposite site of the tip structure 
(see Fig.1.3). The tip structure consists of a multitude of hydrophobic adhesines such as P40 
or HMW (high molecular weight) proteins that are assembled to form an electron-dense core, 
visible by thin-section electron microscopy (Seto and Miyata, 2003). It is required for 
attachment and motility of the cells and it was shown that activity of protein kinase C is 
required for assembly or stabilisation of involved proteins (Krause and Balish, 2001; 
Henderson and Jensen, 2006; Schmidl et al., 2010). The trailing filament on the opposite pole 
of the cell is variable in length and is a remainder of cell division. 
 
 
Fig. 1.3 Morphology of M. pneumoniae.  
Scanning electron microscopy picture of M. pneumoniae strain M129 used in this study.   
 
The genome of M. pneumoniae was  a GC content of 40% and a coding capacity of only 689 
putative open reading frames (Himmelreich et al., 1996; Dandekar et al., 2000). Furthermore, 
its genome sequence revealed an extremely reduced metabolic potential: M. pneumoniae lacks 
genes required for the de novo synthesis of amino acids and vitamins. Other metabolic 
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pathways, such as the pentose phosphate pathway or anabolic pathways for nucleotide 
synthesis are incomplete, leading to various auxotrophies and high nutrient demands such as 
for purines and cholesterol, when grown in vitro. (Johnson and Somerson, 1980; Yus et al., 
2009). Enzymes of the tricarboxylic acid cycle, chinones and cytochromes are missing, and 
energy in form of ATP can only be synthesized by substrate level phosphorylation during 
glycolysis. The ATPase present in the genome of M. pneumoniae and other Mycoplasma was 
proposed to function as an ATP-dependent proton pump rather than as an ATP generating 
enzyme (Linker and Wilson, 1985). Even though M. pneumoniae possesses uptake systems 
for glucose, glycerol, fructose, glycerol-3-phosphate, mannitol, ribose/galactose and 
ascorbate, only the first three named carbon sources promote growth in vitro (Halbedel et al., 
2004; Yus et al., 2009). 
In contrast to other members of the Mollicutes, quite a few tools to manipulate and study     
M. pneumoniae are available. Reporter systems such as lacZ or green fluorescent protein 
(GFP) fusions have been used to monitor gene expression, to analyse promoters or to locate 
proteins (Halbedel and Stülke, 2006; Halbedel et al., 2007; Hasselbring and Krause, 2007). 
Targeted gene knockout by homologous recombination was shown to be working in              
M. pneumoniae, though with very low efficiency (Sluijter et al., 2009; Krishnakumar et al., 
2010). To date, the most common method for targeted gene knockout is a method referred to 
as the Haystack mutagenesis, in which desired clones are detected and isolated from a pool of 
random transposon insertion mutants by using a PCR-based screening system (Halbedel et al., 
2006). Neither naturally occurring nor constructed plasmids have been described for                
M. pneumoniae or other members of the M. pneumoniae clade of the Mollicutes, even though 
there are plasmids available for other Mollicutes such as Mycoplasma pulmonis and 
Spiroplasma citri (Cordova et al., 2002; Lartigue et al., 2002). Several studies use in vitro 
assays to characterize M. pneumoniae enzymes and proteins. The proteins are either derived 
by directly expressing tagged proteins in M. pneumoniae or from heterologous hosts like       
E. coli (Schmidl et al., 2007). For the direct expression of genes in M. pneumoniae, either 
constitutively active or TetR/tetracycline regulated promoters can be used (Schmidl et al., 
2007; Kühner et al., 2009; Breton et al., 2010). Expression of M. pneumoniae genes in other 
bacteria requires mutation of the TGA codon since it is coding for tryptophan instead of 
acting as a translational stop codon in this and other Mollicutes (Schaper et al., 1987). 
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1.2.4 Transcription in M. pneumoniae 
Transcription in M. pneumoniae basically resembles the principles in other bacteria in terms 
of mechanisms. However, some differences have been observed, either due to its reduced 
genome or to mutations in the transcription apparatus. All components of the RNA 
polymerase known in other bacteria are present in the genome of M. pneumoniae 
(Himmelreich et al., 1996; Dandekar et al., 2000). In addition, the amino acid sequences of 
some of the RNA polymerase subunits show mutations in conserved regions, leading to 
important phenotypes such as rifampine tolerance (Gadeau et al., 1986). Transcription is 
initiated by only one sigma factor, the housekeeping sigma70 SigA. Promoters recognized by 
this sigma factor have a weakly conserved consensus sequence for the -10 region, consisting 
of TANNAT (with N=T/A/G). The -35 region is only weakly conserved in a subset of 
promoters and plays no significant role in transcription initiation in vivo (Weiner 3rd et al., 
2000; Halbedel et al., 2007; Güell et al., 2009). Promoters are mainly located in short 
distances to their corresponding genes, leading to short leader sequences, and often multiple 
transcription start points can be found upstream of genes or operons, resulting in mRNA 
length polymorphism (Weiner 3rd et al., 2000; Halbedel et al., 2007; Güell et al., 2009). The 
majority of transcripts are polycistronic due to the high coding density of the genome and the 
orientation of the genes, and formation of new operons was found for several transcripts 
under changing environmental conditions. In addition, a high frequency of antisense 
transcription is observed in M. pneumoniae and its close relative, M. genitalium, probably due 
to unspecific promoter-like sequences that can be recognized by the sigma factor (Lluch-
Senar et al., 2007; Güell et al., 2009). 
The transcription terminator protein Rho described in other bacteria is missing in the genome 
of M. pneumoniae. This leads to transcription termination by hairpin formation as the only 
possible known mechanism in this organism (Himmelreich et al., 1996; Weiner 3rd et al., 
2000; Epshtein et al., 2010). In silico studies about Rho-independent transcription terminators 
in M. pneumoniae and other Mollicutes show contrary results, either doubting or supporting 
the presence and functionality of transcription termination by hairpin formation (de Hoon et 
al., 2005; Washio et al., 1998). However, recent publications show that the majority of 
transcripts in M. pneumoniae indeed terminate at predicted hairpins in vivo (Güell et al., 
2009; Vivancos et al., 2010).  A low Gibbs´ free energy density of stem loop formation in all 
Mollicutes might be the reason why the majority of Rho-independent transcription terminators 
have been missed in previous studies (de Hoon et al., 2005). 
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In summary, transcription in M. pneumoniae seems to proceed in a relaxed mode and leads to 
a model in which transcription can initiate and stop at various regions in the genome. 
 
 
1.2.5 Putative transcription regulators in M. pneumoniae 
This work only focuses on genes that might directly be involved in transcription regulation. 
Therefore RNases or RNA binding proteins that can alter transcript stability are not further 
considered neither in this chapter nor in this work.  
A model of relaxed transcription as described above requires tight regulation of genes that 
might be toxic for the cell or whose uncontrolled expression interferes with fundamental 
cellular processes, such as cell division. Interestingly, only very few genes that might be 
involved in the regulation of gene expression are found in M. pneumoniae (Himmelreich et 
al., 1996):  
 
Mpn124/HrcA 
Open reading frame mpn124 encodes an orthologue of the heat shock repressor protein HrcA 
in Gram-positive bacteria. HrcA is best described in B. subtilis, where it represses the 
transcription of class 1 heat-shock genes at low or moderate temperatures by binding to the so 
called CIRCE (controlling inverted repeat of chaperone expression) element at the 
corresponding promoters (Zuber and Schumann, 1994; Schulz and Schumann, 1996). At 
elevated temperatures, the HrcA homodimer dissociates into its subunits, thereby loosing 
DNA binding activity and leading to enhanced transcription of regulated genes. The 9bp-N9-
9bp CIRCE element is present at promoters of chaperones and proteases belonging to class 1 
heat-shock proteins in M. pneumoniae and other Mycoplasmas, and HrcA binds to this 
elements in vitro (Chang et al., 2008). In addition, up-regulation of transcription of these 
genes was observed after exposing M. pneumoniae and its relative M. genitalium to elevated 
temperatures, suggesting the same mode of regulation as described for B. subtilis (Weiner 3rd 
et al., 2003; Musatovova, et al., 2006). Therefore HrcA is the only transcription regulator 
among all Mollicutes whose putative targets are known so far.  
 
Mpn239/GntR family 
Open reading frame mpn239 encodes a putative helix-turn-helix transcriptional regulator 
belonging to the GntR family. This family is named after the repressor of the gluconate 
operon in B. subtilis (Fujita and Fujita, 1987). To date, more than 8.500 different protein 
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sequences from all bacterial clades are documented in the Pfam database 
(http://pfam.sanger.ac.uk), making it the largest family of transcription regulators in bacteria. 
The GntR family divides into six sub-groups, namely AdR, HutC, PlmA, MocR, YtrA and 
AraR, and all members described so far are metabolite responsive proteins involved in the 
regulation of various metabolic pathways or virulence (Rigali et al., 2002; Hoskisson and 
Rigali, 2009). BLAST analysis and multiple alignments show that Mpn239 belongs to the 
MocR sub-family, regulators that are thought to bind to DNA in an unusual head-to-tail 
conformation (Rigali et al., 2002; this work). The targets of this transcription regulator are so 
far unknown. 
 
Mpn329/Fur family 
Open reading frame mpn329 encodes a protein of the Fur (ferric uptake repressor) family 
present in Gram-positive bacteria. This family is named after B. subtilis Fur, a Fe2+ responsive 
transcriptional repressor, that regulates the expression of siderophores and iron uptake 
systems in response to iron depletion. Members of this family require Fe2+ as a cofactor for 
homodimerization and thus to obtain DNA binding activity. The active homodimers bind to 
an 19bp operator harbouring two overlapping, similar 7bp-N-7bp inverted repeats, thereby 
repressing transcription of their corresponding genes (Baichoo and Helmann, 2002; 
Jacquamet et al., 2009). Three members of the Fur family in Gram-positive bacteria have 
been described: Fur, Zur (zinc uptake repressor) and PerR (peroxide stress response 
regulator).   
 
Fig. 1.4: Mpn329/Fur is related to PerR in the Firmicutes 
Multiple alignment of PerR proteins from S. aureus (Sar), B. lichiniformis (Bli) and B. subtilis (Bsu) with 
Mpn329. The DNA binding domain (DBD) required for recognition of the PerR box and histidines His37 and 
His91 (*) required for H2O2 sensing are conserved in the M. pneumoniae protein. In addition, His93 (#) required 
for Fe2+ binding is conserved (Jacquamet et al., 2009). 
 
Multiple alignments with the amino acid sequences of Mpn329 and Fur, Zur or PerR proteins 
from other Firmicutes show, that the DNA binding domain and conserved histidine residues 
of PerR proteins are conserved in the M. pneumoniae protein, suggesting a function as a 
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peroxide response regulator rather than in iron homeostasis (Fig. 1.4) (Lee and Helmann, 
2006; Jacquamet et al., 2009). Even though the DNA binding domain of Mpn329 resembles 
those of PerR in the Firmicutes, no putative PerR box is found in the genome of M. 
pneumoniae. The target genes of this regulator are so far unkown. 
 
Mpn266/Spx family 
Open reading frame mpn266 encodes an orthologue of the pleiotropic transcriptional regulator 
Spx of disulphide stress in Gram-positive bacteria. Its presence in the genome of                  
M. pneumoniae has been missed until recently, due to the fact that it was misannotated as an 
ArsC (arsenate reductase) family member described in E. coli (Kühner et al., 2009; Güell et 
al., 2009; this work). In B. subtilis in which Spx is described best, Spx interacts with the C-
terminus of RpoA subunits of the RNA polymerase, thereby acting both as a transcriptional 
repressor and activator: by binding to RpoA, Spx prevents binding of alternative transcription 
regulators to the RNA polymerase and in addition masks operator sequences of promoters, 
thereby acting as an anti-activator (Nakano et al., 2003; Zuber, 2004). In contrast, a subset of 
promoters was found to be activated by RpoA-Spx interactions: Binding of Spx leads to 
conformational changes in the structure of RNA polymerase and is thereby altering its affinity 
to a motif upstream of the -35 region of activated promoters. Spx itself does not interact with 
DNA (Reyes and Zuber, 2008). Expression of Spx in B. subtilis is transcriptionally controlled 
by repressors the YodB and PerR, and by the sigma factors SigB and SigM (Petersohn et al., 
1999; Thackray and Moir, 2003; Leelakriangsak et al., 2007). Most important, its expression 
is post-translationally regulated by proteolysis through protease ClpXP (Nakano et al., 2002). 
Spx is an important pleiotropic regulator in all Gram-positive bacteria and has been shown to 
be also involved in stress tolerance and virulence in S. mutans or biofilm formation in S. 
epidermidis and other bacteria (Kajfasz et al., 2010; Wang et al., 2010).  
 
 
Fig. 1.5: Mpn266 is an Spx ortholog in M. pneumoniae  
Multiple alignment of Spx from B. subtilis (Bsu), L. monocytogenes (Lmo), S. aureus (Sau) with Mpn266. The 
CxxC motif involved disulphide stress sensing and the domain required for interaction with RpoA are conserved 
in Mpn266. 
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A conserved CxxC motif involved in stress sensing and the domain required for interaction 
with RpoA in Mpn266 are conserved (see Fig. 1.5). In addition, Mpn266 was co-purified with 
the RNA polymerase in a global interactome study in M. pneumoniae, suggesting an 
analogous function in this bacterium (Kühner et al., 2009). However, neither cis-acting 
transcription activators nor activator proteins that might interact with the RNA polymerase are 
known in M. pneumoniae, and DNA motifs of orthologous genes up-regulated by Spx in other 
bacteria are missing. Therefore, the role of Mpn266 in transcription regulation is not known to 
date.  
 
Mpn241/WhiA family 
Mpn241 is a protein encoded in an operon conserved in all Gram-positive bacteria. It is 
named after its orthologue WhiA in Streptomyces coelicolor, in which disruption of this gene 
leads to impaired sporulation, loss of autoregulatory transcription activation prior to 
sporulation and white colonies (Aínsa et al., 2000). To date, S. coelicolor is the only organism 
in which a phenotype has been described. However, if the phenotype of WhiA deletion in      
S. coelicolor is due to unregulated transcription of WhiA controlled genes is not known.  
In silico predictions show that WhiA proteins possess a helix-turn-helix like structure 
(Knizewski and Ginalski, 2007). A structural analysis of a WhiA ortholog from T. maritima 
confirmed the presence of a helix-turn-helix-domain that strongly resembles regions of 
bacterial sigma70 factors that bind to the -35 region of promoters. In addition, it could be 
shown that this domain is tethered to LAGLIDADG homing endonucleases scaffold, proteins 
so far only described in eukaryotes. Analysis of the putative catalytic domain shows that these 
proteins have lost their nuclease activity and only retained the ability to bind nucleic acids, 
either DNA or RNA (Longo et al., 2005; Kaiser et al., 2009). Thus, these proteins seem to be 
domesticated enzymes with eukaryotic ancestors that have been transformed to a new 
subgroup of proteins with different functions in an evolutionary process after horizontal gene 
transfer. 
 
Mpn626 
Open reading frame mpn626 encodes a protein of unknown function. It was proposed to be a 
secondary sigma factor due to sequence and predicted structural homologies to B. subtilis 
SigD (Bornberg-Bauer and Weiner 3rd, 2002). However, it was not co-purified with the        
M. pneumoniae RNA polymerase in a global interactome study, even though it seems to be 
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associated with the ribosome (Kühner et al., 2009; Anne-Claude Gavin, personal 
communication). Therefore, function of this protein remains to be unknown. 
 
Mpn244/DisA 
Open reading frame mpn244 encodes a putative DisA orthologue from B. subtilis. B. subtilis 
DisA (DNA integrity scanning protein) forms an octamer that possesses unspecific DNA 
binding activity and moves rapidly along the DNA, pausing only at sites of DNA damage 
(Bejerano-Sagie et al., 2006). Sporulation is delayed in a DisA-dependent manner until 
damaged DNA is repaired. In addition, DisA was shown to possess diadenylate cyclase 
activity, leading to formation of c-di-ATP which was proposed to be involved in signalling 
aiming to recruit the DNA repair machinery (Witte et al., 2008).  Furthermore, a protein with 
cyclic dinucleotide phosphodiesterase activity that hydrolyzes c-di-ATP and c-di-GTP 
involved in DNA damage recognition has been identified in B. subtilis (Rao et al., 2009). 
Secondary nucleotide messengers such as (p)ppGpp or cAMP are involved in transcriptional 
regulatory processes in other bacteria, and additional roles for the analogue messenger c-di-
AMP were recently discovered. Therefore, a role of c-di-AMP in regulating gene expression 
cannot be excluded. 
 
Mpn273/Hit 
Open reading frame mpn273 encodes a HIT orthologue conserved in all organisms. The 
protein contains a histidine triad (HIT) motif, His-x-His-x-His-x-x (with “x” being a 
hydrophobic amino acid) and is thought to be involved in cell cycle regulation (Séraphin, 
1992). 
 
Further proteins putatively involved in transcription regulation are Mpn397/RelA involved in 
the so called ´stringent response´, and the kinase/phosphatase couple Mpn223/HprK and 
Mpn247/PrpC that are involved in transcription regulation in other Gram-positive bacteria, a 
regulatory mechanism referred to as carbon catabolite repression. These two signalling 
pathways are the main scope of this work; therefore they will be discussed separately in the 
next chapter. 
In addition to these proteins, a recent study revealed the presence of about 30 small non-
coding RNAs in the genome of M. pneumoniae, none of which had been described so far 
(Güell et al., 2009). Since these findings were published at the end of this work, their putative 
implications in regulation events are not further discussed here.  
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1.3 Mpn397/RelA and the ´stringent response´ 
One of the best-studied signalling pathways in bacteria is the stringent response, which is 
induced during nutrient starvation. It is characterized by the accumulation of the secondary 
nucleotide messengers or alarmones pppGpp and ppGpp (collectively referred to as (p)ppGpp, 
see Fig. 1.6) that result from the ATP-dependent phosphorylation of GTP and GDP, 
respectively, and by the down-regulation of stable RNA synthesis such as tRNA and rRNA. 
 
 
Fig. 1.6: ppGpp and pppGpp  
Structures of the secondary nucleotide messenger molecules guanosin-5´-diphosphate-3´-diphosphate (ppGpp) 
and guanosin-5´-triphosphate-3´-diphosphate (pppGpp), collectively referred to as (p)ppGpp. Both are generated 
by the ATP-dependent phosphorylation of GDP and GTP, respectively.  
 
The stringent response is a global regulatory mechanism shown to control transcription, 
translation, enzymatic activities and even the cell cycle. It is conserved among most bacteria 
and even in higher plants (van der Biezen et al., 2000). 
In Gram-negative bacteria such as E. coli in which the stringent response is described most 
exhaustively, two enzymes, RelA and SpoT, are responsible for the synthesis of (p)ppGpp. 
RelA is a (p)ppGpp synthetase that responds to amino acid starvation. Its activity is triggered 
by the interaction with ribosomal proteins in the presence of unloaded tRNAs (Haseltine et 
al., 1973). The second emzyme, SpoT, functions both as a (p)ppGpp synthetase and 
hydrolase. Its synthethase activity is triggered by the interaction with the acyl carrier protein 
and thereby reflects fatty acid synthesis (Battesti and Bouveret, 2006; Battesti and Bouveret, 
2009). In contrast, in B. subtilis and other Gram-positive bacteria only one enzyme is 
responsible for (p)ppGpp synthesis and hydrolysis under stringent conditions. To avoid any 
confusion, this enzyme will be referred to as RelA, even though a different name was 
proposed in recent publications (Potrykus and Cashel, 2008). In addition, small constitutively 
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active (p)ppGpp synthetases are present in most Gram-positive bacteria. However, they are 
not responsible for (p)ppGpp synthesis under stringent conditions and their expression is 
regulated in response to certain stresses, thereby triggering intracellular (p)ppGpp levels 
(Nanamiya et al., 2008; Cao et al., 2009).  
(p)ppGpp itself is a global regulator that controls both transcription and enzymatic activities. 
In E. coli, transcription regulation is mediated by the complex formation of (p)ppGpp with the 
protein DksA which interacts with the RNA polymerase, and by GC-rich discriminator 
sequences of certain promoters (Magnusson et al., 2007; Wagner, 2002). In B. subtilis and 
other Gram-positive bacteria, no DksA is present and transcriptional changes are passive 
effects that are resulting from lowered intracellular GTP levels in stringent cells: In                
B. subtilis, (p)ppGpp inhibits the activity of IMP dehydrogenase, a key enzyme of GTP 
synthesis, thereby leading to lowered GTP levels that can be detected by transcription factors 
such as CodY (Pao and Dyess, 1981; Lopez et al., 1981; Ochi et al., 1982; Tojo et al., 2008). 
More importantly, lowered intracellular GTP levels lead to a significant down regulation of 
transcription of genes initiating transcripts with GTP, and it was shown that changes of the 
initial base leads to a loss of down-regulation during stringent conditions (Krásny and Gourse, 
2004; Tojo et al., 2010). In addition to IMP dehydrogenase, (p)ppGpp was shown to inhibit 
various enzymes, and recently it was shown that (p)ppGpp dependent inhibition of DNA 
primase in stringent controlled cells leads to a stop in replication in both E. coli and B. subtilis 
(Wang et al., 2007; Maciąg et al., 2010).  
Functioning as a global regulator that helps to respond to changing nutrient availability, 
(p)ppGpp is also involved in pathogenesis in several bacteria. For example, RelA proteins are 
required for the expression of the virB secretion system in Brucella suis, for surface attached 
growth and virulence of Listeria monocytogenes and for virulence of Enterococcus faecalis 
(see Dalebroux et al., 2010 for more examples). Moreover, an almost unnoticed publication 
compared available microarray data of several facultative intracellular pathogens, thereby 
showing that the stringent response is commonly induced when these bacteria are entering 
their host cells (La et al., 2008). This finding is supported by publications that show that RelA 
proteins are either strictly required for intracellular growth or to establish virulence in 
facultative intracellular pathogens (Dalebroux et al., 2010). The absence of RelA proteins in 
eukaryotes, with the exception of higher plants, makes them ideal targets of novel antibiotics 
(Wexsellblatt et al., 2010). 
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1.4 The phosphotransferase system (PTS) and carbon catabolite repression  
Uptake of different carbon sources in bacteria is achieved either passively by diffusion or by 
active transport. Many carbon sources are imported by substrate-specific phosphotransferase 
systems (PTS), a family of transporters that couples uptake of the respective carbon source 
with its phosphorylation. The PTS in Gram-positive bacteria is best studied in the model 
organism B. subtilis (see Fig. 1.7 A; for a comprehensive overview about the PTS in bacteria, 
see Deutscher et al., 2006): phosphate is transferred to a histidine residue (His15) of 
phosphocarrier protein HPr by PTS enzyme I, using phosphoenolpyruvate as phosphate 
donor. HPr(His15-P) then transports the phosphate to the PTS enzyme II complex located in 
the membrane, where glucose (or other carbon sources, depending on the PTS) is taken up 
and thereby phosphorylated to glucose-6-phosphate, the first intermediate of glycolysis. The 
unphosphorylated HPr can then again be loaded with a phosphate at the His15 residue by 
enzyme I. In addition to the phosphorylation of His15 by enzyme I, HPr can be 
phosphorylated at a serine residue Ser46 by the enzyme HPr kinase/phosphorylase, HPrK/P, 
using ATP as phosphate donor. Even though this enzyme both catalyzes the phosphorylation 
and dephosphorylation of Ser46, its kinase activity is enhanced by elevated intracellular levels 
of fructose-1,6-bisphosphate and ATP (Jault et al., 2000; Ramström et al., 2003). To prevent 
phosphorylation of all HPr at high intracellular levels of fructose-1,6-bisphosphate and ATP, 
a second enzyme was found to be involved in dephosphorylation of HPr-SerP, the protein 
phosphatase PrpC (Singh et al., 2007). Both phosphorylation states of HPr are mutually 
exclusive, and HPr(Ser46-P) is a cofactor for the carbon catabolite control protein CcpA 
(Deutscher et al., 1995). HPr(Ser46-P) forms a heteromeric complex with CcpA, thereby 
activating its DNA binding activity. The CcpA/Hpr(Ser46-P) complex then regulates 
transcription of catabolic genes by binding to the so called cre (catabolite repression element) 
sequence upstream of these genes (Miwa et al., 2000). On the other hand, HPr(His15-P) can 
interact with and thereby activate transcriptional regulator YesS to activate transcription of 
genes required for pectin/rhamnogalacturonan utilization (Poncet et al., 2009). In addition, 
HPr-HisP can transfer the phosphate from His15 to other protein such as the glycerol kinase 
GlpK or proteins involved in antitermination such as LicT, thereby triggering their enzymatic 
activity or their affinity towards their regulated target, respectively (Lindner et al., 1999; 
Charrier et al., 1997). Thus, the phosphorylation state of HPr helps the cell to monitor and to 
respond to the availability of different sugars, making HPr the key mediator of regulation in 
response to different carbon sources in B. subtilis and other Firmicutes.  
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In M. pneumoniae, four different PTS for glucose, fructose, mannitol and ascorbate are found, 
howevr only glucose and fructose were shown to promote growth (Halbedel et al., 2004; Yus 
et al., 2009; this work). The main mechanisms in phosphate transfer in M. pneumoniae are the 
same as in B. subtilis (see Fig 1.7 B). However, a characterisation of HPrK/P from                
M. pneumoniae showed that this enzyme is mainly active as a kinase due to an elevated 
affinity of the enzyme towards ATP (Steinhauer et al., 2002). The finding of contrary 
phosphorylation states of HPr in M. pneumoniae mutants lacking HPrK and PrpC supported 
this finding, suggesting monofunctional and antagonistic roles of HprK and PrpC in HPr 
phosphorylation (Halbedel et al., 2004; Halbedel et al., 2006). Although these two enzymes 
tightly control the phosphorylation state of HPr, no regulatory elements such as antiterminator 
proteins or transcriptional regulators described in other bacteria are found in M. pneumoniae. 
In addition, a recent phosphoproteome analysis of an HPrK mutant showed that HPr is the 
only substrate of HprK in vivo, ruling out additional roles of this enzyme in this organism 
(Schmidl et al., 2010). These findings raise the question about the role of this conserved 
mechanism in M. pneumoniae, which is so far unknown. 
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Fig. 1.7: Comparison of the PTS in B. subtilis (A) and M. pneumoniae (B). 
The mechanisms of HPr phosphorylation are conserved in M. pneumoniae. However, the function of     
HPr(Ser46-P) in this organism is so far unknown. 
 
1.5 Aims of this work 
During its reductive evolution, M. pneumoniae not only reduced its metabolic potential and its 
size, but also its genetic requirements to sense and to react to environmental changes. This 
raises the questions if a minimal genome only requires a minimum of regulation, and which 
processes in particular need to be regulated in a minimal cell. Until recently, M. pneumoniae 
and other Mollicutes were thought to regulate transcription only by very few, rather simple 
mechanisms. In contrast to this concept, the work of Güell et al. (2009) suggested surprisingly 
complex changes in the transcriptome in response to environmental changes and stresses. 
However, the work of Güell et al. did neither reveal any mechanism how transcription is 
regulated, nor if the transcriptional changes observed are physiologically relevant.  
The main aim of this work was to find target genes under control of the so far uncharacterized 
transcription regulators and/or to identify additional genes that are involved in transcription 
regulation in M. pneumoniae.  
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2. Materials and methods 
 
2.1 Microbiological techniques 
 
Materials: Chemicals, utilities, equipment, commercial systems, proteins, antibodies, 
enzymes, oligonucleotides, software and websites are listed in the appendix of this work.  
 
 
2.1.1 Bacterial strains and plasmids 
A list of all bacterial strains and plasmids used in this study can be found in the appendix of 
this work. 
 
 
2.1.2 Growth media and facultative additives 
All buffers, solutions and media were prepared with deionized water and autoclaved (20 min 
at 121°C and 2 bar). Thermolabile substances were dissolved and sterilized by filtration. All 
solutions are prepared with water; other solvents are indicated if used. Final volumes are 
indicated. For solid media, 15 g l -1 agar was supplemented. 
 
Media used to grow Escherichia coli and Bacillus subtilis 
 
LB medium (1 l)   Tryptone    10 g    
(Bertani, 1951)    Yeast extract   5 g 
      NaCl     10 g 
 
5x C salts (1 l)    KH2PO4     20 g 
      K2HPO4 x 3 H2O  80 g 
      (NH4)2SO4    16.5 g 
 
III´salts (1 l)    MnSO4 x 3 H2O   0.232 g 
      MgSO4 x 7 H2O   12.3 g 
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10x MN medium (1 l)   K2HPO4 x 3 H2O  136 g 
      KH2PO4    60 g 
      Sodium citrate x 2 H2O  10 g 
 
1x C minimal medium  5x C salts    20 ml 
(100 ml)     Tryptophan (5 mg ml-1) 1 ml 
      Ammonium iron citrate 1 ml 
      (2.2 mg ml-1)     
      III´ salts    1 ml 
 
1x CS medium with glucose 5x C salts    20 ml 
(100 ml)     Tryptophan (5 mg ml-1) 1 ml 
      Ammonium iron citrate 1 ml 
      (2.2 mg ml-1)     
      III´ salts    1 ml 
      Sodium succinate (30%) 2 ml 
      Glucose (20%)   2.5 ml 
 
SP medium (1 l)    Nutrient Broth   0.8 g 
      MgSO4 x 7 H20   0.25 g 
      KCl     1 g 
      H20     ad 1 l 
      (autoclave, after cooling addition of:) 
      CaCl2 (0.5 M)   1 ml 
      MnCl2 (10 mM)   1 ml 
      Ammonium iron citrate  2 ml 
      (2.2 mg ml-1) 
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MNGE medium (10 ml)  1x MN medium   8.77 ml 
      Glucose (20%)   1 ml 
      Potassium glutamate (40%) 50 µl 
      Ammonium iron citrate  50 µl 
      (2.2 mg ml-1) 
      Tryptophan (5 mg ml-1) 100 µl 
      MgSO4 x 7 H2O (1 M)  30 µl 
      +/- CAA (10%)   100 µl 
 
Starch agar plates (1 l)  Nutrient broth   7.5 g 
      Starch    5 g 
      Agar     15 g 
 
Media used to grow of Mycoplasma pneumoniae 
 
MP medium (500 ml)   PPLO broth   7.35 g 
Modified Hayflick medium  HEPES    11.92 g 
(Chanock et al., 1962)   Phenol red (0.5%)  2 ml 
      Sodium hydroxide (2 N) 14 ml 
(addition of water, adjust pH to 7.6 – 7.8 and autoclave;  
after cooling add the following:) 
Horse serum   100 ml  
(heat inactivated) 
Penicillin (100 000 U ml-1) 5 ml 
Glucose or glycerol (50%) 10 ml 
 
The medium later referred to as ´Hayflick light´, is based on the same composition as 
described above, but lacks phenol red and horse serum to reduce signal background in LC/MS 
experiments. To get the same volume, water was used instead. 
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Defined medium    Reagent   Final concentration 
MM14   Basal solution Na2HPO4    2 mM 
(Yus et al., 2009)    NaCl     100 mM 
       KCl     5 mM 
       MgSO4    0.5 mM 
       CaCl2    0.2 mM 
 
    Carbon sources Glucose    10 g l-1 
       Glycerol    0.5 g l-1 
        
    Vitamins  Spermine    0.1 mM 
       Nicotinic acid   1 mg l-1  
       Thiamin    1 mg l-1  
       Pyridoxamine   1 mg l-1  
       Thioctic acid (lipoamide) 0.2 mg l-1  
       Riboflavin    1 mg l-1  
       Choline    1 mg l-1   
       Folic acid    1 mg l-1  
       Coenzyme A   1 mg l-1  
        
    Bases  Guanine/Cytidine/Adenine 20 mg l-1  
        
    Lipids  Cholesterol   20 mg l-1  
       Palmitic acid   10 mg l-1  
       Oleic acid    12 mg l-1  
       BSA (fatty acid free)  2 g l-1  
        
    Amino acids Cysteine    2 mM 
       Peptone    2.5 g l-1  
        
    Others  HEPES    50 mM 
       Phenol red     2 mg l-1  
       Penicillin    1000 U ml-1  
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The medium was prepared by mixing concentrated stock solutions of the different compounds 
(indicated below). Stocks were stored at -20°C until used. Except for the lipids that were 
solved in ethanol, all stock solutions were prepared with deionized water. Lipids were mixed 
with BSA as a carrier when added. After mixing the compounds, the pH was adjusted to 7.7 – 
7.8, the medium was sterilized by filtration and stored at 4°C. 
 
Compound   Concentration 
Basal      5x 
MgSO4    2000x 
CaCl2    4000x 
Peptone 5%   20x 
Cysteine 100 mM  50x 
Glucose 50%   50x 
Glycerol 5%   100x 
Cytidine/Guanine/Adenine 100x 
Vitamins    100x 
Coenzyme A   1000x 
Lipids (serum substitute) 5x 
HEPES 1M   20x  
 
Medium used for human cell cultures (HeLa and A549 cells) 
 
DMEM     GIBCO DMEM    90 ml 
(Dulbecco's modified Eagle's  (high glucose, with 
medium, Dulbecco and Freeman,  pyruvate) 
1959)     Fetal calf serum   10 ml 
      L-glutamine (1 mM)  200 µl  
      Penicillin (100 000 U ml-1) 500 µl 
       
Antibiotics 
All antibiotics were prepared as 1000x concentrated solutions. Except for erythromycin, 
which was solved in 70% ethanol, all antibiotics were solved in deionized water. The 
solutions were sterilized by filtration and stored at -20°C. When used, solutions were thawed 
on ice and added to the fresh, autoclaved medium after it was cooled down to about 50°C. For 
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the different organisms, the following final concentrations have been used. 
 
E. coli     Ampicillin    100 µg ml-1 
      Kanamycin   50 µg ml-1 
 
B. subtilis     Chloramphenicol  5 µg ml-1 
      Kanamycin   5 µg ml-1 
      Erythromycin*   2 µg ml-1 
      Lincomycin*   25 µg ml-1 
      Spectinomycin   100 µg ml-1 
 
*for selection for ermC, a mixture of erythromycin and 
lincomycin was used in their respective concentration, see 
above. 
 
M. pneumoniae    Gentamycin (liquid media) 80 µg ml-1 
      Gentamycin (solid medium) 160 µg ml-1 
Penicillin    1000 U ml-1 
 
X-Gal (5-Brom-4-chlor-3-indoxyl-β-D-galactopyranosid) 
A stock solution of 40 mg ml-1 was prepared; the final concentration in solid media             
was 40 µg ml-1. DMF (dimethylformamide) was used as solvent, and the solution was stored 
in darkness at -20°C. 
 
 
2.1.3 Cultivation techniques 
 
Cultivation and storage of E. coli 
Unless otherwise stated, E. coli was grown in LB medium at 37°C and 200 rpm in glass tubes 
or flasks. Cultures were inoculated with single colonies on fresh agar plates or from overnight 
cultures. Growth was monitored by OD measurement at λ = 600 nm. 
E. coli was stored on LB agar plates at 4°C for up to 4 weeks. For long-term storage, aliquots 
of fresh cultures were mixed with glycerol or DMSO to a final concentration of 15% and 
10%, respectively, chilled on ice and than frozen and stored at -80°C. 
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Cultivation and storage of B. subtilis 
B. subtilis was grown in LB medium, CS glucose medium or MNGE medium at 37°C and 
200 rpm in glass tubes or flasks. Cultures were inoculated with single colonies on fresh agar 
plates, with spores from SP agar plates or from overnight cultures. Growth was monitored by 
OD measurement at λ = 600 nm. For faster growth on solid medium, the agar plates were 
incubated at 42°C. 
B. subtilis was stored on LB medium at room temperature not longer than 3 days. For long-
term storage, B. subtilis was grown on SP agar plates and stored at room temperature, or 
frozen stock cultures with glycerol were prepared as described for E. coli. 
 
Cultivation and storage of M. pneumoniae 
Unless stated otherwise, M. pneumoniae was grown at 37°C in modified Hayflick medium for 
96 h in culture flasks. Culture flasks with 12.5, 75, 150 and 300 cm2 surface with 10, 50, 100 
and 200 ml modified Hayflick medium were used. Cultures were inoculated with 1 ml stock 
culture per 100 ml medium. 
For long-term storage of M. pneumoniae, the supernatant of a fresh culture was discarded 
after 96h and cells were scraped in 20 ml fresh modified Hayflick medium. Aliquots of 10 ml 
were frozen and stored at -80°C. 
 
Cultivation and storage of human cell lines (HeLa, A549) 
Human cell lines were grown in DMEM medium at 37°C and 5% CO2 in culture flasks. After 
4 days of growth the medium of a confluent culture was discarded, cells washed twice with 
PBS and incubated with 500 µl trypsin/EDTA at 37°C for up to 5 minutes. When all cells 
were detached, the trypsin treatment was stopped by the addition of 15 ml fresh DMEM. The 
cell suspension was transferred into a sterile falcon tube and cells were pelleted by 
centrifugation  (1000 rpm, 10°C, 5 minutes). The supernatant was discarded, and the pellet 
was diluted in 10 ml fresh DMEM. Viability was controlled by microscopy and life/death 
staining using trypan blue. 200 µl of the suspension were used for the inoculation of a 25 cm2 
culture flask containing 25 ml DMEM.  
Cell lines were grown for a maximum of 10 passages and then fresh cells from frozen stocks 
were used to start new cultures. 
Cell density was determined by using a Neubauer chamber (0.1 mm depth, 0.0025 mm 
surface). 10 µl cell suspension were gently mixed with 10 µl trypan blue and incubated for 3 
min. 10 µl of the stained cells were transferred into the space between the cover slip and the 
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Neubauer chamber. Living cells within 4 big squares (consisting of 16 smaller squares each) 
were counted. The number of cells per ml was calculated by the multiplication of the average 
number of cells per big square by the dilution factor 2 and the volume factor 1 x104.  
 
€ 
Cells /ml = Σcells4 × 2 ×10
4  
 
 
2.2 Molecular biology and biochemical techniques 
 
2.2.1 General methods 
A summary of standard methods used during this study is given, together with its relevant 
publication, in table 2.1 below. 
 
Method Reference 
Absorption measurement Sambrook et al., 1989 
Ethidiumbromide staining of nucleic acids Sambrook et al., 1989 
Precipitation of nucleic acids Sambrook et al., 1989 
Gel electrophoresis of DNA Sambrook et al., 1989 
Ligation of DNA fragments Sambrook et al., 1989 
Determination of Protein concentration Bradford, 1976 
Denaturating gel electrophoresis of proteins Laemmli, 1970 
DNA Sequencing by Sanger et al. Sanger et al., 1977  
 
Tab. 2.1: Standard methods used in this work and their corresponding Publication 
 
 
2.2.2 Genetic manipulation of E. coli, B. subtilis and M. pneumoniae  
  
Preparation of competent of E. coli 
Two different methods were used to prepare competent E. coli cells: 
 
I. Method: MnCl2 
4 ml LB medium were inoculated with a single colony of E. coli and incubated at 37°C and 
200 rpm overnight. This preculture was used to inoculate 250 ml SOB medium. The culture 
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was grown for up to 24 h at 18°C and 200 rpm until an OD600 of 0.5 to 0.9 was reached. The 
culture was chilled on ice for 10 min and then centrifuged (10 min, 5000 U min-1, 4°C). The 
supernatant was discarded and the pellet dissolved in 80 ml ice-cold TB buffer and again 
incubated on ice for 10 min.  Cells were sedimented by centrifugation  (10 min, 5000 U min-1, 
4°C) and the pellet suspended in 18.6 ml ice-cold TB buffer. Quickly, 1.4 ml of DMSO was 
added. Aliquots of 200 µl were transferred into sterile Eppendorf cups, frozen in liquid 
nitrogen and stored at -80°C until used. 
 
SOB medium (1 l)   Trypton   20 g 
     Yeast extract   5 g 
     NaCl    0.584 g 
     KCl    0.188 g 
     (add 980 ml water, autoclave, then add ) 
     MgCl2 (1 M)   10 ml 
     MgSO4 (1 M)   10 ml 
 
TB buffer (500 ml)   PIPES    1.51 g 
     CaCl2 x H2O   1.1 g 
     KCl    9.32 g 
     (add 472 ml water, autoclave, then add ) 
     MnCl2 (1 M)   28 ml 
     pH 6.7 
 
II. Method: RbCl2 
500 ml of LB medium were inoculated with 4 ml preculture (prepared as described in method 
I). The culture was grown at 37°C and 200 rpm for 4 hours in a baffled flask. Shaking in ice 
water chilled the culture and cells were then sedimented by centrifugation (10 min, 5000 U 
min-1, 4°C). The pellet was suspended in 20 ml ice-cold TfbI. Cells were centrifuged (10 min, 
5000 U min-1, 4°C) , the supernatant discarded and the pellet suspended in 4 ml ice-cold 
TfbII. Aliquots of 200 µl were frozen in liquid nitrogen and stored at -80°C until used. 
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Buffer TfbI (100 ml)  Potassium acetate  0.29 g 
    MnCl2    0.99 g 
    RbCl2    1.21 g 
    CaCl2    0.147 g 
    Glycerol   30 ml 
    pH 5.8 
 
Buffer TfbII (100 ml) MOPS    0.21 g 
    CaCl2    1.1 g 
    RbCl2    0.121 g 
    Glycerol   30 ml 
    pH 6.8 
  
Transformation of competent E. coli 
For the transformation of competent E. coli, the aliquots were gently thawed on ice. Cells 
were mixed with 1 µl of a 1/10 dilution of a high-copy plasmid preparation, 5 µl of a low-
copy plasmid preparation or 10 µl of a plasmid ligation sample and incubated on ice for 20 
min. Then, the samples were incubated at 42°C for 2 min, chilled on ice for 5 min and mixed 
with 800 µl LB medium. After growth at 37°C and 200 rpm for 1 h, 100 µl of the samples 
were streaked on LB selection plates and the rest sedimented by centrifugation. The 
supernatant was discarded, the pellet suspended in 100 µl LB and plated on a separate LB 
selection plate. The plates were incubated overnight at 37°C. Every time this experiment was 
performed, a negative control without added DNA was performed in parallel. 
 
Preparation of competent B. subtilis 
An overnight culture was used to inoculate 10 ml MNGE medium containing 1% casamino 
acids (CAA) to an OD600 of 0.1 and incubated at 37°C and 200 rpm. Growth was monitored 
by following the OD600. When an OD600 of 1.3 was reached, 10 ml MNGE medium without 
CAA were added to dilute the culture. After another incubation at 37°C and 300 rpm for 1 h, 
the cells were centrifuged (5000 rpm, 5 min at room temperature), the supernatant transferred 
into a sterile tube and the pellet suspended in 2.5 ml of the supernatant. Cells could directly be 
used for transformation (400 µl aliquots per transformation sample) or were mixed with 
glycerol to a final concentration of 10%, frozen in liquid nitrogen and stored at -80°C for later 
use. 
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Transformation of competent B. subtilis 
Aliquots of frozen competent B. subtilis cells were thawed at 37°C and supplemented with 
100 µl of the following solution: 
  
 MN (1x)   1.7 ml 
 Glucose (20%)  43 µl 
 MgSO4 (1 M)   34 µl 
 
About 5 µg of plasmid DNA or a whole LFH-PCR sample was added to the cells and the 
sample was incubated at 37°C and 200 rpm for 30 min. Meanwhile, a nutrient rich expression 
solution was prepared: 
 
Expression solution  Yeast extract (5%)  50 µl 
(105 µl)   CAA (10 %)   25 µl 
 Tryptophan (5 mg ml-1) 5 µl 
    Water    25 µl 
 
The transformation sample was supplemented with the expression solution and incubated for 
another hour at 37°C and 200 rpm. After that, the cells were spread on SP or LB plates 
containing the selective antibiotic. 
 
Targeted mutagenesis of B. subtilis 
Targeted knockout of genes in B. subtilis was achieved by homologous recombination. 
Competent B. subtilis cells were either transformed with chromosomal DNA containing the 
desired mutation to obtain isogenic strains, or with DNA fragments that contained a resistance 
cassette flanked by the neighbouring regions (+/- 1 kbp) of the targeted gene. Such fragments 
were generated by long-flanking homology PCR (LFH-PCR, see chapter 2.2.3 for a detailed 
protocol). 
 
Transformation of M. pneumoniae 
M. pneumoniae lacks the genomic background to develop competence. Therefore it can only 
be transformed by electroporation. Since no plasmid or protocol for homologous 
recombination is available for M. pneumoniae, genetic manipulation can only be done by the 
use of transposons. Resistance towards gentamycin was the only marker for M. pneumoniae 
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mutants used in this study. Since spontaneous resistance towards gentamycin occurs 
randomly, a negative control was always prepared together with the transformation sample to 
monitor the spontaneous mutation rate. 
A 100 ml culture of M. pneumoniae, sufficient for 3 to 4 transformations, was grown for 96 h 
at 37°C in Hayflick medium. The medium was discarded and adherent cells were washed 
twice with ice-cold electroporation buffer. Then, cells were scraped in 1.5 ml of 
electroporation buffer, sedimented by centrifugation (5 min, 10000 rpm, 4°C) and the pellet 
again suspended in 15 µl of electroporation buffer. 
50 µl of cells were transferred into an electroporation cuvette (0.2 cm space, pre-incubated on 
ice) and mixed with 8-10 µg DNA and 1 µl yeast tRNA (500 µg µl-1). The mixture was 
brought to a final volume of 80 µl with electroporation buffer and incubated on ice for         
15 min. After electroporation (2.5 kV, 25 µF, 100 Ω), the sample was incubated for another 
15 min on ice. The sample was mixed with 4 ml MP medium with glucose (but without 
gentamycin) and incubated at 37°C for 4 h.  
To get a mixed culture of random transposon insertion mutants, 1 ml of this sample was 
transferred to a culture flask (12.5 cm2), brought to final volume of 10 ml with Hayflick 
medium containing gentamycin and incubated at 37°C until a colour change from red to 
yellow was visible. 
To get single colonies, the cells were sedimented by centrifugation (5000 rpm, 5 min, room 
temperature), the pellet suspended in 1 ml Hayflick by using a syringe (∅ 0.1 mm) and a 
dilution series (1:10 steps) was prepared. 250 µl from dilutions 1-4 to 1-10 were plated on MP 
medium plates containing 160 µg ml-1 gentamycin, the plates dried for 30 min and incubated 
at 37°C and elevated humidity. After about 2 weeks, single colonies were visible and could be 
used to inoculate 1.5 ml Hayflick medium containing gentamycin. Cells were seeded in 
higher volumes as soon as a colour change from red to yellow was visible. 
 
Electroporation   HEPES   8 mM 
buffer (1 l)   Sucrose   272 mM  
    pH 7.4 
 
Targeted mutagenesis of M. pneumoniae: Haystack mutagenesis 
The only tool to manipulate M. pneumoniae are transposons, genetic elements that insert 
randomly but stably in the genome. To isolate mutants with a transposon insertion in the gene 
of interest (goi) from a mixture of random insertions, Haystack mutagenesis was used 
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(Halbedel et al., 2006). The principle of this method is that about 3000 single random 
transposon insertion clones are grouped to pools of 50 clones. To identify clones with a 
desired transposon insertion, these pools are screened by PCR where primer pairs specific for 
the gene and for the transposon are used (couples A/C and B/D in figure 2.1). Once a positive 
pool is identified it is sub-screened with the same primer couples to identify the individual 
positive clone. This method allows the isolation of desired mutants affected in non-essential 
genes with a probability of 99.999%. 
 
 
 
Figure 2.1: Principle of Haystack mutagenesis. 
Individual mutants harbouring a transposon (Tn) insertion within a gene of interest (goi) can be identified and 
isolated from a pool of several random transposon mutants by PCR using primer pairs specific for the gene (A 
and B) and for the transposon (C and D).  
 
Sequencing of the PCR products can then identify the exact insertion site. Identified clones 
are grown and further investigated by Southern blot analysis for single or multiple transposon 
insertions and to confirm gene disruption. 
 
 
2.2.3 Experiments with DNA 
For the work with DNA, only DNase-free solutions and materials were used. Unless 
mentioned otherwise, work was performed at room temperature, and DNA was solved in 
deionized water. Chromosomal DNA was stored at 4°C. Plasmids, oligonucleotides, PCR 
products and other fragmented DNA were stored at -20°C and thawed on ice when used. 
DNA concentrations were measured with a ND-1000 NanoDrop (Peqlab, Erlangen, 
Germany). 
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Isolation of chromosomal DNA from B. subtilis and M. pneumoniae 
Genomic DNA from B. subtilis and M. pneumoniae was isolated using the DNeasy Tissue Kit 
(Qiagen, Hilden, Germany).  
B. subtilis was grown overnight in LB medium at 37°C and 200 rpm. 1.5 ml of the culture 
was harvested by centrifugation (13.000 rpm, 2 min, room temperature), the pellet suspended 
in 180 µl lysis buffer and incubated at 37°C for 60 min. Further steps were performed 
according to the manufacturers instructions. 
M. pneumoniae was grown in Hayflick medium (100 ml, 150 cm2 flask) at 37°C for 96 h. The 
medium was discarded and adherent cells were washed twice with PBS. Cells were scraped in  
1 ml PBS, centrifuged (13.000 rpm, 5 min, room temperature) and suspended in 540 µl lysis 
buffer (for simplicity only; lysozyme is not required since M. pneumoniae doesn’t have a cell 
wall). 180 µl of the sample were directly used to isolate chromosomal DNA according to the 
manufacturers instructions, the rest was stored at -20°C for later use. 
 
Preparation of plasmid DNA from E. coli 
Plasmid DNA was isolated from E. coli by using the Mini Prep Kit (Macherey-Nagel, Düren, 
Germany). E. coli carrying the desired plasmid was grown overnight in 4 ml LB medium 
containing a selective antibiotic at 37°C and 200 rpm. Cells were harvested by centrifugation 
(13.000 rpm, 2 min at room temperature) and the pellet used to isolate the plasmid according 
to the manufacturers instructions or stored at -20°C for later use. 
 
DNA sequencing 
Sequencing was done based on the chain termination method (Sanger et al., 1977) with 
fluorescence labeled dideoxynucleotides. SeqLab (Göttingen, Germany) and the 
Laboratorium für Genomanalyse (G2L) of the Georg-August-University Göttingen performed 
the sequencing reactions. The sequences were analyzed with the LaserGene package 
(DNASTAR, Madison, Wisconsin, USA). 
 
Gel electrophoresis and ethidium bromide staining 
According to the expected size of the DNA fragments, 1% to 2% agarose gels in TAE buffer 
were used for analytical and preparative separation. To facilitate loading and to monitor 
migration of the samples in the gel, DNA samples were mixed with 5x DNA loading dye. 
Gels were run at 80-120 V until the xylencyanol color marker reached the lower third of the 
gel. After the run was finished, the gels were incubated in ethidium bromide solution for        
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5 min and then briefly rinsed with water. Visualisation and documentation was performed 
with a UV transilluminator 2000 (Bio-Rad, Munich, Germany) by exposing the gels to UV 
light (λ = 254 nm). The size of DNA fragments in the gel was estimated by comparison with 
λ DNA (digested with restriction enzymes EcoRI and HindIII) or with commercial DNA 
markers.  
If DNA fragments should be isolated from the gel, UV exposure was performed at                   
λ = 365 nm wavelength to prevent GC cross-linking. Desired bands were excised from the gel 
with a DNA-free scalpel and DNA was isolated with the QIAquick PCR purification kit 
(Qiagen, Hilden, Germany) according to the manufacturer´s instructions.  
 
Southern blot analysis 
Southern blots were used to validate single transposon insertions in the genome of                 
M. pneumoniae mutants. An RNA probe that targets the gentamycin resistence cassette 
introduced by the transposon was used. Chromosomal DNA from M. pneumoniae wild type 
served as a negative control. 
10 µg chromosomal DNA were digested overnight with restriction enzyme BglII, separated in 
a 1% agarose gel by electrophoresis and stained with ethidium bromide as described above.  
Transfer of DNA fragments from the gel onto a positively charged nylon membrane (Roche) 
was performed with a vacuum blot device (VavuGeneTM XI). 12 x 11 cm nylon membrane 
were moistened with deionized water, placed on the blotting device and covered with a plastic 
foil. The foil helps to establish the vacuum by sealing the surface not covered by the gel. The 
agarose gel was put onto the foil and a vacuum of 80 mbar was established.  10 ml of the 
following buffers were consecutively loaded onto the gel and incubated as indicated: 
 
1. Depurination buffer 15 min 
2. Denaturation buffer 20 min 
3. Neutralisation buffer 20 min 
4. 20x SSPE   5 h 
 
The remaining buffer was discarded before the next buffer was added. After transfer, the 
DNA was cross-linked to the nylon membrane with UV light (λ = 254 nm) and stored dry and 
clean until further usage.  
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The nylon membrane was incubated with 20 ml pre-hybridisation buffer at 68°C in a 
hybridisation oven for 60 min. Then the pre-hybridisation buffer was replaced with 
hybridisation buffer (5 µl DIG-labelled RNA probe solved in 15 ml hybridisation buffer) and 
incubated overnight at 68°C in the hybridisation oven. The next day, the hybridisation buffer 
was transferred into a falcon tube and stored at -20°C until further usage. The membrane was 
washed twice for 15 min with 50 ml buffer 1 and twice with 50 ml buffer 2, each at room 
temperature, to get rid of unbound RNA probes.  
 
Detection of DNA-RNA hybrids on the membrane followed directly after the hybridisation 
step. All steps were performed at room temperature and with gentle shaking. The membrane 
was incubated with buffer DIG-P1 for 5 min, then for 30 min with buffer DIG-P2. Then, anti-
DIG antibodies coupled with alkaline phosphatase dissolved in buffer DIG-P2 (1:10000) were 
added onto the membrane and incubated for 30 min. After this, the membrane was washed 
and equilibrated three times 5 min with buffer DIG-P3. For visualisation of DNA-RNA 
hybrids, the membrane was put between clear plastic foil and incubated with 5 µl CDP* 
(diluted in 1 ml buffer DIG-P3) for 5 min. CDP* is a substrate of the alkaline phosphatase 
coupled to the anti-DIG antibody, resulting in chemo-luminescence as a coproduct which can 
be visualized and quantified. Depending on the intensity of the chemo-luminescence, the 
membrane was exposed for 14 – 45 min in a Chemi-SmartTM 5000 luminescence system 
(PEQLAB, Erlangen, Germany).  
 
PCR techniques: qPCR, PCR, LFH, and CCR 
Reactions were prepared in PCR µl reaction tubes tubes in a final volume of 50 µl. Personal 
Thermocyclers (Biometra, Germany) or Labyclers (SensoQuest, Göttingen, Germany) were 
used. PCR products were purified either by agarose gel extraction or directly by using the 
QIAquick PCR Purification Kit (Qiagen, Hilden, Germany). Reagents and PCR products were 
stored at -20°C and thawed on ice when used. 
 
Oligonucleotides 
Specific oligonucleotide primers (here referred to as primers) were designed to amplify DNA 
fragments of interest. Primers were purchased from Eurofins MWG Operon (Ebersberg, 
Germany) or from Sigma-Aldrich (Munich, Germany). Mutagenesis primers used for CCR 
(combined chain reaction) are 5´ phosphorylated. If the DNA fragment should be cloned into 
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a plasmid vector, recognition sequences for restriction enzymes were added via primers at 
both ends of the PCR product.  
The annealing temperature of a PCR reaction has to be 2-5°C lower than the melting 
temperature of the primers used. The melting temperature Tm of a primer depends on its 
length and G/C content and can be calculated with the given formula, where %G+C 
represents the GC content of the primer and n the number of nucleotides: 
 
€ 
Tm[°C] = 69.3 + 0.41 × (%G + C) − 650n  
 
All primers used in this work are listed in the appendix (chapter 9.2). 
 
qPCR (quantitative PCR) 
qPRC was used to validate enrichment of specific DNA fragments in SPICE experiments (see 
chapter 2.5). All primers used for qPCR have a melting temperature of 60°C and were 
designed to amplify a DNA fragment of 150 bp size. qPCR was performed in an iCycler 
(Biorad) by using the iScript™ One-Step Kit with SYBR® Green (Biorad) according to the 
manufacturers instructions except for the following modifications: Since DNA was used as a 
template, no reverse transcriptase was added to the reaction and the reverse transcription step 
was skipped in the PCR program. Instead, the program started with the Taq activation step (5 
min, 95°C). 5 ng and 10 ng of fragmented, co-purified DNA were used as template in the 
reactions.  
 
Polymerase chain reaction (PCR) 
Different enzymes were used for various applications: for check PCR to identify positive 
clones carrying desired plasmids or screening for M. pneumoniae mutants, the thermo-stable 
DNA polymerase from Thermus aquaticus (Taq) was used. Taq polymerase synthesizes DNA 
with a speed of 100bp/sec at 72°C (Lawyer et al., 1993), does not possess proof-reading 
activity and is known to statistically create one mismatch per 9000 bp (Tindall and Kunkel, 
1988). Therefore, PhusionTM DNA Polymerase (Finnzymes, Espoo, Finland), an engineered 
DNA polymerase from Pyrococcus furiosus with enhanced proofreading activity, was used if 
the PCR product should be cloned in a plasmid vector.  
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PCR with Taq DNA polymerase (50 µl reaction) 
Template  10 ng plasmid DNA or 
100 – 200 ng chrom. DNA 
10x Taq reaction buffer  5 µl  
dNTPs 12.5 mM  2 µl  
Forward primer (20 pmol)  2.5 µl  
Reverse primer (20 pmol)  2.5 µl  
Taq DNA polymerase  1 µl  
Deionized H2O  Ad. 50 µl  
PCR standard program for Taq DNA polymerase  
Initial denaturation  95°C 5 min 
Denaturation  95°C 30 sec 
Annealing  As calculated 45 sec              30x 
Elongation  72°C 1 min/kb 
Final elongation  72°C 5 min 
Hold  15°C ∞ 
PCR with PhusionTM DNA polymerase (50 µl reaction) 
Template  10 ng plasmid DNA or 
100 – 200 ng chrom. DNA 
5x  PhusionTM  reaction buffer  10 µl  
PhusionTM dNTPs 10 mM  1 µl  
Forward primer (20 pmol)  2.5 µl  
Reverse primer (20 pmol)  2.5 µl  
PhusionTM  DNA polymerase  1 µl (1 U)  
Deionized H2O  Ad. 50 µl  
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Long flanking homology PCR (LFH-PCR) 
LFH-PCR (Wach, 1996) was used to synthesize DNA fragments for targeted gene knockout 
of fur in B. subtilis  (strain GP879, see appendix, chapter 9.5.2). For this purpose, 3 individual 
DNA fragments are required: first, a resistance cassette promoting resistance against 
chloramphenicol, erythromycin, kanamycin or spectinomycin was amplified from plasmids 
pDG646, pDG780, pDG1726 or pGEM-cat, respectively (Guerout-Fleury et al., 1995). 
Second, about 1000 bp DNA fragments of the 5´ and 3´ flanking regions (here referred to as 
upstream and downstream fragment) of the targeted gene were amplified with PhusionTM 
DNA polymerase. The 3´end of the upstream fragment as well as the 5´end of the downstream 
fragment were extended into the target gene in a way that all expression signals of 
neighbouring genes remain intact, thus preventing polar effects. These three DNA fragments 
were joined and amplified in another PCR with ExtenderTM DNA polymerase: 150 ng of the 
up- and downstream fragment, respectively, and 300 ng of the resistance cassette were mixed, 
denaturated and cooled down briefly to allow joining of the fragments. Joining was possible 
by complementary sequences of 25 bp that were attached to the single fragments by the 
respective primers. Thus, the 3` end of the upstream fragment was linked with the 5` end of 
the resistance cassette and the 3`end of the resistance with the 5`end of the downstream 
fragment. In a second step the annealed fragments were elongated to obtain joined PCR 
products consisting of all three DNA fragments. The fused DNA fragments were then 
amplified in a third step by using the forward primer of the upstream and the reverse primer 
of the downstream fragment. 
 
 
 
 
PCR standard program for PhusionTM DNA polymerase  
Initial denaturation  98°C 1 min 
Denaturation  98°C 10 sec 
Annealing  As calculated 30 sec              30x 
Elongation  72°C 20 sec/kb 
Final elongation  72°C 3 min 
Hold  15°C ∞ 
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Combined chain reaction (CCR) 
The combined chain reaction was used for site directed mutagenesis of M. pneumoniae 
promoters and UGA stop codons to allow recombinant expression of M. pneumoniae genes in 
Long flanking homology PCR (LFH-PCR) with ExtenderTM DNA polymerase  
10x ExtenderTM buffer  10 µl  
Upstream fragment  150 ng  
Downstream fragment  150 ng  
Resistance cassette  300 ng  
Deionized H2O  Ad. 87 µl  
After step 1 addition of dNTPs and ExtenderTM DNA polymerase: 
dNTPs 12.5 mM  4 µl  
ExtenderTM DNA polymerase  1 µl (2.5 U)  
After step 2 addition of primers: 
Forward primer upstream fragment (20 pmol)  4 µl  
Forward primer downstream fragment (20 pmol)  4 µl  
LFH-PCR standard program for ExtenderTM DNA polymerase 
Step 1 Initial denaturation 94°C 2 min 
 Annealing Stepwise to 15°C 5°C/min 
 Pause 15°C ∞ 
Add dNTPs and ExtenderTM DNA polymerase, then proceed:  
Step 2 Elongation 68°C 8 min 
 Denaturation 94°C 20 sec 
 Annealing As calculated 45 sec            10x 
 Elongation 68°C 8 min 
 Pause 15°C ∞ 
Add primers, then proceed:   
Step 3 Denaturation 94°C 20 sec 
 Annealing As calculated 45 sec            30x 
 Elongation 68°C 10 min 
 Hold  15°C ∞ 
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E. coli and B. subtilis. The principle is based on a PCR that contains an additional, third 
primer that inserts one or multiple point mutations during amplification. This mutagenic 
primer is characterized by its +10°C higher melting temperature Tm compared to the 
amplification primers and by its 5´ phosphorylation. The phosphorylation allows ligation to 
the 3´-OH group of the extended upstream primer by a thermo-stable DNA ligase. A high 
number of mismatching nucleotides in the mutagenesis primer decrease the efficiency of the 
reaction. Furthermore, these mismatches have to be located in the middle of the mutagenic 
primer. Therefore, if multiple mutations should be introduced during amplification, additional 
mutagenic primers are required. This allows up to seven point mutations in one step, a 
variation of the CCR named multiple mutation reaction (MMR) (Hames et al., 2005). The 
CCR reaction was perfomed with 2.5 U of AccuzymeTM DNA polymerase (Bioline, 
Luckenwalde, Germany) and Ampligase® (Epicentre, Madison, USA) in CCR buffer (20 mM 
Tris-HCl pH 8.5, 3 mM MgCl2, 50 mM KCl, 0.5 mM NAD+) and 0.4 mg/ml bovine serum 
albumin (BSA, New England BioLabs, Ipswich, USA) in a total volume of 50 µl. To reduce 
unspecific amplification, a plasmid containing the native gene was used as a template instead 
of chromosomal DNA. 
 
 
 
 
 
 
Combined chain reaction (CCR) with AccuzymeTM DNA polymerase (50 µl) 
Plasmid DNA  200 ng  
10 x CCR buffer  5 µl  
Forward primer (20 pmol)  2 µl  
Reverse primer (20 pmol)  2 µl  
Mutagenic primer (20 pmol)  4 µl  
dNTPs 12.5 mM  1 µl  
Bovine serum albumine (10 mg/ml) 2 µl   
Ampligase  3 µl (15 U)  
AccuzymeTM DNA polymerase  1 µl (2.5 U)  
Deionized H2O   Ad. 50 µl  
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Enzymatic digestion of DNA 
The digestion of DNA with endonucleases was performed with buffers as recommended by 
the manufacturer. Reaction buffers, concentration of enzymes and DNA as well as incubation 
temperatures were chosen according to the manufacturer’s instructions. The digestion was 
allowed to proceed for up to 2 h and was, if possible, followed by heat inactivation of the 
restriction endonucleases (20 min; 65°C or 80°C). The DNA was purified using the PCR 
Purification Kit (Qiagen, Hilden, Germany) following the manufacturer’s instructions. 
 
Dephosphorylation of 5´ends of DNA 
To avoid re-circularization of a previously digested DNA vector, the 5’ phosphate groups of 
the linearized vector were removed prior to the ligation reaction. The dephosphorylation of 
the 5`-prime end of DNA fragments was performed with the FastAP (alkaline phosphatase) 
(Fermentas, Lithuania) with buffers supplied by the manufacturer. Approximately 3-10 ng/µl 
DNA were mixed with 1 µl FastAP (1U/µl) and incubated at 37°C for 30 min. The FastAP 
was inactivated by incubation at 75°C for 10 min. 
 
Ligation of DNA 
DNA fragments were ligated using T4 DNA ligase (Fermentas, Lithuania) with buffers 
supplied by the manufacturer. The ligation reaction contained 20 - 200 ng of vector DNA and 
an excess of the DNA fragment (insert to vector molar ratio of 10:1 to 20:1). The reaction was 
started after addition of 5 U T4 DNA ligase in a final volume of 20 µl. The ligation occurred 
for 2 h at room temperature or overnight at 16°C. 
 
 
 
CCR standard program for AccuzymeTM DNA polymerase  
Initial denaturation  95°C 5 min 
Denaturation  95°C 30 sec 
Annealing  As calculated 30 sec              30x 
Elongation  65°C 3 min/kb 
Final elongation  65°C 5 min 
Hold  15°C ∞ 
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Buffers for experiments with DNA 
 
Lysis buffer (2.5 ml)  Lysozyme   50 mg 
    Tris-HCl pH 8.0 (1 M) 50 µl 
    EDTA pH 8.0 (0.5 M) 10 µl 
    Ad H2O 2.5 ml, make aliquots and store at -20°C. 
 
10x PBS (1 l)   KCl    2 g 
    KH2PO4   2 g 
    Na2HPO4 x2 H2O  14.24 g  
    NaCl    80 g 
    pH 7. 4 	  
50x TAE buffer (500 ml) Tris    242 g 
    Acetic acid (100%)  57.1 ml 
    EDTA pH 8.0 (0.5 M) 100 ml 
    Deionized H2O  ad 500 ml 
 
5x DNA loading dye  Glycerol   5 ml  
(10 ml)   TAE buffer (50x)  200 µl 
    Deionized H2O  4.5 ml 
    Bromphenol blue  0.01 g 
    Xylencyanol   0.01 g 	  
Depurination buffer  250 mM HCl 
(Southern blot) 
 
Denaturation buffer (1 l) NaCl    87.66 g  
(Southern blot)  NaOH    20 g 
 
Neutralisation buffer (1 l) Tris HCl    121.14 g 
(Southern blot)  NaCl    87.66 g 
    pH 7.5     
 
 
Materials and Methods 
	  
45	  
20x SSPE buffer (1 l) NaCl    175.3 g 
    NaH2PO4 xH2O  26.6 g 
    EDTA    7.4 g 
    pH 7.4   
 
20x SSC buffer (1 l)  Na3-Citrate x2 H2O  88 g 
    NaCl    175.3 g   
    pH 7.0  
Autoclaving required. 
 
Pre-hybridisation  Formamide   200 ml  
buffer (400 ml)   20x SSC   100 ml 
    N-Lauroylsarcosin (10%) 4 ml 
    Blocking reagent  8 g 
    SDS    28 g 
    Ad H2O 400 ml, solve at 60°C and store at -20°C.   
 
Buffer 1   2x SSC buffer with 0.1% SDS 
(Southern blot) 
 
Buffer 2   0.1x SSC buffer + 0.1% SDS 
(Southern blot) 
 
5x Buffer DIG-P1 (1 l) Maleic acid   58.04 g 
    NaCl    43.83 g  
    pH 7.5 
    
Buffer DIG-P2  Buffer DIG-P1 with 1% blocking reagent 
   
Buffer DIG-P3  (1 l)  Tris    12.1 g 
    NaCl    5.8 g 
    pH 9.5 
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2.2.4 Experiments with RNA 
All materials, buffers and consumables used to work with RNA were RNase free. Surfaces, 
pipettes and gloves were cleaned with 70% ethanol and 0.5% SDS prior to work. Unless 
mentioned otherwise, RNA was solved in RNase free water supplied from commercial 
systems or with DEPC treated water and stored at -80°C. RNA concentrations were measured 
with a ND-1000 NanoDrop (Peqlab, Erlangen, Germany). 
 
DEPC treated water 
Diethylpyrocarbonate (DEPC) is a chemical agent commonly used to inactivate RNases. 
DEPC is solved in water to a final concentration of 0.1%, stirred at room temperature for 
several hours and then autoclaved. RNases are inactivated by covalent modification of 
histidin residues, and unused DEPC resolves into ethanol, H2O and CO2 during autoclave 
treatment.  
 
RNA preparation 
RNA preparations for Slot blot and Northern blot analysis were prepared with the RNeasy 
Midi Kit (Qiagen, Hilden, Germany). M. pneumoniae cultures (150 cm2) were grown for 96 h 
at 37°C, adherent cells washed twice with PBS and lysed directly with 2 ml buffer RLT with 
1% β-mercaptoethanol from the kit. The lysate was stored at -80°C or used for RNA 
preparations according to the manufacturer´s instructions. 
 
If RNA was used for cDNA synthesis and microarray analysis, RNA preparation was 
performed with the RNeasy Plus Mini Kit (Qiagen, Hilden, Germany) as described before 
(Güell et al., 2009). M. pneumoniae cultures (150 cm2) were grown for 6 h, 24 h, 48 h, 72 h 
and 96 h, adherent cells washed twice with PBS and then lysed directly by the addition of 1.5 
ml buffer RLT plus β-mercaptoethanol. The lysate was stored at -20°C or used for RNA 
preparations according to the manufacturer´s instructions with the following modifications: 
two DNA Eliminator columns and two RNeasy spin columns per sample were used for 
cultures that had been grown for 6 h and 24 h. For samples that had been grown longer than 
24 h, four DNA Eliminator columns and 4 RNeasy spin columns per sample were used. RNA 
was eluted in 50 µl RNase free water per column. The collected sample was dried in a 
SpeedVac at room temperature, the RNA pellet dissolved in 20 µl RNase free H2O and stored 
at -80°C.  
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RNA gel electrophoresis 
RNA was separated by electrophoresis for quality control and for Northern blotting. 1 – 5 µg 
RNA (10 µl final volume) were mixed with 5 µl RNA loading buffer (with ethidium bromide) 
and denaturated at 65°C for 10 min. The sample was cooled on ice, briefly centrifuged and 
loaded on a 1.5% agarose gel containing 6% formaldehyde. The gel ran for 120 min at 100-
120 V in MOPS buffer. Visualisation and documentation were performed with a UV 
transilluminator 2000 (Bio-Rad, Munich, Germany) by exposing the gels to UV light (λ = 254 
nm). 
 
Bioanalyser 
The quality of RNA used for cDNA synthesis and microarray analysis was randomly 
controlled with a 2100 Bioanalyzer (Agilent).  
 
Slot blot /Northern blot analysis 
Slot blots are a variant of dot blots in which RNA is directly transferred onto a nylon 
membrane without separation by gel electrophoresis. In contrast to dot blots, RNA is 
transferred by vacuum through a small slot, thereby forcing it onto a small, defined space on 
the membrane. As for dot blots, a defined amount of whole RNA (10 µg) is diluted in 20x  
buffer and a dilution series in steps of 10-1 are prepared. These dilution series are blotted onto 
the membrane and can be analyzed like Northern blots. 
For Northern blotting, RNA was first separated by agarose gel electrophoresis and then 
transferred onto a nylon membrane as described for Southern blotting with the following 
changes: No depurination buffer was used, and incubation with denaturation buffer and 
neutralisation buffer was only done for 5 min. 20x SSC buffer was used for the transfer 
instead of 20x SSPE buffer 
Visualisation and analysis of Northern blots and Slot blots with DIG labelled RNA probes 
was performed as described for Southern blots. 
 
Microarray analysis 
Microarray analysis was performed as described before (Güell et al., 2009). Cultivation of 
strains, RNA preparation, cDNA synthesis and Cy5 labelling of cDNA as well as data 
evaluation were carried out at the CRG, Barcelona, Spain, with assistance of Eva Yus. 
Hybridisation, scanning of microarrays and data processing were performed by Sabine 
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Schmidt at the Genomics Core Facility, EMBL, Heidelberg, Germany. Marc Güell (CRG, 
Barcelona) helped with the data analysis. 
cDNA synthesis and Cy5 labelling were conducted with the SuperScriptTM Indirect cDNA 
Labeling System (Invitrogen), the S.N.A.P.TM Column Purification module (Invitrogen) and 
the Cy5TM Mono-Reactive Dye module (Amersham Biosciences) in accordance to the 
manufacturer´s instructions with the following modifications: 9 µg of total RNA were mixed 
with 0.84 µl random hexamer primers and water to a final volume of 18 µl. For annealing of 
hexamer primers to RNA the samples were incubated at 70°C for 5 min and then chilled on 
ice for at least one minute. A master mix was prepared consisting of 6 µl 5x First-Strand 
buffer, 1.5 µl DTT, 1.5 µl modified dNTP mix, 1 µl RNaseOUTTM (40 U/µl) and 2 µl 
SuperScriptTM III RT (400 U/µl) per sample. 12 µl of the master mix were added to each 
sample and mixed gently. Samples were incubated at 37°C for 3 – 4 h.  cDNA concentration 
was measured with a ND-1000 NanoDrop (Peqlab, Erlangen, Germany). 
Design and manufacture of the microarray as well as hybridisation conditions have been 
described before (Güell et al., 2009). All experiments were performed as one-channel 
experiments (one sample per microarray, no competitive hybridisation of two different 
labelled samples). 
Microarray data was processed with software R (www.r-project.org) and Excel (Microsoft). 
For statistical analysis, quantile normalization was done using the bioconductor package 
marray after background substraction (www.bioconductor.org). Differential expression 
analysis of array data was performed using R limma package. 
 
Synthesis of DIG labelled RNA probes by in vitro transcription 
Digoxygenin (DIG) labelled RNA probes were used to detect and quantify nucleic acids in 
Southern, Northern and slot blot experiments. The probes are in vitro transcribed anti-sense 
RNAs of 500 – 1000 bp length that consist of labelled nucleotides which can be recognized 
by specific antibodies.  
A DNA fragment of the intragenic region of the gene of interest was amplified by PhusionTM 
PCR. The fragment contained a T7 RNA polymerase promoter at the 5´end of the non-coding 
strand that was added by the reverse primer: 
 
5 ́-CTAATACGACTCACTATAGGGAGA-primer-3´ 
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The DNA fragment was purified with the QIAquick PCR Purification Kit (Qiagen) and used 
as a template for in vitro transcription by T7 RNA polymerase. The following reaction was 
prepared: 
 
 
T7 transcription buffer, T7 polymerase, DIG RNA labelling mix and RNase Inhibitor were 
purchased from Roche Diagnostics. The reaction was incubated at 37°C for up to 4 h and then 
stopped by the addition of 1 µl 0.5 M EDTA (pH 8.0). RNA was precipitated by the addition 
of 2.5 µl 4 M LiCl and 75 µl ice-cold ethanol and by overnight incubation at -80°C. RNA was 
sedimented by centrifugation (30 min, 13000 rpm and 4°C), the pellet washed with 70% ice-
cold ethanol and then dried at room temperature to remove traces of ethanol. The RNA was 
eluted in 100 µl DEPC treated water containing 1 µl RNase inhibitor (Roche Diagnostics) and 
stored at -80°C.  To control the quality of the RNA probe, dilution series (in steps of 10-1) 
were prepared, 1 µl of each dilution step spotted onto a nylon membrane and luminescence 
tested as described previously (see Southern Blots). 
 
Buffers for experiments with RNA 
 
RNA loading buffer  Formamide   6.5 ml 
(10 ml)   Formaldehyde   1.2 ml 
    10x MOPS buffer  2 ml 
    Sucrose (50%)  0.4 ml 
    Bromphenol blue  10 mg 
    Xylencyanol   10 mg 
 
 
 
 
In vitro synthesis of DIG labelled RNA probes (20 µl reaction) 
Template DNA  13 µl 
10x T7 transcription buffer  2 µl  
DIG RNA labelling mix  2 µl  
RNase Inhibitor  1 µl  
T7 RNA polymerase  2 µl  
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10x MOPS buffer  MOPS    41.8 g 
(1 l)    Sodium acetate  6.8 g 
    EDTA (0.5 M)  20 ml 
    H2O     ad 1000 ml 
    pH 7.4 
Do not autoclave. Store at 4°C in the dark. 	  
 
2.2.5 Experiments with proteins 
Unless mentioned otherwise, proteins were stored for short terms in aqueous solution at 4°C 
or for long terms in buffers containing 40% glycerol and DTT at -20°C. 
 
Overexpression of recombinant proteins in E. coli 
Overexpression from plasmids based on pWH844 was performed in E. coli DH5α, and 
overexpression from plasmids based on pGP172 (T7 RNA polymerase dependent expression) 
was performed in E. coli BL21. An overnight culture of E. coli, carrying the relevant plasmid, 
was used to inoculate one litre of LB medium to OD600 ~ 0.1. Cultures were grown with 
shaking at 16°C or 37°C until they had reached an optical density of 0.6 - 0.8. Expression of 
recombinant proteins was induced by the addition of isopropyl-β-D-thio-galactopyranoside 
(IPTG, final concentration: 1 mM) (PeqLab, Erlangen, Germany). The cultures were 
incubated for three more hours. To test the expression, small aliquots (sample [µl] = 
100/OD600) were taken before and after the induction. The samples were boiled in SDS 
loading dye and analyzed on a SDS gel. The main culture was harvested by centrifugation (10 
min; 8,000 rpm; 4°C). After removing the supernatant the cells were washed in cold cell 
disruption buffer and the pellets were stored at -20°C. 
 
Disruption of bacterial cells 
E. coli and B. subtilis cells were disrupted using a French press or a One shot device.            
M. pneumoniae was disrupted by sonication or using a One shot device. 
 
French press 
The prechilled bomb was filled with the cell suspension and the remaining air was squeezed 
out before the bomb was locked. After closing the release valve the bomb was placed in the 
French press and set under pressure. The disruption took place with a pressure of 1400 bar 
and was performed three times. 
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One Shot 
The cell disruption with the One Shot was in principle similar to the French press. Here, 6 ml 
of the cell suspension were pipetted into the precooled cylinder and closed airtight. Internal 
pressure was established using the starter stick. The disruption of the cells was carried out at 
maximum pressure (2,500 psi; 2 to 3 passages) 
 
Sonication 
Harvested cells were suspended in PBS buffer and placed on ice. Sonication was performed   
5 – 10 times 20 sec (60 W, 0.5 sec clearance). 
 
Protein purification 
Proteins were purified from crude extracts by affinity purification. Overexpressed proteins 
carry a His6 or STREP affinity tag that allows binding to and controlled elution from a 
relevant matrix.  
 
Purification of His6 tagged proteins 
The frozen pellets were resuspended in cold ZAP buffer (200 mM NaCl, 10 mM Tris-HCl pH 
7.5), and the cells were disrupted using the French pressure cell. Cell debris and other 
insoluble material were removed by ultracentrifugation (Beckmann, L7-55) (60 min; 27.000 
rpm; 4°C). For purification of recombinant His6-tagged proteins the supernatant fraction was 
loaded onto a 4 ml bed volume of Ni2+-NTA resin (Qiagen) in a Poly-Prep Chromatography 
Column (Biorad, Munich, Germany). The Ni2+-NTA resin had been pre-equilibrated with 10 
ml ZAP buffer. After extensive washing with 20 ml of ZAP buffer containing 10 mM 
imidazole (Roth, Karlsruhe, Germany) and 20 ml with 20 mM imidazole the His6-tagged 
proteins were eluted. The elution was performed in 10 ml steps with ZAP buffer containing an 
increasing concentration of imidazole (50 mM, 100 mM, 200 mM, and 500 mM). To analyze 
the purification success, 15 µl of each fraction was mixed with SDS loading dye and boiled at 
95°C for 10 minutes. The samples were loaded onto a SDS gel and after electrophoresis 
stained with Coomassie brilliant blue. The relevant fractions were combined and dialyzed 
overnight. Protein concentration was determined using the Bio-Rad dye-binding. 
 
Purification of STREP tagged proteins 
Overexpression and cell disruption were performed as described above. The proteins were 
purified using 1 ml Strep-Tactin Sepharose (IBA, Göttingen, Germany) loaded on a Poly-Prep 
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Chromatography Column (Biorad, Munich, Germany). The matrix specifically binds a 
sequence of eight amino acids (WSHPQFEK). D-desthiobiotin was used to elute the bound 
proteins. The matrix was equilibrated with 5 ml of buffer W. Afterwards the column was 
loaded with 10 ml of the crude extract. Washing steps were performed with 5 ml buffer W. 
The bound proteins were eluted with buffer E in 6 fractions of 500 µl. The fractions were 
analyzed by SDS-PAGE 
 
Dialysis of purified proteins 
Fractions containing eluted protein from Ni2+-NTA or STREP purifications contain high 
concentrations of imidazole or D-desthiobiotin, respectively, which both can interfere with 
further applications. To remove imidazole or D-desthiobiotin, elution samples were dialyzed 
in a dialysis tube (3.5 kDa exclusion size, boiled in 100 mM EDTA for 10 min) against 
protein storage buffer (in a ratio 1:2000) for 24 h at 10°C. 
 
Protein concentration measurements  
Protein concentration was determined either with the Bio-Rad dye-binding assay (Bio-Rad) or 
the BCA Protein assay (Pierce) using bovine serum albumin as the standard. 
 
Discontinuous SDS polyacrylamide gel electrophoresis (SDS-PAGE) 
SDS-PAGE was performed as described by Laemmli (1970). Protein samples were mixed 
with SDS loading dye and heated at 95°C for 10 min to denature before loading onto the gel. 
The polyacrylamide (PAA) concentration of the gels was chosen according to the expected 
proteins sizes, varying from 10 – 16% (v/v). Gels were run at 120 V in electrophoresis buffer 
at room temperature until the bromphenol blue had reached the lower end of the gel. Gels 
consist of two phases with different PAA concentrations: a thin, low concentrated stacking 
phase in which proteins are focussed, and a running gel of 10 – 16% PAA concentration in 
which proteins are separated during electrophoresis according to their molecular mass. Self-
constructed unstained protein marker (Page King) or pre-stained, purchased protein markers 
(Fermentas, Lithuania) were used as size standards. Gels were either used for Western 
blotting or analyzed by Coomassie or silver staining. 
 
Coomassie staining of polyacrylamide gels 
Coomassie staining was most commonly used to analyse protein gels. Gels were incubated in 
fixing solution for 5 – 10 minutes, stained with Coomassie solution for up to 15 minutes and 
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destained until the contrast between protein bands and background was optimal. For 
documentation, the gels were put in plastic wrap and scanned. 
 
Silver staining of polyacrylamide gels 
Silver staining of protein bands was performed as described by Nesterenko (1994). Silver 
staining is highly sensitive and has a detection limit of approximately 5 ng protein. In contrast 
to Coomassie staining it is more time consuming, less reproducible and not quantifiable, due 
to the physics of silver accumulation in the gel (Butcher and Tomkins, 1985). For staining, 
polyacrylamide gels were incubated in the following solutions at room temperature with 
shaking: 
 
 
 
 
 
 
 
 
 
 
 
 
 
Western blot analysis 
Western blots (Towbin et al., 1979) allowed the detection and quantification of STREP 
tagged proteins after SDS-PAGE by using an anti-GlpKMpn antibody (Hames et al., 2005). 
Proteins were transferred from the gel to a polyvinylidene difluoride (PVDF) membrane (Bio-
Rad) with a semi-dry blotting apparatus (Amersham). The PVDF membrane was activated in 
methanol and equilibrated in transfer buffer. A stack of following layers was prepared (from 
bottom to top): 2 layers Whatman paper soaked with transfer buffer, activated and 
equilibrated PVDF membrane, PAA gel (unstained), 2 layers of Whatman paper soaked with 
transfer buffer. The stack was loaded on the blotting apparatus and proteins were transferred 
for 1 h at 0.8 mA/cm2. Protein transfer to the membrane was controlled by staining of the 
membrane with 1 ml Ponceau S. The membrane was incubated in Blotto overnight at 10°C 
Step Reagent Duration 
Fixing Fixing solution 1 to 24 h 
Washing Ethanol 50% 3x 20 min 
Reduction Thiosulfate solution 90 sec 
Washing Deionized H2O 3x 20 sec 
Staining Impregnating solution 25 min 
Washing Deionized H2O 2x 20 sec 
Developing Developer Until sufficiently stained 
Washing Deionized H2O 5 sec 
Stopping Stop solution 5 min 
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while shaking to remove Ponceau S and to block unspecific binding sites on the membrane. 
Antibodies were diluted in Blotto and incubated with the membrane for 3 h at room 
temperature while shaking. The antibody was removed, the membrane washed three times 30 
min with Blotto and then incubated with a secondary antibody (anti-rabbit IgG coupled with 
alkaline phoshatase from Promega, diluted 1:100000) for 30 min at room temperature. Again, 
the membrane was washed 3 times 30 min in Blotto, shortly rinsed with water and then 
equilibrated 5 min in buffer DIG-P3 (see chapter 2.2.3, Southern blot). Proteins were detected 
and quantified by chemiluminescence using CDP* as a substrate for alkaline phosphatase as 
described for Southern blots.  
 
Protein identification by mass spectrometry 
Protein bands were excised from the gel with a scalpel and analysed by mass spectrometry. 
This was performed by Dörte Becher (University Greifswald, Germany) or by the Zentrum 
für Molekulare Medizin, Zentrale Bioanalytik (ZBA, University of Cologne, Germany). 
 
Buffers for experiments with proteins 
 
ZAP buffer   NaCl    200 mM 
    Tris-HCl pH7.5  50 mM 
 
Buffer W   Tris-HCl pH 8.0  100 mM 
    NaCl    150 mM 
    EDTA    1 mM 
  
Buffer E   Tris-HCl pH 8.0  100 mM 
    NaCl    150 mM 
    EDTA    1 mM 
    D-desthiobiotin  2.5 mM 	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Protein storage buffer Tris-HCl pH 7.9  20 mM 
    EDTA    0.1 mM 
    KCl    100 mM 
    Glycerol   50% 
    Tween 20   0.5% 
    Autoclave, then add before usage: 
    DTT    1 mM 	  
5x SDS loading dye  Tris-HCl pH 7.0 (1 M) 1.4 ml 
(10 ml)   Glycerol   3 ml 
    SDS (20%)   2 ml 
    β-mercaptoethanol  1.6 ml 
    Bromphenol blue  0.01 g 
    Deionized H2O  2 ml 
 
6% Stacking gel (v/v) Acrylamide-Bisacrylamide 740 µl    
(SDS-PAGE)   (39:1, 40%) 
    Tris-HCl pH 6.8 (1 M) 650 µl 
    SDS (20%)   50 µl 
    APS (10%)   200 µl 
    Deionized H2O  5.35 ml 
    TEMED   10 µl 
 
12% Running gel (v/v) Acrylamide-Bisacrylamide 4.6 ml    
(SDS-PAGE)   (39:1, 40%) 
    Tris-HCl pH 8.8 (1 M) 1.3 ml 
    SDS (20%)   200 µl 
    APS (10%)   200 µl 
    Deionized H2O  6.5 ml 
    TEMED   15 µl 
 
10x Electrophoresis buffer Glycine   1.92 M 
(SDS-PAGE)   Tris    0.5 M 
    SDS    10% 	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Fixing solution  Methanol   50% 
(Coomassie staining)  Acetic acid   10% 
    Deionized H2O  40% 
 
Staining solution  Coomassie Brilliant   2.5 g 
(Coomassie staining)  Blue R250 
    Methanol   50% 
    Acetic acid   10% 
    Deionized H2O  40% 
    (Can be used several times!) 
 
Destaining solution  Acetic acid   10% 
(Coomassie staining)  Deionized H2O  90%  	  
Fixing solution (100 ml) Methanol   50 ml 
(Silver staining)  Acetic acid   12 ml 
    Formaldehyde  (37%)  100 µl 
    Deionized H2O  Ad. 100 ml 
 
Thiosulfate solution  Na2S2O3 x5 H2O  20 mg 
(100 ml)   Deionized H2O  Ad. 100 ml 
 
Impregnating solution AgNO3   0.2 g 
(100 ml)    Formaldehyde (37%)  37 µl 
(Silver staining)  Deionized H2O  Ad. 100 ml 
 
Developer (100 ml)  Na2CO3    6 g  
(Silver staining)  Thiosulfate solution  2 ml 
    Formaldehyde (37%)  50 µl 
    Deionized H2O  Ad. 100 ml 
 
Stop solution (100 ml) EDTA    1.86 g 
(Silver staining)  Deionized H2O  Ad. 100 ml 	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Transfer buffer (5 l)  Tris    15.1 g 
(Western Blot)  Glycine   72.1 g 
    Methanol   750 ml 
    Deionized H2O  Ad. 5 l 
 
10x TBS (1 l)   Tris    60 g 
(Western Blot)  NaCl    90 g 
    Deionized H2O  Ad. 1 l 
    pH 7.6 
  
Blotto (1 l)   10x TBS   100 ml 
(Western Blot)  Skim milk powder  25 g 
    Tween 20   1 ml 
    Deionized H2O  Ad. 1 l 	  
 
2.3 Metabolite analysis by liquid chromatography-mass spectrometry (LC-MS) 
LC-MS was used to monitor (p)ppGpp synthesis and to analyse the metabolome of                
M. pneumoniae. The author performed cultivation of bacterial strains and sample preparation, 
LC-MS analysis and data processing were performed by Manuel Liebeke at the University of 
Greifswald as described before (Geiger et al., 2010).  
For the detection of (p)ppGpp, M. pneumoniae strains were grown in Hayflick medium at 
37°C. After 96 h growth, the medium was discarded and adherent cells were washed twice 
with PBS buffer pre-warmed to 37°C. Traces of buffer were removed and cells covered with 
25 ml pre-warmed „Hayflick light“ (modified Hayflick´s medium with 1% glucose and 1 % 
glycerol, but without horse serum and phenol red) with or without 1mg/ml (8,3 mM) DL-
serine hydroxamate (Sigma-Aldrich). After an incubation at 37°C for indicated time points, 
adherent cells were lysed with 10 ml ice cold 60% ethanol (HPLC grade, Sigma-Aldrich) and 
100 µl 1 mM 8-bromoadenosine 5′-triphosphate (Sigma-Aldrich) which served as an internal 
standard. The cell lysate was transferred into a 15 ml Falcon tube and stored in liquid nitrogen 
until all samples were collected. All samples were than thawed while centrifuged (5000 rpm, 
2°C), the supernatant transferred into a fresh 50 ml Falcon tube on ice and the remaining 
pellet supended in 10 ml HPLC water. Cell debris was pelleted again by centrifugation and 
the supernatant transferred into the 50 ml Falcon tube. This extraction step was repeated once. 
Samples were frozen in liquid nitrogen, stored at -80°C and shipped to Greifswald on dry ice. 
Materials and Methods 
	  
58	  
2.4 Bacterial adenylate cyclase based two-hybrid system (BACTH) 
The bacterial adenylate cylase based two-hybrid system (Karimova et al., 1998; distributed by 
Euromedex, France) was used to study protein-protein interactions in vivo in heterologous E. 
coli. It is based on the interaction-mediated reconstitution of catalytic activity of the adenylate 
cyclase  CyaA from Bordatella pertussis (Ladant and Ullmann, 1999).  The catalytic domain 
of CyaA consists of two complementary fragments (T25 and T18) that loose enzymatic 
activity when physically separated. Activity can be restored when the two fragments are fused 
to interacting proteins, resulting in interaction of T25 and T18, and hence, in cAMP synthesis. 
cAMP binds to E. coli catabolite activator protein (CAP), thereby activating its function as a 
pleiotropic transcription regulator and allowing transcription of the reporter genes, such as 
lacZ . Since heterodimerization of the proteins fused to T25 and T18 is a prerequisite for 
reconstitution of CyaA activity, β-galactosidase activity can be used as a qualitative indicator 
for protein-protein interactions (see figure 2.2 below).  
To detect protein-protein interactions, the T25 and T18 domains were either fused to the N- or 
the C-terminus of the target proteins. The plasmids used to construct these fusions can be 
found in the appendix (chapter 9.3.2) of this work. Genes of putatively interacting proteins 
were amplified by PCR and cloned into the vectors between restriction sites XbaI and KpnI, in 
frame to the respective sequence of the T25 or T18 domain. If necessary, opal codon UGA 
coding for tryptophane in M. pneumoniae but acting as a stop codon in E. coli was mutated by 
CCR (see chapter 2.2.3) to allow expression in E. coli. To prevent cytotoxic effects by the 
expression of fusion proteins and selection towards suppressor mutants, cloning was 
performed in E. coli XL1-Blue. This strain over-expresses the repressor lacI, thereby blocking 
transcription of fusion genes.  
Co-expression of fusion proteins was performed in E. coli BTH101 (Δcya). 5 ng of each   
pUT18/pUT18C and pKT25/p25-N derivative were mixed with 30 µl competent BTH101 
cells and incubated on ice for 30 min. After a heat shock (42°C, 2 min), the cells were mixed 
with 120 µl LB medium and incubated at 30°C for 2 h. 4 µl of the sample were plated on LB 
medium containing ampicillin, kanamycin and X-gal and incubated at 30°C. Pictures were 
taken after 24 h, 36 h and 48 h. Protein interactions could be identified by the blue colour of 
the colonies. 
   
 
 
 
Materials and Methods 
	  
59	  
 
 
Figure 2.2: The bacterial-2-hybrid system (BACTH) 
Physical contact of domains T25 and T18 is a prerequisite for enzymatic activity of CyaA (A, B).  Physical 
contact can be mediated by artificial fusions of domains T25 and T18 to interacting proteins X and Y, thereby 
restoring adenylate cyclase activity (C). cAMP is a required cofactor of transcription regulator CAP in E. coli. In 
the presence of cAMP, CAP binds to operators of the lacZ reporter gene, thereby inducing transcription (D, E).  
Hence, β-galactosidase activity directly correlates with the interaction of proteins X and Y. Figure taken and 
modified from the BACTH manual. 
 
 
2.5 Chromatin affinity purification (ChAP): SPICE 
Chromatin affinity precipitation (ChAP) is a variation of widely used chromatin 
immunoprecipitation (ChIP). In ChIP, DNA binding proteins are cross-linked to specifically 
bound DNA in vivo, and protein-DNA complexes then purified by immunoprecipitation using 
specific antibodies against the target protein. In ChAP, protein-DNA complexes are affinity 
purified by a protein tag like His6, TAP or STREP (Ishikawa et al., 2007). Cross-linked, co-
purified DNA can be recovered and analysed by qPCR, sequencing or microarray analysis 
(ChAP-chip). In this work, a modified ChAP protocol was developed as an attempt to identify 
the DNA binding-sites of putative transcription regulators in M. pneumoniae.  
First, plasmids to over-express putative transcription regulators with a C-terminal STREP tag 
in M. pneumoniae were constructed based on plasmid pMTclpB-TAP (Kühner et al., 2009).  
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M. pneumoniae was transformed with these plasmids, spread on Hayflick agar plates 
containing gentamycin and single colonies picked to grow homogeneous insertion strains. 
Expression of STREP-tagged proteins was controlled by Western blotting using anti-GlpKMpn 
antibodies that do also recognize STREP-tagged proteins (Hames et al., 2005).  For ChAP, 
two liters of culture (10 culture flasks of 300 cm2) were grown in Hayflick medium with 
glucose and gentamycin for 96 h. Cross-linking was either performed by covering adherent 
cells with 0.2% para-formaldehyde (solved in PBS, pH 6.5) for 10 min at 30°C after washing, 
or by the addition of 0.2%  (final concentration) para-formaldehyde to cells harvested in PBS 
and 10 min incubation at 30°C while shaking (90 rpm). Cross-linking was stopped by 
centrifugation of the cells and washing the pellet once with PBS. The pellets were stored at -
80°C until further used.  
The pellet was suspended in 15 ml buffer W (see chapter 2.2.5) and cells were disrupted using 
the OneShot manifold.  DNA was sheared by sonication and debris removed by centrifugation 
(8500 rpm, 4°C, 15 min). STREP-tagged proteins were purified with 500 µl Streptactin 
sepharose, purifcation controlled by SDS-PAGE and Western blotting and cross-linking 
reversed by overnight incubation of at 67°C. DNA was recovered from samples using the 
QIAquick PCR purification kit (Qiagen, Hilden, Germany), DNA concentration determined 
with a ND-1000 Nanodrop photospectometer (Peqlab), and analyzed by qPCR (see chapter 
2.2.3).   
 
 
2.6 Characterisation of M. pneumoniae mutants 
In this chapter, some experiments to characterise M. pneumoniae mutants are described. 
 
Growth curves 
Growth curves of M. pneumoniae strains were performed by measuring the wet weight of 
cultures as described previously (Halbedel et al., 2004). At indicated time points, the medium 
was discarded, cells harvested in 1.5 ml PBS and transferred to an Eppendorf cup. Cells were 
sedimented by centrifugation (5 min, 13000 rpm), all liquid removed with a pipette and the 
weight determined with a balance. The wet weight is calculated by subtracting the weight of 
the empty Eppendorf tube from the weight of the Eppendorf tube with M. pneumoniae cells. 
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HeLa/A549 cytotoxicity assay 
HeLa and A549 cell cytotoxicity assays were performed as described previously (Hames et 
al., 2009). HeLa and A549 cell lines were grown in 24-well plates at 2.5 x104 cells per well in 
700 µl Dulbecco modified Eagle medium (DMEM) for 24 h at 37°C with 5% CO2. M. 
pneumoniae cultures were grown for 96 h at 37°C. M. pneumoniae cells were washed three 
times with 67.6 mM HEPES (pH 7.3), 140 mM NaCl, and 7 mM MgCl2. The cells were 
scraped with 1 ml buffer and resuspended with a 0.4 by 20-mm syringe. Depending on the 
size of the pellet, it was resuspended in 5 to 8 ml buffer. HeLa/A549 cells were infected with 
an MOI (multiplicity of infection) of 1 x106: 0.1 A550 units were taken from the suspension 
and centrifuged for 5 min at 10000 rpm at 4°C. The pellet was resuspended in 125 µl of 
modified Hayflick medium with a 0.4x20 mm needle. The cells were then pipetted onto the 
lawn of HeLa or A549 cells and incubated for 2 h at 37°C and 5% CO2. Then the supernatant 
was removed and replaced by 700 µl fresh Dulbecco modified Eagle medium. 
Cell cultures were monitored for 120 h. To investigate the cytotoxicity of M. pneumoniae 
strains towards HeLa/A549 cells, the medium was removed from one micro titre plate well at 
each time point. The cells were incubated with 100 µl methyl violet solution (0.75% methyl 
violet, 0.25% NaCl, 1.75% formaldehyde and 50% ethanol) for 10 min at room temperature. 
After this, cells were washed twice with 600 µl of water, dried and pictures were taken. 
Cytotoxicity was judged by HeLa/A549 cell lysis in samples infected with M. pneumoniae. 
 
Determination of in vivo hydrogen peroxide production 
The hydrogen peroxide production by M. pneumoniae was determined as described 
previously (Hames et al., 2009) The Merckoquant peroxide test (Merck, Darmstadt, 
Germany), which has a detection range of 0.5 to 25 µg of hydrogen peroxide per ml of 
solution, was used. The supernatant of a 100 ml culture was discarded, and the cells were 
washed twice with a buffer containing 67.6 mM HEPES (pH 7.3), 140 mM NaCl, and 7 mM 
MgCl2. The cells were scraped with 1.5 ml buffer, transferred into a fresh tube, and 
centrifuged (10 min, 10000 rpm, 4°C). The pellet was washed with 1 ml and finally 
resuspended in 4 ml of the same buffer. Aliquots of 1 ml were adjusted to an A550 of 1.0. 
After incubation for 1 h at 37°C, glycerol or glucose (final concentration, 100!mM) was 
added to one aliquot. An aliquot without any added carbon source served as the control. The 
test strips were dipped into the suspensions for 1 sec and subsequently read. 
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Scanning electron microscopy 
Maria Lluch-Senar performed scanning electron microscopy experiments of M. pneumoniae 
strains at the Universitat Autònoma de Barcelona (Spain). 
After growing to mid-log phase in 5 ml of  Hayflick medium, cells were scraped off and 
passed ten times through a syringe (0.2 mm diameter). Then, 20 µl of this cell suspension 
were inoculated to 2 ml of modified Hayflick medium containing glucose in a Lab-Tek 
chamber slide (Nunc). After growing cells to mid-log phase, the medium was removed and 
the cells were washed three times with PBS and fixed with 1% glutaraldehyde for 1h. 
Samples were washed three times with PBS and then dehydrated sequentially with 30, 50, 70, 
90 and 100% ethanol for 10 min each. Samples were point dried immediately (K850 critical 
point drier; Emitech Ashfort, United Kingdom) and subsequently coated with 20 nm of gold. 
Samples were observed using a Hitachi S-570 (Tokyo, Japan) scanning electron microscope. 
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3. Results 
 
3.1 Transposon insertions in genes putatively involved in transcription regulation 
The most important tools to characterize the function of genes in vivo are genetic knockouts. 
Former studies aimed to characterize essential genes in M. pneumoniae and its relative,         
M. genitalium by random transposon mutagenesis (Hutchison et al., 1999; Glass et al., 2006). 
However, these studies were shown to comprise errors due to the experimental approach that 
did not successfully differentiate between viable and non-viable transposon insertions. For 
example, the ldh gene coding for lactate dehydrogenase was found to be essential in 
Hutchison et al., 1999, whereas a viable ldh mutant was isolated in later works (Halbedel et 
al., 2007). On the other hand, a transposon insertion in open reading frame Mpn352 coding 
for the only sigma factor sigA was found in Hutchison et al., 1999. This observation is rather 
unlikely since this protein is essential to initiate transcription and could not be confirmed by 
this work. Therefore, to date, screening of the transposon library described previously 
(Halbedel et al., 2006) is the most reliable method to determine essentiality of genes and the 
only method to isolate desired transposon insertion mutants of target genes in M. pneumoniae. 
 
 
3.1.1 Screening for M. pneumoniae transposon insertion mutants 
The M. pneumoniae transposon library was screened for transposon insertions in genes 
putatively involved in transcription and transcription regulation as described previously 
(Halbedel et al., 2006). With the exception of Mpn397/RelA and Mpn241/WhiA, all tested 
genes were found to be essential in this study. Mpn244/DisA, Mpn273/Hit and Mpn329/Fur 
were reported to be not essential in previous studies but could not be isolated from the 
transposon library. Therefore, they are thought to be essential for viability. As expected, no 
disruption mutant of Mpn352/SigA could be isolated. In addition, the essentiality of 
Mpn266/Spx and Mpn626/SigD-like could be confirmed.  
An overview about the essentiality of genes presumably involved in transcription or 
transcription regulation is given in table 3.1. The essentiality of the transcription regulators 
Mpn239/GntR and Mpn124/HrcA has been shown before (S. Halbedel, personal 
communication), and mutants Mpn223/HPrK and Mpn247/PrpC have been isolated and 
described previously (Halbedel et al., 2006). The primers used in this study to screen for 
transposon insertion mutants can be found in the appendix (chapter 7.2.2) of this work.  
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Orf/ 
Description 
Screening 
primer 
Essential in 
previous 
studies 
Essential in this 
study/strain 
designation 
Author 
mpn266/spx-like HE272/HE273 Yes Yes This work 
mpn241/whiA 
family 
HE324/HE325 No# No/GPM22 This work 
mpn244/disA 
family 
HE326/HE327 No# Yes This work 
mpn273/hit-like HE328/HE329 No# Yes This work 
mpn329/fur family HE181/HE182 No# Yes This work 
mpn352/sigA HE238/HE239 No# Yes This work 
mpn397/relA HE285/HE286 No# No/GPM21 This work 
mpn626/sigD-like HE179/HE180 Yes Yes This work 
mpn124/hrcA SH91/SH92 Yes Yes S. Halbedel, 
2006 
mpn239/gntR 
family 
SH87/SH88 Yes Yes S. Halbedel, 
2006 
mpn223/hprK KS9/KS10 No# No/GPM51 Halbedel et 
al., 2006 
mpn247/prpC SH67/SH29 Yes No/GPM68 Halbedel et 
al., 2006 
 
Tab. 3.1: Essentiality of genes in M. pneumoniae putatively involved in transcription regulation.  
#, not essential in either Hutchison et al., 1999 or Glass et al., 2006. The primers used to screen for these 
mutants are either found in the appendix of this work or of the corresponding publications. 
    
 
3.1.2 Verification of M. pneumoniae transposon insertion mutants 
M. pneumoniae strains with putative transposon insertions in mpn241/whiA and mpn397/relA 
were  isolated from the transposon library and further analyzed to determine the transposon 
insertion site and the number of transposon insertions. Genes were regarded to be inactivated 
if the transposon insertion fulfilled the Glass criteria established previously (Glass et al., 
2006). 
 
 
Results 65	  
mpn397/relA 
Three M. pneumoniae strains with transposon insertions in mpn397/relA were isolated from 
the library. The PCR fragments obtained from these strains using primer pairs HE285/SH30 
and HE286/SH29 were sequenced and aligned with the MPN397/RelA DNA sequence to 
identify the transposon insertion sites. All three transposon insertions met the Glass criteria. 
Two strains, namely F7.2-2 and F5.29-1, have transposon insertions between bases 546/547 
and 769/770 in respect to the first base of the gene, respectively. Clone A7.31-2 harbours a 
transposon insertion between bases 904/905, thereby disrupting the gene within the region 
coding for the putative (p)ppGpp synthesis domain described previously (Sajish et al., 2007). 
Therefore, this clone was chosen for further studies and it was renamed GPM21. 
 
 
 
Fig. 3.1: Isolation of mpn397 transposon insertion mutants.  
A: Schematic overview of the screen and orientation of the transposon insertion; B: Schematic overview of the 
three different transposon insertions in clones F7.2-2 (1*), F5.29-1 (2*) and A7.31-2 (3*) in respect to the 
sequences coding for the conserved (p)ppGpp hydrolysis (HD) and (p)ppGpp synthesis (spoT) domains (Aravind 
and Koonin, 1998; Sajish et al., 2007). F7.2-2 (1*), F5.29-1 (2*) and A7.31-2 (3*) harbour transposon insertions 
after bases  546, 769 and 904 in respect to the first nucleotide of the gene, respectively.   
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Strain GPM21 was grown for 5 passages and then tested for contamination with strains 
carrying the mpn397/relA wild type allele by PCR, using the same primer pairs used for the 
primary isolation. Chromosomal DNA from the wild type served as a negative control. As can 
be seen in Fig. 3.2 (A), strain GPM21 is homogeneous. To verify that only one single 
transposon insertion is present in the genome of GPM21, chromosomal DNA was digested 
with BglII and analyzed by Southern blot using a probe against the aac-ahpD gentamycin 
resistance cassette present on the transposon. BglII cuts several hundred times in the genome 
of M. pneumoniae and once in the transposon, thereby ensuring that the gentamycin resistance 
cassette is always located at the end of one of the resulting fragments. Wild type 
chromosomal DNA served as a negative control, the transposon delivery vector pMT85 as a 
positive control. As can be seen in Fig. 3.2 (B), a single band is visible for strain GPM21, 
confirming a single transposon insertion in the genome of this strain. 
 
 
Fig. 3.2: Verification of strain GPM21 
A: Test PCR to verify homogeneity of strain GPM21; B: Southern blot analysis of GPM21 to verify the single 
transposon insertion in the genome. GPM21 is a homogeneous strain with a single transposon insertion between 
bases 904/905 of mpn397/relA.  
 
mpn241/whiA 
A single clone harbouring a transposon insertion in Mpn241/WhiA was identified in position 
E10.11-2 and isolated from the library. The PCR fragments obtained from this strain using 
primer primers HE324/SH29 and HE325/SH30 were sequenced and aligned with the wild 
type sequence of mpn241/whiA. The transposon inserted after base 260 in respect to the first 
nucleotide of the gene and therefore met the Glass criteria. However, the transposon insertion 
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generated a duplication of the first 8 nucleotides upstream of the insertion site, which now can 
also be found downstream of the insertion. This duplication results in the formation of an 
alternative ORF downstream of the insertion site with TTG as a possible start codon. The 
possible ORF consists of 197 codons from the newly formed start TTG to the native stop 
codon TAA of the gene, leaving the conserved sequences for the conserved WhiA domain 
unaffected (see Fig. 3.3). Even though it is unclear if the transposon insertion disrupted the 
gene or just shortened the open reading frame, the strain was renamed GPM22 and used for 
further studies that might answer this question. 
 
 
Fig. 3.3: Isolation of a mpn241/whiA transposon insertion mutant.  
A: Schematic overview of the screen and orientation of the transposon insertion; B: Schematic overview of the 
transposon insertion in strain E10.11-2. The duplication of the sequence TTGTTAGC results in the formation of 
an alternative ORF downstream of the insertion site, using TTG from this sequence as a possible start codon. 
 
Strain GPM22 was grown for 3 passages and tested for contaminations with the mpn241/whiA 
wild type allele by PCR, using the same primer pairs used for the primary screen. Because 
such contaminations were detected, the strain was spread on MP agar plates containing 
gentamycin. Single colonies were picked after 14 days, transferred in liquid medium and 
again grown for 3 passages and tested by PCR. 9 of 11 clones were free from contamination, 
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and two of these were grown to higher passages and tested by Southern blot for single 
transposon insertions. These experiments finally confirmed that GPM22, after re-isolation, is 
a homogeneous strain harbouring a single transposon insertion in Mpn241. 
 
 
Fig. 3.4: Verification of strain GPM21  
A: Colony PCR from 11 single clones from clone E10.11-2. The PCR fragments resulting from primer couples 
SH29/HE324 confirm the disruption of mpn241/whiA. B: Southern blot analysis of clone1 and clone2 of E10.11-
2 confirms a single transposon insertion in strain GPM22. 
 
 
3.2 SPICE: An approach to identify binding sites of DNA-binding proteins in vivo 
A common method to determine the binding sites of DNA binding proteins in eukaryotes are 
ChIP-chip or ChIP-seq, chromatin immuno-precipitation combined with tiled microarray 
chips (-chip) or high throughput sequencing (-seq). In principle, the DNA binding protein is 
covalently bound to its binding site by chemical cross-linking, the cells are lysed, DNA 
fragmented and the protein-DNA complexes (the chromatin) immuno-precipitated with 
specific antibodies against the protein of interest. The DNA bound to the protein is finally 
recovered and further analyzed using the methods mentioned above. 
Aside from eukaryotes, this method has also been applied to study trafficking of transcription 
units during transcription initiation or to map promoters in E. coli (Mooney et al., 2009; 
Herring et al., 2005). In addition, a modified method referred to as ChAP-chip (chromatin-
affinity precipitation combined with tiling microarrays) has been used to determine the 
binding sites of DnaA in B. subtilis in vivo (Ishikawa et al., 2007). In contrast to ChIP, cross-
linked chromatin is isolated by affinity purification using tagged versions of the DNA binding 
protein that are expressed in vivo. Since this method theoretically can be applied to every 
Results 69	  
DNA-binding protein in bacteria, the idea was to use it to identify the binding sites of the 
essential, putative transcription regulators in M. pneumoniae. To achieve this, M. pneumoniae 
strains expressing STREP-tagged transcription regulators were constructed and a protocol to 
cross-link and purify protein-DNA complexes should be developed.  
 
 
3.2.1 Proof of principle: B. subtilis GltC 
Using STREP-tagged protein baits to purify cross-linked protein has been published for        
B.  subtilis GltC and other proteins, a method referred to as SPINE (Commichau et al., 2007; 
Herzberg et al., 2007). GltC is the transcriptional activator of the gltAB operon known to bind 
to its operator sequence in the presence of glucose and ammonium with concomitant absence 
of external glutamate, thereby enhancing the expression of the glutamate synthase GltAB. 
Because a B. subtilis gltC::spc strain, a complementation plasmid expressing a STREP-tagged 
GltC and a cross-linking protocol for B. subtilis are available in our lab, GltC was chosen as a 
proof of principle. 
 
 
Fig. 3.5: Co-purification of DNA cross-linked to GltC 
A: confirmation of GltC-STREP purification after cross-linking by SDS-PAGE; B: ethidium bromide staining of 
the same gels reveals cross-linked, co-purified DNA as faint smears in samples treated with para-formaldehyde 
(PFA) but not in the untreated sample. The dark spot on the left picture is an artefact. 
 
A pre-culture of B. subtilis GP738 (gltC::spc) complemented with plasmid pGP951 was 
grown overnight in LB medium and used to inoculate two times 1 l of  CS-glucose medium. 
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Cross-linking was performed according to the SPINE protocol (Herzberg et al., 2007) with 
slight modifications: cells were incubated with 0.6% para-formaldehyde for 20 min and        
30 min, and with 1% para-formaldehyde for 30 min to find the optimal conditions for protein-
DNA cross-linking. An untreated sample was kept as a negative control. Cells were disrupted 
by using a OneShot manifold and sonicated to fragment the DNA. Purification of GltC was 
verified by SDS-PAGE and in addition examined for the presence of DNA by ethidium 
bromide staining of the PAA gels (see Fig. 3.5, see above). DNA was visible in samples 
treated with para-formaldehyde. Elution fractions containing protein-DNA complexes were 
pooled, the volume reduced and the cross-linking reversed by overnight incubation at 65°C. 
The DNA was recovered by using the QiaQuick PCR Purification kit. For qualitative 
validation of specific co-purification of the gltAB promoter, the recovered DNA was used as 
template in a PCR using primers IW01 and IW02 that specifically amplify the region 
containing the GltC binding site. Primers MZ01 and MZ02 that amplify crh were chosen as a 
negative control because of similar chemical properties, same fragment size and distance of 
crh to gltAB (about 1560 kbp). 
 
 
 
Fig. 3.6: PCR analysis of recovered DNA from GltC 
Qualitative analysis of the ChAP-chip experiment with GltC. Recovered DNA has an average size of 500 bp 
(lanes 1 and 2); the gltAB promoter (PgltAB) can be amplified from recovered DNA, whereas crh fragment cannot 
(lanes 3-8). Extended cross-linking (1% PFA, 30´) leads to contamination with DNA other than PgltAB (lanes 8 
and 9). Chromosomal DNA as a template served as a positive control (lanes 11 and 12). 
 
The results of this experiment are summarized in Fig. 3.6. The promoter of the gltAB operon 
can specifically be co-purified with GltC and recovered, whereas the negative control cannot.  
This experiment suggests that targets of any transcription regulator can be identified by this 
Results 71	  
method. In analogy to the adapted SPINE technique and to later applications, i.e. analysis of 
co-purified DNA using microarray chips, the experimental design was named SPICE, the 
SPINE on a chip experiment.  
 
 
3.2.2 Applying SPICE to M. pneumoniae 
To apply the SPICE technique to M. pneumoniae, strains expressing STREP-tagged 
transcription regulators had to be constructed. Therefore, the genes mpn124/hrcA, 
mpn239/gntR, mpn241/whiA and mpn329/fur were cloned between the NotI/EcoRI or 
NotI/SacI restriction sites of the expression vector pClpB-TAP which has been used to 
express modified genes in M. pneumoniae previously (Kühner et al., 2009). The sequence for 
a C-terminal STREP-tag followed by two stop codons was added to each gene with the 
respective reverse primer. The resulting plasmids pGP1455 (HrcA-STREP), pGP1456 
(Mpn239-STREP), pGP1457 (Mpn329-STREP) and pGP1458 (Mpn241-STREP) were then 
used to transform M. pneumoniae M129. 
 
Fig. 3.7: Transposon delivery vector pGP1455 
Plasmid pGP1455 is shown as an example for the over-expression vectors constructed. The vectors integrate 
once into the genome and allow expression of genes under the control of the clpB promoter. 
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M. pneumoniae strains transformed with plasmids pGP1455-1458 were spread on MP agar 
plates to obtain single colonies. Four colonies from each transformation sample were picked, 
grown for three passages and then tested by PCR for the integration of the transposon using 
primer SH09 and the respective reverse primer of each gene (Fig. 3.8, below). Two clones of 
these four were named and used for further experiments (see appendix, Tab. 7.16). 
 
Fig. 3.8: Verification of the inserted promoter-gene fusions in by PCR 
Test PCR for the detection of integrated transposons. The artificial promoter-gene fusion could be detected in all 
strains and in the positive control (P), but not in wild type cells that served as a negative control (N). The 1 kb 
DNA ladder from Fermentas was used as a size standard. 
 
After growing strains GPM13/14 (expreesing HrcA-STREP), GPM15/16 (expressing 
Mpn239-STREP), GPM17/18 (expressing Mpn329-STREP) and GPM19/20 (expressing 
Mpn241-STREP) to the fifth passage, all strains were investigated by Western blot for the 
expression of the STREP-tagged proteins. An antibody against M. pneumoniae GlpK that also 
detects STREP-tagged proteins was used for this analysis (Hames et al., 2005).                       
M. pneumoniae strain GPM78 expressing STREP-tagged HPrK served both as a positive 
control and an internal standard to determine the size of detected signal (Schmidl et al., 2007). 
Only Mpn124/HrcA-STREP and Mpn241/WhiA-STREP were detectable by Western blotting 
of 12% (see Fig. 3.9) and 16% SDS-PAGE (not shown), even though all proteins are 
expressed under the control of the same promoter, suggesting post-transcriptional regulation. 
In addition, only Mpn124/HrcA-STREP, Mpn239/GntR-STREP and Mpn241/WhiA-STREP 
could be purified from M. pneumoniae extracts of two litres of culture (10x 300 cm2), with 
Mpn239/GntR-STREP and Mpn241/WhiA-STREP in little amounts only detectable by 
Western blotting (Fig. 3.10). 
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Fig. 3.9: Detection of STREP-tagged transcription regulators in GPM13 to GPM20 
Western blot of a 12% SDS-PAGE to detect STREP-tagged proteins in strains GPM13 to GPM20. GlpK (57 
kDa) is visible in all strains; in addition, signals of tagged proteins are visible in strains GPM13/14, GPM19/20 
and in the positive control GPM78. No signals are visible in extracts of GPM14/16 and GPM17/18. 
 
 
 
Fig. 3.10: Test-purification of STREP-tagged proteins from strains GPM13, GPM15 and GPM19.  
All three proteins were detected in the elution fractions resulting from STREP purification; only minor amounts 
of Mpn239/GntR-STREP and Mpn241/WhiA-STREP could be purified from extracts of GMP15 and GPM19, 
respectively. 2 l of culture (10x 300 cm2) were used as starting material. 
 
Strain GPM13 was used to develop a cross-linking protocol. Since the target genes of HrcA in      
M. pneumoniae have been described before, their promoters can be used as a proof of 
principle for the functionality of the SPICE technique in this organism (Chang et al., 2008). 
To detect specific up-concentration of M. pneumoniae DNA fragments carrying the CIRCE 
element by co-purification with HrcA-STREP after cross-linking, primers for qPCR were 
designed to amplify promoter regions of lon and dnaK. The promoters of these genes harbour 
perfect CIRCE elements, and the PCR primers were designed to amplify DNA fragments 
including these sequences. Primers pairs that amplify the promoter regions of ldh and ackA 
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were designed to serve as a negative control to calculate the ratio of specific and unspecific 
DNA cross-linked to HrcA (Halbedel et al., 2007). GPM13 was grown at 37°C for 96 h, 
washed with PBS and then cross-linked by directly incubating adherent cells at 37°C with 
0.5% PFA or scraped and incubated with 0.5% PFA while shaking. Purification of HrcA-
STREP was controlled by Western blot analysis and co-purified DNA quantified after 
recovering. Cross-linking longer then 20 min eliminated the possibility to purify HrcA-
STREP from extracts of GPM13. 5 ng and 10 ng of the recovered DNA were analyzed by 
qPCR to calculate the ratios of specific (Plon/PdnaK) and unspecific bound DNA (Pldh/PackA). 
 
 
 
 
 
 
 
 
 
 
Tab. 3.2: Results of SPICE experiments with GPM13 
Ratios of specific to unspecific bound DNA cross-linked to HrcA, calculated from the results from qPCR of 5 
individual experiments. No significant up-concentration of DNA specifically bound by HrcA (Plon and PdnaK) was 
achieved.   
 
According to the current literature, a 30-fold enrichment of specifically bound DNA has to be 
achieved by ChIP/ChAP for downstream analysis such as tiling arrays or high throughput 
sequencing. The highest enrichment of expected DNA fragments achieved in these 
experiments was about 20 times. Even though this is close to the minimal enrichment required 
it lacks reproducibility, was only achieved for one of the two expected fragments and might 
therefore also be artificial (see Tab. 3.2 above).  
In summary, no optimized SPICE protocol like that for B. subtilis could be developed for     
M. pneumoniae. In addition, the inefficient purification of other transcription regulators from 
M. pneumoniae strains GPM15/16 and GPM19/20 made SPICE experiments impossible for 
those proteins. Moreover, due to the experimental effort and the running costs for medium 
and material, the SPICE project on M. pneumoniae was stopped. 
 
 
 PdnaK/Pldh PdnaK/PackA Plon/Pldh Plon/PackA 
Experiment 1 0,6 0,9 1,5 2,3 
Experiment 2 0,6 1,0 1,7 2,7 
Experiment 3 0,8 1,2 1,8 2,5 
Experiment 4 6,6 1,5 20,5 4,8 
Experiment 5 1,3 1,0 20,8 15,3 
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3.3 Experiments aiming to identify targets of Mpn329/Fur 
Fur and other members of the Fur family require Fe2+ ions that are bound by conserved 
histidines to dimerize and to obtain DNA-binding activity (Herbig and Helmann, 2001; 
Jacquamet et al., 2009). These histidines are also conserved in the protein encoded by 
mpn329/fur of M. pneumoniae. However, this gene is essential in M. pneumoniae, thereby 
preventing the identification of target genes of this regulator by comparative proteome or 
transcriptome analysis. Thus, the question was raised if genes under control of this regulator 
can be identified if cells are starved starved iron. To achieve this, cells were grown in the 
presence of the iron chelator 2,2'-dipyridyl which has been used to induce iron starvation in 
bacteria previously, and were then analyzed by proteome or microarray analysis (Baichoo et 
al., 2002; Merrel et al., 2003).  
 
 
3.3.1 Proteome analysis of M. pneumoniae grown in the presence of 2,2'-dipyridyl 
A growth experiment probing different concentrations of 2,2'-dipyridyl was performed to 
determine the MIC in Hayflick medium containing glucose. A final concentration of 1 mg/ml 
was found to inhibit growth of M. pneumoniae. Therefore, a final concentration of 0.5 mg/ml 
was chosen to induce iron starvation in the following experiments.  
In the first set of experiments, cells were grown for 96 h in the presence or absence of 2,2'-
dipyridyl, lysed in ZAP buffer and centrifuged. The supernatant (the soluble fraction) was 
removed and the pellet resolved in 6 M urea. After a second centrifugation step the 
supernatant (the insoluble fraction) was collected. 8 µg of both fractions were separated by 
SDS-PAGE and silver stained. Extracts of untreated wild type cells and cells that have been 
grown in the presence of an equal amount of the solvent served as controls. Differences in the 
protein composition are marked in Fig. 3.11 (no. 1 to 8). No differences between untreated 
cells and the solvent control were observed, whereas some bands occur in higher or lower 
intensity in extracts of cells grown in the presence of 2,2'-dipyridyl. The bands were excised 
from the gel and the proteins analyzed by mass spectrometry. Amounts of proteins 
Mpn394/Nox, Mpn120/GrpE and Mpn517 were elevated in treated cells. Peptides of proteins 
Mpn314/MraZ and Mpn254/CinA were found in a fourth band that showed higher intensity in 
extracts of treated cells. However, it is unclear if only one or both identified proteins are more 
abundant in the sample. Furthermore, proteins were identified in bands of lower intensity, 
namely Mpn555/TriggerC and peptides of Mpn321/DhfR and Mpn323/NrdI in a second band. 
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Fig. 3.11: Comparison of the proteome of cells grown in the presence or absence of 2,2'-dipyridyl 
Silver stained SDS-PAGE of soluble and insoluble fraction of M. pneumoniae grown in the presence or absence 
of iron chelator 2,2'-dipyridyl. The color of the pictures was changed for better visibility of the bands. 
Differences in the proteome are marked with numbers; 1 and 2: Mpn394/Nox; 3 and 4: Mpn555/TriggerC; 5: 
Mpn120/GrpE; 6: Mpn517; 7: Mpn321/DhfR and Mpn323/NrdI; 8: Mpn314/MraZ and Mpn254/CinA. 
 
Since all Fur-family transcription regulators described in the Firmicutes are acting as 
repressors, only genes that are up-regulated during iron starvation are regarded as possible 
targets of Mpn329/Fur in this experiment. The heat shock protein Mpn120/GrpE is encoded in 
the second gene of the mpn119/dnaJ operon that is controlled by Mpn124/HrcA (Chang et al., 
2009). Therefore it is unlikely that Mpn329/Fur might regulate this gene. mpn321/dhfR and 
mpn323/nrdI are both located in the thyA operon consisting of 5 genes involved in nucleotide 
synthesis. Because this pathway is not related to any function regulated by Fur-family 
transcription regulators in other Firmicutes, i.e. metal ion homeostasis or oxidative stress, 
they were not further considered. ORFs mpn394/nox and mpn517 are coding for a NADH 
oxidase and a putative flavin mononucleotide dependent reductase, respectively. Thus, both 
enzymes are putatively involved in regulating the redox-state of the cell. Since Mpn329/Fur 
shows some similarity with PerR from B. subtilis (see introduction) and the mechanism how                     
M. pneumoniae protects itself from self-induced oxidative stress by H2O2 formation is 
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unknown it was anticipated that these genes might be involved in an oxidative stress response 
and are under control of Mpn329/Fur. To verify this hypothesis, Slot blot experiments with 
RNA from treated and untreated cultures were performed to determine if the regulatory effect 
observed in the proteome is also visible on the transcription level.  
 
Fig. 3.12: Slot blot analysis of RNA from cells grown on the presence or absence of 2,2'-dipyridyl.  
Whereas transcription of mpn517 was almost stable under different conditions, transcription of mpn394/nox was 
elevated in cells upon iron depletion. Glu: glucose; Gly: glycerol; EtOH: 50% ethanol (solvent); 2,2´-BP: 2,2'-
dipyridyl. 
 
Transcription of mpn394/nox was enhanced in cultures grown in the presence of 2,2'-
dipyridyl, but not in cultures that were grown in the presence of equal amounts of the solvent 
or in untreated cells. In addition, this effect was independent of the carbon source available. 
On the other hand, transcription of mpn517 was found to be almost stable in the same cultures 
(Fig. 3.12).  
To test if Mpn329/Fur directly regulates transcription of mpn394/nox by binding to its 
promoter, Mpn329/Fur was cloned in plasmid pWH844, over-expressed in E. coli and 
purified by His-tag affinity purification. Purified Mpn329/Fur was used for EMSA 
(electrophoretic mobility shift assays) with DNA fragments of the 5´ regions of mpn394/nox, 
mpn517 and mpn329/fur since members of this regulator family are often auto-regulated. 
None of the three DNA fragments shifted after the addition of increasing amounts of purified 
Mpn329/Fur, showing that no protein-DNA interaction occurred in vitro (Fig. 3.13). EMSA 
experiments with the same DNA fragments were also performed with purified Mpn239/GntR 
to exclude the involvement of this protein in the regulatory events observed. As expected, no 
interaction of Mpn239/GntR with any of the three DNA fragments was observed (data not 
shown). Therefore, the regulation of mpn394/nox in response to iron starvation seems not to 
be mediated by Mpn329/Fur or Mpn239/GntR. 
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Fig. 3.13: EMSA to proof Mpn329/Fur-DNA interactions 
A: DNA fragments used for EMSA. Start (ATG) and stop (TAA) codons of neighboured genes are indicated.    
B: EMSA with DNA fragments harbouring the putative promoters of mpn394/nox, mpn517 and mpn329/fur and 
purified Mpn329/Fur. No protein-DNA interaction is observed in vitro. 
 
 
3.3.2 Probing M. pneumoniae promoters in B. subtilis 
In vitro approaches to confirm protein-DNA interactions are difficult if the interaction is 
mediated by unknown cofactors such as ions or metabolites. To overcome this problem, the 
idea to establish a screening system for M. pneumoniae promoters in a related heterologous 
system such as B. subtilis was developed. Promoter activities of putatively regulated genes 
could then be probed by lacZ fusions in B. subtilis strains expressing or lacking the putative 
transcription regulators.  
To test M. pneumoniae promoters that are putatively regulated by Mpn329/Fur in B. subtilis, 
B. subtilis ∆fur ∆perR double mutants were constructed that either express or lack 
Mpn329/Fur (Tab. 7.15, appendix). These strains were then transformed with transcriptional 
lacZ fusions of the mpn517 and mpn394/nox promoters and tested for ß-galactosidase activity. 
Enzymatic activities were lower than 5 Miller units in all strains tested, suggesting no 
transcription from these promoters. Since M. pneumoniae promoters are only weakly 
conserved and lack sequences of -35 regions described in other bacteria (Weiner et al., 2000), 
the promoter sequences were mutated to obtain optimal -35 regions. However, these strains 
also lack ß-galactosidase activity. 
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Fig. 3.14: Mutation of the -35 regions of putative promoters 
Putative promoters of mpn517 and mpn394/nox were mutated by CCR to achieve optimized -35 regions 
recognized by sigma70 factors. -35 regions are required to initiate transcription in B. subtilis but are dispensable 
in M. pneumoniae (Halbedel et al., 2007). TATTAA has been shown to function as -10 region in M. pneumoniae 
in previous works (Weiner et al., 2000). (nat): native promoter; (mut): mutated promoter with optimized -35 
region)  
 
The reason for this might be general differences in promoter recognition or transcription 
initiation due to differences in conserved amino acid compositions in conserved regions of the 
SigA from M. pneumoniae (see discussion).  
To test this hypothesis, B. subtilis strains harbouring transcriptional lacZ fusions of 
mpn394/nox, mpn517 and ldh promters (Halbedel et al., 2007) were transformed with a 
plasmid that allows expression of SigA from M. pneumoniae to achieve transcription from the 
these promoters. This kind of experiment has been used previously to allow transcription from 
Rhizobium etli promoters in E. coli (Ramirez-Romero et al., 2006). Because cloning of M. 
pneumoniae sigA into expression vector pBQ200 was not working in E. coli, B. subtilis 
strains were directly transformed with the ligation sample. Resulting plasmid pGP283 was 
then isolated from B. subtilis and controlled by sequencing. Again, no ß-galactosidase activity 
was detected in any of these strains expressing SigA from M. pneumoniae. 
In summary, B. subtilis is not able to recognize and/or to initiate transcription from               
M. pneumoniae promoters, suggesting fundamental differences in requirements for promoter 
recognition in these two bacteria (see discussion). In addition, expression of M. pneumoniae 
SigA in  B. subtilis does not allow transcription from these promoters. Therefore, B. subtilis is 
not suitable as a heterologous host to probe M. pneumoniae promoters. 
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Tab. 3.3: Activities of M. pneumoniae promoters in B. subtilis 
ß-galactosidase activities (in Miller units) in B. subtilis strains harbouring transcriptional lacZ fusions of            
M. pneumoniae promoters. Plasmid pGP283 was used to express SigAMpn in B. subtilis. Strain GP278 (Singh et 
al., 2007) served as a positive control. nat: native promoter; mut: promoters with optimized -35 regions. 
 
 
3.3.3 Microarray analysis of M. pneumoniae grown in the presence of 2,2'-dipyridyl 
Proteome analyses of different bacterial mutants or the comparison of the proteome from 
treated and untreated cells allow studying the output of all regulations that might occur in the 
different strains. However, proteome analyses lack information about the level at which the 
regulations occur and if the regulations observed are direct or indirect effects. In addition, 
excreted, insoluble or proteins with extreme size or pI are often not recognized, leaving a gap 
in the global analysis. To study global transcription in response to certain stimuli or in 
different strains, microarrays or, until recently, deep transcriptome sequencing is used. Since 
no target of Mpn329/Fur was identified by studying the proteome of cells treated with iron 
chelator 2,2'-dipyridyl, microarrays were performed using the same conditions.                        
Strain Genotype Miller Units 
GP869 perR::spc, fur:mls, gltA::PdegQ-mpn329 0,7 
GP870 perR::spc, fur:mls, gltA::pGltA-Kan 3,7 
GP871 perR::spc, fur:mls, gltA::PdegQ-mpn329, amyE ::PMpn517(nat)-lacZ 0,8 
GP872 perR::spc, fur::mls, gltA::pGlt-Kan,  amyE ::PMpn517(nat)-lacZ 1,1 
GP873 perR::spc, fur::mls, gltA::PdegQ-mpn329,amyE ::Pnox(nat)-lacZ 0,2 
GP874 perR::spc, fur:mls, gltA::pGlt-Kan,  amyE ::Pnox(nat)-lacZ 1,0 
GP875 perR::spc, fur:mls, gltA::PdegQ-mpn329, amyE ::PMpn517(mut)-lacZ 1,4 
GP876 perR::spc, fur::mls, gltA::pGlt-Kan,  amyE ::PMpn517(mut)-lacZ 1,0 
GP877 perR::spc, fur::mls, gltA::PdegQ-mpn329,amyE ::Pnox(mut)-lacZ 1,4 
GP878 perR::spc, fur:mls, gltA::pGlt-Kan,  amyE ::Pnox(mut)-lacZ 1,1 
GP880 amyE ::P517(nat)-lacZ 0 
GP880 + 
pGP283 
amyE ::P517(nat)-lacZ, [PdeqQ-mpn352/sigA] 
0 
GP882 amyE ::Pldh(nat)-lacZ 0 
GP882 + 
pGP283 
amyE ::Pldh(nat)-lacZ [PdeqQ-mpn352/sigA] 
 0 
GP278 trpC2 amyE::(xynP-lacZ cat) xylR::ErmR 376,4 
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M. pneumoniae was grown for 96 h in pre-culture in Hayflick medium containing glucose and 
then seeded in the same medium with or without 2,2'-dipyridyl. Samples were taken after 
6/24/48/72/96 h. In theory, transcription of target genes of Mpn329/Fur should be constantly 
up-regulated along the growth curve in cells that grow in the presence of the chelator due to 
the lack of ferric iron, the cofactor of Fur-family proteins required for DNA binding. 
However, global transcription patterns of treated and untreated cells after 48 h showed 
fundamental differences making comparisons impossible for the later time points. Therefore, 
only time points 6 h, 24 h and 48 h were compared. Several changes in transcription were 
observed in cells treated with the iron chelator, but only a small set of genes exhibited a 
constant up-regulation compared to untreated cells.  
 
 
Fig. 3.15: Induction of the HrcA regulon upon iron depletion. 
Fold changes of the HrcA operon in cells grown in the presence of 2,2´-dipyridyl. Transcription of the whole 
operon is constantly up-regulated upon iron depletion. 
 
Among those genes was the whole HrcA regulon, consisting of dnaK, groEL/groES, dnaJ, lon 
and clpB and genes located downstream of these genes. Induction of the HrcA regulon was 
reported for several stresses beside heat shock in M. pneumoniae (Güell et al., 2009). 
Interestingly, genes harbouring a conserved CIRCE element in their promoter region showed 
the highest regulations, whereas genes with cryptic CIRCE elements (such as dnaJ) only 
showed minor up-regulation (Fig.3.15).  
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A second group of genes constantly up-regulated in cells treated with 2,2'-dipyridyl was the 
oppB operon, consisting of genes coding for four subunits of a putative peptide transporter 
and two ribosomal proteins. As for the HrcA regulon, up-regulation of transcription of the 
oppB operon in response to several different conditions was already reported previously 
(Güell et al., 2009). 
 
 
Fig. 3.16: Induction of the oppB operon upon iron depletion 
Fold changes of genes of the oppB operon and neighbouring upon iron depletion. Below: Scheme of the oppB 
operon. The whole oppB operon (oppB to Mpn220) is constitutively up-regulated in cells grown in the presence 
of 2,2´-dipyridyl whereas neighbouring genes are not. 
 
Finally, the array data was analyzed for transcriptional changes of genes identified in the 
proteome analysis described in chapter 3.3.1. In good agreement with the data obtained from 
Slot-blot experiments, no up-regulation of transcription of mpn517 was observed.  
Transcription of mpn394/nox was only slightly elevated after 6 h but increased constantly 
during the next time points, also confirming prior experiments. However, sequence analysis 
of the promoter regions of genes up-regulated upon iron depletion and their orthologues in    
M. genitalium showed that none of them harboured a common DNA motif in their promoter 
region. Moreover, none of the promoters contained DNA sequences resembling Fur or PerR 
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boxes described in other bacteria. Thus, it is unlikely that Mpn329/Fur directly regulates these 
genes and the mechanisms leading to their enhanced transcription requires further 
investigation. 
 
 
Fig. 3.17: Increasing transcription of mpn394/nox upon iron depletion 
Fold changes of nox and neighbouring genes. S02 is a putative small RNA not considered in the microarray 
analysis. nox shows adjacent transcription patterns compared to neighbouring genes.  
 
Since no protein encoded in the oppB operon was identified in the proteome analysis 
described in chapter 3.3.1, an alternative method was applied allowing the comprehensive 
analysis of all proteins from M. pneumoniae by SDS-PAGE without the separation of soluble 
and insoluble fractions.  
For this analysis, M. pneumoniae wild type, GPM21 (mpn397/relA::Tn) and GPM52 
(glpD::Tn) were grown in the presence or absence of 2,2'-dipyridyl and directly lysed in 
protein loading buffer. GPM52 served as a general control, and GPM21 was chosen to 
exclude the possibility that probable regulatory effects observed are mediated by (p)ppGpp 
(Miethke et al., 2006). 
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Fig. 3.18: Proteome analysis of M. pneumoniae strains grown in the presence or absence of 2,2'-dipyridyl 
Complete proteome of M. pneumoniae wild type, GPM52 and GPM21 treated or untreated with 2,2'-dipyridyl. 
Elevated levels of OppF (upper band indicated) and PtsI (lower band indicated) were found in all three strains 
when treated with the iron chelator. No enhanced levels of Nox are visible by this method, probably due to the 
lack of separation of soluble and insoluble protein factions.  
 
Only two bands showing elevated protein amounts were observed in samples from all cultures 
treated with 2,2'-dipyridyl. MS analysis identified these proteins as PtsI (fold change of 1.5) 
and OppF (fold change of 3.5). No up-regulation of ptsI transcription was found in the 
microarray analysis. Therefore, the finding of elevated amounts of PtsI might be a secondary 
effect due to a modified stability of the protein. On the other hand, transcriptome and 
proteome data of the oppB operon correlate well, indicating that this operon indeed is up-
regulated during iron depletion due to a direct mechnism that still needs to be explored. The 
up-regulation of the oppB operon might have been overlooked in the first proteome analysis 
(chapter 3.3.1) due to the fact that these proteins are anchored in the membrane of                 
M. pneumoniae. Thus, they might have got lost during the separation of soluble and insoluble 
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fractions. Transcription of other genes identified in the proteome analysis (chapter 3.3.1) 
either showed no or opposed regulations compared to the proteomic data. Thus, transcriptome 
and proteome data do not necessarily correlate in M. pneumoniae (as described previously: 
Halbedel, 2006), underlining the importance of coupling both approaches.  
 
 
3.4 Experiments aiming to characterize the function of Mpn266 
When this work started, only three putative transcription regulators were described in            
M. pneumoniae: Mpn124/HrcA, Mpn239/GntR and Mpn329/Fur. Transcription regulator 
Mpn266/Spx was missanotated as an arsenate reductase and its homology to B. subtilis Spx 
was discovered during this work. B. subtilis Spx is an unusual transcription regulator because 
its does not make direct contact with DNA. Instead, Spx mediates conformational changes of 
the RNA polymerase holoenzyme by interacting with RpoA C-terminal domain, thereby 
allowing it to bind to additional, cis acting elements upstream of promoters (Reyes and Zuber, 
2008). Expression of Spx in B. subtilis is tightly controlled at the level of transcription. In 
addition, the protein has a notably short half-life due to its C-terminal amino acid sequence 
that mediates immediate proteolysis by the protease ClpXP. 
 
 
3.4.1 Proof of interaction of Mpn266/Spx with RpoA 
To proof whether Mpn266/Spx really is an Spx orthologe, interaction of Mpn266/Spx with 
RpoA, the alpha subunit of M. pneumoniae RNA polymerase was studied. The genes coding 
for Mpn266/Spx and Mpn191/RpoA were cloned into vectors of an adenylate cyclase based 
bacterial-two-hybrid system (B2H), expressed in E. coli and colonies examined for ß-
galactosidase activity as an indicator of protein-protein interactions. B. subtilis Spx and RpoA 
served as a positive control.  
As expected, a strong interaction of B. subtilis RpoA with Spx was found (coordinates A3-A4 
and C1-C2 in Fig. 3.19). In addition, both B. subtilis and M. pneumoniae RpoA interact with 
themselfes as already known from crystal structures of the RNA polymerase from                  
T. aquaticus (Zhang et al., 1999). Surprisingly, no interaction between B. subtilis and            
M. pneumoniae RpoA is observed even though these proteins are highly conserved in all 
bacteria. A weak interaction of Mpn266/Spx is visible with Mpn191/RpoA (H5), 
demonstrating that this protein behaves similar its orthologe Spx in B. subtilis. Furthermore, 
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Mpn266/Spx interacts with RpoA from B. subtilis providing evidence that the amino acid 
residues required for this interaction are conserved in the M. pneumoniae protein (C5 and E3). 
 
 
 
Fig. 3.19: Interaction of Spx and Mpn266 with RpoA from M. pneumoniae and B. subtilis 
Scanned picture of the B2H experiment. N- and C-terminal fusions of probed proteins with the T18 and T25 
domain of the B. pertussis adenylate cyclase in the respective vectors are indicated. The experiment provides 
evidence that Mpn266 indeed interacts with the C-terminal domain of Mpn191/RpoA in vivo.  
 
 
3.4.2 Complementation of B. subtilis ∆spx with Mpn266/Spx 
Since Mpn266/Spx is a putative orthologe of B. subtilis Spx, the question was raised if 
Mpn266/Spx could complement a B. subtilis ∆spx strain. To test this, Mpn266/Spx was 
cloned into plasmid pGP382 that allows expression of the gene with a C-terminal STREP-tag 
in B. subtilis. The resulting plasmid pGP1454 was used to transform B. subtilis ∆spx. Only 
one single colony resulted from this transformation whereas >200 colonies were achieved in a 
parallel sample using the same amount of empty vector pGP382, which served as a positive 
control. To proof that this strain does not harbour suppressor mutations, the chromosomal 
rpoA gene and the plasmid were sequenced again and expression of Mpn266/Spx in this strain 
verified by test purification using the STREP-tag. No mutations were found and Mpn266/Spx 
Results 87	  
could be purified from extracts of the strain (not shown). However, the possibility of 
suppressor mutations in other loci cannot be excluded. 
B. subtilis 168, B. subtilis ∆spx and B. subtilis ∆spx carrying either the empty expression 
vector pGP382 or complementation plasmid pGP1454 were probed in an agar disc diffusion 
assay for their sensitivity against the chemical compound paraquat. Paraquat uncouples the 
oxidative phosphorylation and leads to the intracellular formation of hydrogen peroxide, thus 
to oxidative stress, and B. subtilis ∆spx was reported to be highly sensitive (You et al., 2008).  
 
Fig. 3.20: Outcome of the disc diffusion experiment.  
A: Sample picture of the experiment. B. subtilis wild type (top left), ∆spx (top right), ∆spx with pGP382 (bottom 
left) and ∆spx with complementation plasmid pGP1454 treated with 10 µl paraquat solution. B: Diameters of the 
bacteria-free areola caused by increasing amounts of paraquat solution (10 mg/ml).  
 
As can be seen in Fig. 3.20, B. subtilis ∆spx indeed shows an elevated sensitivity towards 
increasing amounts of paraquat in this experiment. However, complementation plasmid 
pGP1454 did not restore resistance to paraquat to the wild type level. This is either due to the 
fact that the protein Mpn266/Spx itself is not capable to complement the spx deletion in         
B. subtilis, or because the unregulated expression of Mpn266/Spx leads to unknown 
suppressor mutations in B. subtilis ∆spx after transformation with pGP1454.  
 
At the time these experiments were performed, a contemporary publication about protein 
interactions in M. pneumoniae and the identification of Mpn266/Spx as a putative 
transcription regulator was announced (Kühner et al., 2009; Anne-Claude Gavin, personal 
communication). Therefore, no further experiments concerning this transcription regulator 
and its role in M. pneumoniae were performed.  
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3.5 Experiments aiming to characterize the role of Mpn397/RelA 
Whereas no mutants of other transcription regulators could be isolated, several transposon 
insertions were found in mpn397/relA (chapter 3.1.2). The availability of mutants allows 
performing several experiments to characterize the role of this gene and to characterize a 
phenotype of the mutant. 
 
 
3.5.1 Analysis of conserved domains in Mpn397/RelA 
RelA homologues are conserved in all Mycoplasmas for which a genome sequence is 
available, with the exception of the members of the M. hominis group. M. pneumoniae 
Mpn397/RelA has 32% amino acid identity (E value: 2e-63) with B. subtilis RelA which has 
been characterized previously. In addition, the conserved RxKD motif present in bi-functional 
RelA protein, i.e. RelA proteins that possess both (p)ppGpp synthetase and hydrolase activity, 
is present in Mpn397/RelA, although as HxKD. In monofunctional proteins such as E. coli 
RelA, an ExDD motif replaces these amino acid residues (Sajish et al., 2007; Sajish et al., 
2009). Furthermore, the HD superfamily hydrolysis domain is conserved in the N-terminus of 
the protein as described for all bi-functional Rel proteins (Aravind and Koonin, 1998). This 
domain was shown to hydrolyse (p)ppGpp in a Mg2+ dependent manner (Sajish et al., 2009). 
Since no other proteins with (p)ppGpp synthetase activity are encoded in the genome of        
M. pneumoniae, Mpn397/RelA is the only protein in this organism putatively responsible for 
the synthesis and hydrolysis of (p)ppGpp (Nanamiya et al., 2008). 
 
Fig. 3.21: Partial multiple alignment of bi-functional RelA proteins 
Amino acid sequences from conserved domains of RelA from Synechocystis sp., Aquifex sp., H. pylori,               
S. pyogenes, M. tuberculosis, E. coli, B. subtilis and Mpn397/RelA. The conserved amino acids residues of the 
(p)ppGpp synthesis and hydrolysis domain are indicated. 
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3.5.2 Detection of (p)ppGpp and other metabolites in M. pneumoniae                              
Mpn397/RelA harbours two conserved domains that resemble the (p)ppGpp synthesis and 
hydrolysis domains of bi-functional RelA enzymes. However, the conserved RFKD motif 
located in the synthesis domain is present as HFKD in Mpn397/RelA. To test whether this 
and other differences in the amino acid composition of Mpn397/RelA affect its enzymatic 
activity, M. pneumoniae and the Mpn397/RelA mutant GPM21 were tested for their ability to 
synthesize (p)ppGpp.  
Common methods to induce (p)ppGpp synthesis in bacteria are either starving cells for 
essential amino acids in a defined medium or treating cells with chemicals such as norvaline, 
serine-hydroxamate or antibiotics like mupirocin that all mimic amino acid starvation. 
Norvaline is a synthetic amino acid unfeasible for protein synthesis that competes against 
valine in being loaded to tRNAVal. Serine hydroxamate and mupirocin are synthetic and 
naturally occurring inhibitors of serine and isoleucine tRNA synthethase, respectively. 
(p)ppGpp can be labelled and detected by growing cells in the presence of (P32)-γ-ATP 
followed by nucleotide extraction and thin layer chromatography. Since radioactive labelling 
of pathogenic bacteria in vivo was not allowed in the facility this work was performed, an 
alternative method to detect (p)ppGpp had to be used. Recently developed techniques in the 
research field of metabolomics allow the detection and quantification of nucleotides, amino 
acids and metabolites in extracts of bacterial cultures by mass spectrometry coupled with 
liquid or gas chromatography (LC-MS and GC-MS). These techniques have recently been 
used to study the stringent response in S. aureus (Geiger et al., 2010) and were also adapted to 
detect (p)ppGpp in M. pneumoniae during this work. 
M. pneumoniae was grown in Hayflick medium with glucose for 96 h. Then, the medium was 
exchanged with “Hayflick light” (to reduce background in MS; see chapter 2.1.2) with or 
without mupirocin or serine hydroxamate, cells lysed and nucleotides extracted as described 
previously. Treatment of cells with mupirocin for up to one hour did not induce formation of 
(p)ppGpp. However, detectable amounts of the so far unknown and uncharacterized 
nucleotide ppGp were found instead in samples treated for 90 min (not shown). The source of 
this nucleotide is unknown and is rather thought to be an artefact of the antibiotic than a 
specific cellular response towards amino acid starvation. In contrast, ppGpp but no pppGpp 
could be detected in extracts of cultures that have been treated with serine hydroxamate for    
40 min or 50 min in two separate experiments. No (p)ppGpp was found in control samples 
treated with “Hayflick light” without serine hydroxamate. To exclude the possibility of false 
negative results, two different methods were used to detect (p)ppGpp in these experiments: (I) 
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LC-MS as described in Geiger et al. (2010) and (II) HILIC modified as described in Bajad et 
al. (2006). The same experiment was performed with Mpn397/RelA disruption mutant 
GPM21. As expected, no (p)ppGpp was detected in extracts after treatment with serine 
hydroxamate for up to 60 min (data not shown; M. Liebeke, personal communication). These 
experiments confirm that the stringent response and the mechanism of regulation of (p)ppGpp 
synthesis are conserved in M. pneumoniae and that Mpn397/RelA is the only enzyme 
responsible for the synthesis of ppGpp under these conditions. 
 
 
 
Fig. 3.22: Detection of ppGpp in M. pneumoniae by mass spectrometry 
Detection of ppGpp in wild type cells treated with serine hydroxamate. A: ppGpp (pink) but no pppGpp (green) 
were detected after 40 min of treatment using the method described in Geiger et al. (2010). B: Only ppGpp was 
detectable in cells treated for 50 min (yellow signal, top) but not in the untreated control (pink signal, bottom). 
Here, a modified HILIC approach as described in Bajad et al. (2006) was used. No (p)ppGpp was found in 
mpn397/relA mutant strain GPM21 treated with serine hydroxamate (not shown). 
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Synthesis of (p)ppGpp in the Firmicutes is accompanied by a decrease of intracellular GTP 
due to inhibition of enzymes required for GTP synthesis, and an increase of intracellular ATP 
due to a so far unknown mechanism. Decrease of GTP is a prerequisite for the down-
regulation of rRNA synthesis in B. subtilis (Krásný and Gourse, 2004; Natori et al., 2009).   
M. pneumoniae lacks genes coding for enzymes involved in GTP synthesis and is auxotrophic 
for GTP. Thus, it is tempting to speculate that M. pneumoniae is unable to decrease 
intracellular amounts of GTP in the presence of (p)ppGpp. Quantification of nucleotide 
mono-, di- and tri-phosphates in samples analyzed by the method described in Geiger et al. 
(2010) indeed provides evidence for this hypothesis: only slight changes of intracellular GTP 
and ATP occur in M. pneumoniae wild type cells in which ppGpp was deteclable. However, 
this analysis has only been performed once and requires repetition of these experiments.  
 
In addition to the expected nucleotides, another identified compound is worth mentioning. 
Cyclic adenosine monophosphate (cAMP) functioning as secondary messenger in E. coli has 
been found in extracts of M. pneumoniae, even though at low concentrations. This is 
surprising since no putative adenylate cyclase is present in the genome of M. pneumoniae. 
The finding of cAMP in M. pneumoniae extracts could also be confirmed by other 
workgroups (T. Maier, CRG, Barcelona; personal communication). However, the origin of 
this compound is so far unknown and its role requires further experiments. 
 
 
3.5.3 Growth curves of M. pneumonie GPM21 
Bacterial relA mutants show a very characteristic phenotype in a way that these strains are not 
able to enter stationary phase during growth. Instead, they grow in a log phase-like manner 
until nutrients are completely depleted from the medium and suddenly starve to death. To 
analyze the growth behaviour of M. pneunmoniae GPM21, growth curves were performed 
and the wet weight of cultures from this strain compared with the wild type and strain GPM70 
as controls. Strain GPM70 harbours a transposon insertion in structural gene mpn474 and has 
been described previously (Hegermann et al., 2008). No differences during growth in 
Hayflick medium containing either glucose or glycerol as carbon sources were observed 
within these three strains. 
 
 
 
Results 92	  
 
 
Fig. 3.23: Growth curves of M. pneumoniae strains 
Growth curves of M. pneumoniae wild type, GPM70 and GPM21 determined by the wet weight of cultures 
grown in Hayflick medium containing either glucose (A) or glycerol (B) as carbon sources. 
 
 
3.5.4 Scanning electron microscopy of M. pneumonie GPM21 
(p)ppGpp affects various aspects of bacterial metabolism and also the cell cycle. In addition, 
(p)ppGpp was found to affect the morphology of some bacteria such as Mycobacterium 
smegmatis, Rhizobium etli or Helicobacter pylory (Ojha et al., 2000; Braeken et al., 2008; 
Zhou et al., 2008). Scanning electron microscopy was performed to determine if disruption of 
mpn397/relA in M. pneumoniae GPM21 affects the morphology of the cell. No differences in 
morphology were observed between GPM21 and the wild type. 
 
Fig. 3.24: Scanning electron microscopy of M. pneumoniae strains 
Scanning electron microscopy pictures of M. pneumoniae wild type and GPM21. No differences in the 
morphology of single or dividing cells are observed. 
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3.5.5 Adaptation of M. pneumonie GPM21 to different stresses 
Despite nutrient starvation, (p)ppGpp is also involved in stress adaption in bacteria. 
Implications of (p)ppGpp in the adaption to elevated temperatures, iron depletion, 
osmotolerance and membrane stress induced by ethanol were reported other bacteria 
(Varcamonti et al., 2003; Braeken et al., 2008; Vinella et al., 2005; Miethke et al., 2006; 
Okada et al., 2002; Wei et al., 2004; Yan et al., 2009).  
 
 
Fig. 3.25: Adaptation of M. pneumonie strains to different stresses 
Acidification of Hayflick medium by M. pneumoniae wild type, GPM79 and GPM21. A: Different temperatures; 
B Increasing NaCl concentrations; C: Increasing amounts of iron chelator 2,2'-dipyridyl; C: Increasing amounts 
of ethanol. Ethanol evaporated from the medium. Therefore, this experiment cannot be analyzed. 
 
To test the ability of M. pneumoniae wild type and GPM21 to adapt to these stresses, small-
scale experiments have been performed. M. pneumoniae strains were grown in Hayflick with 
glucose in microtiter plates for 96 h and the acidification of the medium was monitored by 
documenting the colour change of the medium from red (basic) to yellow (acidic). The 
acidification of the medium by lactate or acetate, the end products of glycolysis, correlates 
with the biomass of cells in the culture. Thus, M. pneumoniae strains defective in stress 
adaptation would grow slower and should therefore acidify the medium less compared to 
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strains not defective in stress adaptation. Once such a condition is identified, growth curves as 
described in chapter 3.5.3 would be performed to determine the growth defect by calculating 
the biomasses of the different strains. However, M. pneumoniae wild type, GPM21 and 
GPM70 (as a control) did not exhibit different acidification patterns in these experiments, 
suggesting similar abilities to adapt to the stresses tested. 
 
 
3.5.6 Cytotoxicity of GPM21 towards HeLa and A549 cells 
(p)ppGpp is an important regulator that triggers virulence of pathogenic bacteria and 
adaptation to intracellular growth of facultative intracellular bacteria as shown in various 
animal infection models (Dalebroux et al., 2010; La et al., 2008). Only very few animal 
infection models have been reported for M. pneumoniae, among them guinea pigs and 
baboons (Dumke et al., 2004; Hardy et al., 2009). Instead, cytotoxicity assays using human 
cell lines have been used to determine virulence factors of M. pneumoniae, because of their 
simple experimental setup and the fact that no approval of ethics committees is required 
(Kannan and Baseman, 2006; Hames et al., 2009; Schmidl et al., 2010).  
 
 
 
Fig. 3.26: Cytotoxicity of M. pneumoniae strains towards HeLa and A549 cells 
No differences are observed between M. pneumoniae wild type and GPM21, whereas GPM52 is strongly 
impaired in cytotoxicity 
 
To determine if GPM21 is impaired in cytotoxicity, HeLa cell assays have been performed 
and cytotoxicity was compared with M. pneumoniae wild type and GPM52 (glpD::Tn) which 
was shown to have a reduced cytotoxicity (Hames et al., 2009). In addition to HeLa cells, 
cytotoxicity towards human alveolar basal epithelial cell line A549 was tested using the same 
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strains (Lieber et al., 1967).  The ability of M. pneumoniae to internalise and replicate in this 
cell line was reported previously (Yavlovich et al., 2004). No differences were observed 
between M. pneumoniae wild type and GPM21, whereas GPM52 was impaired in cytotoxicity 
towards both cell lines (Fig. 3.26).  
The killing assay to determine internalisation described in Yavlovich et al. (2004) could not 
be performed since gentamycine is used as a resistance marker in M. pneumoniae mutants. An 
alternative strategy using the Mynox® Mycoplasma Elimination Kit (Minerva Biolabs, Berlin) 
to kill extracellular M. pneumoniae cells failed because the kit was quite ineffective, probably 
due to the high number of M. pneumoniae cells used to infect the host cells (not shown). 
 
 
Fig. 3.27: H2O2 production of M. pneumoniae strains 
Production of H2O2 by M. pneumoniae wild type, GPM52 and GPM21 in the presence of glucose or glycerol. 
H2O2 was measured at three time points (0, 30 min and 120 min). “*” indicates the addition of serine 
hydroxamate. H2O2 concentrations are indicated in [µg/ml]. 
 
As described previously and as can be seen in Fig. 3.26, cytotoxicity of M. pneumoniae 
toward human cell lines mainly results from excreted H2O2 originating from glycerol 
metabolism (Hames et al., 2009). Since no differences in cytotoxicity were observed between 
M. pneumoniae wild type and GPM21, the ability of both strains to produce H2O2 was studied 
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by using the Merckoquant peroxide test (Merck, Darmstadt, Germany). M. pneumoniae wild 
type and GPM21 produced equal amounts of hydrogen peroxide using glucose and glycerol as 
carbon sources. In both strains, H2O2 production increased in the presence of glycerol. 
Addition of serine hydroxamate (1 mg/ml final concentration) to induce (p)ppGpp formation 
lead to a decrease of H2O2 in  all culture supernatants. If this decrease is due to inhibited 
protein synthesis or due to reduction of H2O2 catalysed by serine hydroxamate is unknown. 
Strain GPM52 was used as a control and did only exhibit marginal H2O2 production as 
reported previously in all experiments (Low and Zimkus, 1973; Hames et al., 2009). In 
summary, no differences in H2O2 production were observed between the wild type and 
GPM21, suggesting no involvement of Mpn397/RelA or (p)ppGpp in the regulation of 
glycerol metabolism or cytotoxicity. 
 
 
3.5.7 Microarray analysis of M. pneumonie GPM21  
(p)ppGpp is involved transcription regulation in all bacteria studied so far. To study 
differences in transcription of M. pneumoniae wild type and strain GPM21 in response to 
nutrient starvation, microarray analyses were performed. 
 
Transcription pattern of GPM21 under standard conditions 
To ensure that disruption of mpn397/relA by the transposon or expression of the aac-ahpD 
resistance cassette coded on the transposon does not affect transcription in GPM21, 
microarray analyses of cultures grown for 6 h were performed. Previous experiments showed 
that cultures of different strains could be compared best within the first 24 h. No differences 
in transcription are observed between the wild type and GPM21. This is in good agreement 
with the finding that no (p)ppGpp was detectable in cultures untreated with serine 
hydroxamate: nutrient supply is high and Mpn397/RelA should therefore be inactive (chapter 
3.5.2). Only transcription of mpn397/relA occurred up-regulated in strain GPM21 in these 
experiments, probably due to the fact that the probe detecting mpn397/relA transcripts is 
located downstream of the transposon insertion and affected by read-through originating from 
the aac-ahpD promoter (Fig. 3.28). This effect is also visible in other strains as will be shown 
in the next chapters. 
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Fig. 3.28: Scatter plot of microarray signals from M. pneumoniae wild type and GPM21.  
Only transcription of mpn397/relA occurs up-regulated in GPM21 under these conditions due to polar effects of 
the aac-ahpD promoter located inside the transposon.  
 
Transcriptional response to a glucose downshift  
Glucose starvation was shown to induce the stringent response in B. subtilis (Bernhardt et al., 
2003; Koburger et al., 2005). To study the glucose starvation response and probable influence 
of Mpn397/RelA in M. pneumoniae, a defined medium would be required. Since no defined 
medium is available, the transcriptional response to a glucose downshift was analysed instead. 
M. pneumoniae wild type and GPM21 were grown for 48 h in Hayflick medium containing 
glucose (t0, see Fig. 3.29). Then, the medium was discarded and cells covered with 50 ml 
Hayflick without any carbon source, pre-warmed at 37°C. RNA samples were taken after 2 h, 
4 h and 6 h and the transcriptome compared with that of untreated cells at time point t0 within 
each strain. However, this experimental design has the drawback that two transcriptional 
responses are observed at the same time: first, transcriptional responses towards downshift of 
glucose availability and second transcriptional regulation in response to fresh medium. 
Therefore it is unclear which regulations are influenced by which stimulatory condition and 
require additional experimental validation. 
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Fig. 3.29: Schematic overview about the glucose downshift experiment.  
Transcriptional responses  in reference to t0 were analyzed within each strain.  
 
Only minor differences in transcription were observed between the wild type and GPM21. 
Because the majority of those differences have fold changes lower than 1.0 and/or pValues 
>0.5 they are rather thought to be artificial and physiologically irrelevant than strain specific 
responses. Instead, both M. pneumoniae wild type and GPM21 showed almost similar 
transcriptional responses towards glucose downshift. Both strains showed a down-regulation 
of transcription of the ATPase operon (ORFs mpn605 to mpn596). In addition, an operon 
harbouring genes involved in lipid metabolism (ORFs mpn297 to mpn302), a cluster of 
hypothetical genes (ORFs mpn459 to mpn457) and the oppB operon described in chapter 
3.3.3 were found up-regulated in both strains after 4 h and 6 h. Interestingly, only proteases 
lon and clpB of the HrcA regulon were up-regulated in both strains, too, suggesting a 
separated mode of regulation in contrast to other genes of this regulon. Finally, the thyA 
operon (ORFs mpn320 to mpn324) harbouring genes involved in nucleotide and vitamin 
metabolism was down-regulated in both strains. However, if these transcriptional changes are 
due to the adaptation to fresh medium or to a reduced availability of consumable carbon 
sources requires additional experiments. Even though an involvement of Mpn397/RelA and 
(p)ppGpp can be excluded, the mechanisms behind the transcription regulations observed 
remain unknown.  
 
Transcriptional response towards amino acid starvation  
Whereas it is unclear if M. pneumoniae synthesizes (p)ppGpp in response to glucose 
starvation, its ability to synthesize ppGpp in response to amino acid starvation by treatment 
with serine hydroxamate was shown in chapter 3.5.2. To study the influence of ppGpp on     
M. pneumoniae transcription, an experimental design similar to that described in Fig. 3.29 
was chosen: M. pneumoniae wild type and GPM21 were grown for 48 h. 25 ml of medium 
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supernatant were taken from growing cultures und used to dissolve serine hydroxamate or 
norvaline to a final concentration of 25 mM and 10 mg/ml, respectively. Norvaline is a non-
proteinogenic amino acid that competes with leucine in being loaded to its respective tRNA, 
thereby mimicking amino acid (i.e. leucine) starvation. It has been used previously to study 
the stringent response in B. subtilis (Belitskiĭ and Shakulov, 1980; Riedel et al., 1987; 
Eymann et al., 2002). After serine hydroxamate or norvaline were dissolved, the residual 
medium of M. pneumoniae strains was discarded and replaced by the same medium 
containing one of the chemical compounds. After treatment for 15 min (t1) and 45 min (t2), 
cells were lysed and RNA prepared for microarray analysis. Transcription signals were then 
compared with those from untreated cultures at t0, analogue to the description in Fig. 3.29. 
This experimental design allows studying the effect of serine hydroxamate or norvaline 
without having additional environmental changes such as fresh medium, as described above. 
Transcriptional responses of both M. pneumoniae wild type and GPM21 in response to 
norvaline treatment differed strongly. However, they also differed between the replicates of 
each strain, and thus lead to high pValues for the calculated fold changes. The reason for this 
is unknown since all cultures were treated in the same manner. Therefore the data of this 
experiment is not further regarded in this work. 
As described for the response towards norvaline treatment, the transcriptional responses of 
both M. pneumoniae strains differed strongly when treated with serine hydroxamate, but were 
more reproducible in this experiment. However, differences in transcription do not resemble 
any described phenotype of relA mutants in other bacteria. Major differences in transcription 
were noticed in strain GPM21 originally expected to be unresponsive toward amino acid 
starvation, whereas only minimal changes occurred in the wild type. For example, a cluster of 
putative cytadherence genes (ORFs mpn364 to mpn370) was up regulated in GPM21 but not 
in the wild type, as well as a cluster of conserved hypothetical proteins containing S7 
peptidase domains (ORFs mpn182 to mpn179) and the mpn320/thyA operon. To test whether 
these differences between GPM21 and the wild type are due to specific responses towards 
amino acid starvation or resulting from different growth states of the two strains, transcription 
signals of t0 were compared. Analysis of this data suggests that both strains were indeed in 
different growth states when the experiment was performed, making it impossible to 
differentiate between growth state specific transcription patterns and strain specific responses 
towards serine hydroxamate treatment. 
Despite these differences, also similar transcription responses were observed in both strains. 
Both strains down-regulated transcription of a cluster of genes encoding ribosome associated 
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GTPases Mpn475/EngA and Mpn481/EngB and valine tRNA synthetase Mpn480 (ORFs 
mpn482 to mpn475). Interestingly, transcription of genes encoding other tRNA synthetases 
such as Mpn005/SerS, Mpn023/MetS or Mpn402/ProS was also found to be down-regulated 
in both strains. In addition, transcription of the mpn516/rpoB operon was up-regulated in both 
strains, whereas other genes up-stream of the Mpn516/RpoB promoter were down-regulated.   
In summary, no specific transcriptional phenotype could be identified related to 
Mpn397/RelA or (p)ppGpp. On the other hand these data suggest that M. pneumoniae indeed 
carries out specific responses both towards glucose and amino acid starvation, independently 
from (p)ppGpp. However, the mechanisms behind these regulation events and their 
physiological relevance require additional experimental validation.  
 
 
3.6 Experiments aiming to characterize the role of HPr phosphorylation 
Even though the mechanisms of phosphorylation of phosphocarrier protein HPr have been 
studied extensively in M. pneumoniae, the function of HPr(Ser-P) is still unknown in this 
organism. However, the availability of strains GPM51 (hprK::Tn) and GPM68 (prpC::Tn) 
offers the possibility of experimental designs that allow screening for antagonistic phenotypes 
within these two strains. 
 
 
3.6.1 Microarray analysis of GPM51 and GPM68  
To test whether the phosphorylation state of HPr affects transcription, microarrays have been 
performed with M. pneumoniae strains GPM51 and GPM68 and were compared with 
transcription signals of the wild type. For this experiment, growth curves were performed and 
RNA samples taken at time points 6/24/48/72/96 h to overcome the problem that the growth 
state of M. pneumoniae cultures cannot be monitored by measuring the optical density (see 
discussion). Transcription of genes was regarded to be directly affected by the gene knock-out 
if the regulatory event occurred along the whole growth curve. Because RNA extraction at 
time points later then 48 h was not successful for all strains, only the first three time points 
were used for this study. 
In GPM51, only mpn223/hprK itself was found to be significantly down-regulated constantly 
along the growth curve, a polar phenotype due to the transposon insertion as already 
described for GPM21. In GPM68, genes mpn245/def and mpn246/gmk upstream of the 
transposon insertion are affected in addition to mpn247/prpC itself. Transcription read-
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through of  (+) DNA strand by the aac-ahpD promoter leads to a significant down-regulation 
of mpn246/gmk and an up-regulation of mpn245/def transcription, due to their location on 
opposite DNA strands. However, no antagonistic transcription patterns were observed in 
GPM51 and GPM68, and no constant changes in transcription of single genes or operons 
were noticed in both strains beside the described polar effects of the transposon insertion. 
This finding suggests that neither the phosphorylation state of HPr nor that of other targets 
described for Mpn247/PrpC are involved in transcription regulation in M. pneumoniae. 
 
 
3.6.2 Real-time monitoring of glucose consumption by GPM51 and GPM68 
Beside of being involved in transcription regulation, the phosphorylation state of HPr was 
also shown to directly affect the uptake of PTS sugars in B. subtilis. HPr(Ser46-P) inhibits 
uptake of PTS sugars due to a conformational change of the protein the prevents participation 
in phosphotransfer to the EII complex in the membrane (Reizer et al., 1989). 
As shown in chapter 3.5.5, glucose consumption and acidification of the medium by lactate 
and acetate, the end products of glycolysis in M. pneumoniae, directly correlate with each 
other. To study if HPr phosphorylation at Ser46 affects the uptake of glucose in                     
M. pneumoniae, time dependent acidification of the medium by M. pneumoniae wild type, 
GPM51 and GPM68 was monitored. To achieve this, equal cell amounts of M. pneumoniae 
strains were seeded in 96-well microtiter plates containing minimal medium with defined 
concentrations of glucose and incubated at 37°C for 120 h. Acidification was monitored by 
hourly measuring of the absorbance at 430 nm and 560 nm to determine the colour change of 
pH indicator phenol red from red to yellow, as described previously (Yus et al., 2009).  
As can be seen in Fig. 3.30, no acidification of the medium was observed in wells without 
glucose, which served as negative controls. Acidification of the medium by the wild type 
stopped slowly after about 40 h and stayed constant until the end of the experiment. In 
contrast, acidification by GPM68 stopped about 10 h earlier and at a higher pH compared to 
the wild type, indicating an earlier stop of glucose consumption. The opposite effect was 
observed for GMP51. Acidification by this strain stopped abruptly after about 60 h at a much 
lower pH compared to the wild type. Thus, this data suggests that uptake or utilisation of 
glucose by M. pneumoniae is regulated in a pH-dependent manner, and that this regulation is 
mediated by the phosphorylation state of HPr. This hypothesis is in good agreement with 
observations from HPr in B. subtilis showing that HPr(Ser46-P) cannot participate on 
phosphate transfer to EII of the PTS (Reizer et al., 1989): Whereas M. pneumoniae wild type 
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stops consumption of glucose at a certain pH, strain GPM51 lacking HPrK consumes all 
glucose available, leading to the abrupt stop of acidification, as observed. In contrast, strain 
GPM68 unable to dephosphorylate HPr(Ser46-P) is more sensitive to a lowered pH, leading 
to an early stop of glucose consumption. Hence, glucose uptake in M. pneumoniae seems to 
be regulated by the phosphorylation state of HPr, which itself is modulated by an unknown 
feedback mechanism. If the feedback signal triggering HPr (de-)phosphorylation indeed is a 
lowered pH or accumulation of acidic end products of glycolysis, lactate or acetate, requires 
additional experimental validation. 
 
Fig. 3.30: Real-time acidification of defined medium by M. pneumoniae strains 
 X-axis: time [h]; Y-axis: [log] acidification as described in Yus et al., 2009. Concentration of glucose is (w/v). 
 
 
3.7 Experiments aiming to characterize the role of Mpn241/WhiA 
Even though the putative transcription regulator Mpn241/WhiA is conserved in all Gram-
positive bacteria, nothing is known about its function or its possible targets. To study its 
putative role in transcription regulation in M. pneumoniae, microarrays with GPM22 
(mpn241/whiA::Tn) were performed and transcription signals compared with the wild type. 
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For this purpose, the same experimental setup and the same criteria for directly regulated 
genes were used as for strains GPM51 and GPM68 (see chapter 3.6.1 and discussion).  
 
Fig 3.31: Heat map display of transcription signals from the mpn164/rpsJ operon 
Transcription of the operon (mpn164 to mpn188) decreases along the growth curve in wild type cells, whereas it 
stays constantly high in GPM22. Genes mpn189 and mpn190 are not part of the operon and exhibit similar 
transcription patterns in both strains. Down-regulation of transcription of this operon along the growth curve has 
been described previously (Güell et al., 2009). wt: wild type;  Tn_whiA: GPM22. Time points are indicated.  
 
Transcriptome data for time points 6 h, 24 h, 48 h and 96 h were available for both GPM22 
and the wild type. Polar effects on neighbouring genes caused by the transposon insertion lead 
to an up-regulation of transcription of mpn241/whiA itself and a remote up-regulation of 
downstream genes mpn242/secG and mpn243/rnr. In addition, a constitutive up-regulation of 
transcription of the rpsJ operon was observed in GPM22, whereas transcription of this operon 
decreased along the growth curve in the wild type. This operon has a size of about 13 kbp and 
consists of 25 genes (ORFs mpn164/rpsJ to mpn188/rpmJ), 21 of which encode ribosomal 
proteins. Transcription of other ribosomal genes was not affected in the mutant. Because up-
regulation of this operon occurs along the whole growth curve it meets the criterion to be 
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directly regulated by Mpn241/WhiA. However, the exact mechanism of regulation and the 
role of Mpn241/WhiA in regulating this operon require additional experiments.  
 
Fig 3.32: Heat map display of transcription signals from genes encoding ribosomal proteins 
Only genes encoding ribosomal proteins located in the rpsJ operon are affected in transcription by the 
mpn241/whiA disruption in strain GPM22. 
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Fig. 3.33:  Fold changes of transcription of the rpsJ operon 
A specific up-regulation of the rpsJ operon along the growth curve is observed in GPM21 in comparison to the 
fold changes (X-axis) of surrounding genes.  
-1,5 -1 -0,5 0 0,5 1 1,5 2 2,5 3 3,5 
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4. Discussion 
 
4.1 Last men standing: essentiality of transcription regulators in M. pneumoniae 
M. pneumoniae lives as a parasite in a rather constant and nutrient rich environment, the 
human lung. It was proposed previously that this close adaption to its host is not only 
reflected by its reduced genome, but also by a reduced ability to regulate transcription: only a 
handful of genes putatively involved in transcription regulation are encoded in its genome 
(Ochman and Davalos, 2006). Tab. 4.1 below supports this hypothesis. Obligate pathogenic 
bacteria highly adapted to eukaryotic hosts such as Phytoplasma, Mycoplasma or Chlamydia 
tend to have smaller genomes and a lower number of transcription regulators compared to 
ubiquitous, facultative pathogenic bacteria like Bacillus or Pseudomonas.  
 
Genome Genes Predicted TF Average genes per TF 
(Human mitochondria) (37) (0) (0) 
Onion Yellows Phytoplasma OY-M 754 2 377 
Mycoplasma pneumoniae 689 4 172.3 
Chlamydia trachomatis D/UW-3/CX 895 4 223.8 
Treponema pallidum ssp. pallidum Nichols 1036 6 172.7 
Helicobacter pylori 26695 1576 8 197 
Campylobacter jejuni RM1221 1838 24 76.6 
Neisseria meningitidis MC58 2063 49 42.1 
Streptococcus pneumoniae G54 2115 95 22.3 
Staphylococcus aureus ssp. aureus N315 2588 121 21.4 
Bacillus anthracis Ames 5311 298 17.8 
Pseudomonas aeruginosa PA7 6286 436 14.4 
 
Tab. 4.1: Transcription regulators in pathogenic bacteria. 
Numbers of genes and predicted transcription factors (TF) in selected pathogenic bacteria, sorted by their 
number of genes. Genome reduction and loss of regulatory potential are correlated in obligate pathogenic 
bacteria whereas opposite trends are visible in facultative pathogens (top to bottom). The data were taken from 
www.transcriptionfactor.org (Wilson et al., 2008). 
 
Thus, adaption to a eukaryotic host providing nutrients and offering a stable environment 
allows bacteria to reduce their genome and decreases the need to regulate gene expression. 
This results in a degenerative evolution of the genome with a simultaneous increase of 
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dependency on the host, as proposed for Mycoplasma (Woese et al., 1979). This phenomenon 
raises two important questions: What is the minimal number of genes required for 
autonomous growth, and what is the minimal requirement of regulation for these genes?  
Whereas answers to the first question were given in previous studies, only little is known 
about regulatory events in minimal organisms, such as M. pneumoniae. In this study, a 
transposon insertion library was screened for viable disruption mutants of genes putatively 
involved in transcription regulation. Only two genes were found to be non-essential, i.e. 
mpn397/relA and mpn241/whiA. The finding of several essential transcription regulators is 
surprising since only very few cases in bacteria have been described yet, among them the 
essential WalK/R two-component system conserved in gram positive bacteria with the 
exception of the Mollicutes (Fabret and Hoch, 1998). However, this also raises the question 
why these regulators are essential, whereas their orthologues in other bacteria are not. For 
example, spx mutants have been described in B. subtilis, S. aureus and S. mutants while the 
orthologue Mpn266/Spx is essential in M. pneumoniae (Nakano et al., 2001; Pamp et al., 
2006; Kajfasz et al., 2009). Three general possibilities could explain the essentiality of 
Mpn266/Spx and the other transcription regulators: (I) The transcription regulator is 
constantly required and therefore indispensable for cellular processes, (II) it is required under 
the laboratory growth conditions and therefore dispensable under certain, unknown conditions 
and (III) it is essential because disruption of the gene leads to polar effects on the 
neighbouring genes that affect viability of the cell.  
In the case of mpn266/spx, all three explanations could account for its essentiality. In contrast 
to its orthologues in other bacteria, expression of mpn266/spx is not regulated in                    
M. pneumoniae and it constantly interacts with the core RNA polymerase in vivo, as 
concluded from co-purification experiments (Güell et al., 2009; Kühner et al., 2009).  
Therefore the author of this thesis proposed that Mpn266/Spx might have become an integral 
part of the M. pneumoniae RNA polymerase that helps to overcome the weakly defined 
promoters by allowing it to bind to additional, cis-acting promoter elements. However, no 
consensus sequence up- or downstream of the putative -35 region of promoters was detected 
that could serve as additional or alternative promoter element, neither in two independent 
studies focussing on transcription in M. pneumoniae nor in this work, making it difficult to 
verify this hypothesis (Weiner et al., 2000; Güell et al., 2009). On the other hand, 
Mpn266/Spx might be only essential under laboratory growth conditions, due to oxidative 
stress. Two independent sources of H2O2 have been described in M. pneumoniae, with the 
majority resulting from glycerol metabolism (Low and Zimkus, 1973; Hames et al., 2009). 
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H2O2 can lead to the formation of oxygen radicals by the Fenton reaction, and thus to 
oxidative stress. Spx orthologes are transcriptional activators responding to thiol specific 
oxidative stress, and the responding CxxC motif at the N-terminus of Spx proteins is also 
conserved in Mpn266/Spx. Therefore it is tempting to speculate that this protein fulfils a 
similar role in M. pneumoniae. Because the medium used to grow M. pneumoniae contains 
20% horse serum and hence a certain amount of glycerol or glycerol-3-phosphate, a 
permanent accumulation of H2O2 accompanied by an increasing acidification of the medium 
due to glycolytic activity during growth is very likely. Both H2O2 and acidification are 
prerequisites for the Fenton reaction and could therefore be the cause of permanent oxidative 
stress in M. pneumoniae during growth in Hayflick medium, making Mpn266/Spx 
indispensible under this condition. Finally, mpn266/spx might be essential due to the 
essentiality of its neighbouring genes. mpn266/spx is the first gene of a five-gene operon, 
incoding a putative inorganic polyphosphate/ATP-NAD kinase (mpn267) and the orthologue 
of RNaseY (mpn269) described in B. subtilis (Commichau et al., 2009; Shahbabian et al., 
2009). Besides mpn266/spx, two genes of this operon are essential as was shown in previous 
studies, and at least RNaseY is essential in other bacteria as well (Hutchison et al., 1999; 
Glass et al., 2006; Kobayashi et al. 2003). Therefore, disruption of Mpn266/Spx by a 
transposon could prevent transcription of neighbouring essential genes or interfere with 
transcription regulation of the whole operon, thereby becoming essential due to polar effects 
instead of a required function of the protein itself. 
In the case of Mpn329/Fur, the essentiality presumably results from the fact that it is required 
to regulate one or several target genes whose uncontrolled expression would be cytotoxic for 
the cell. None of the genes downstream of mpn329/fur is essential, eliminating the possibility 
of polar effects by transposon insertion as described for mpn266/spx. Furthermore, all 
members of the Fur-family in Gram-positive bacteria described so far are repressors 
responding to metal homeostasis or, in the case of PerR, to peroxide stress. To date, no 
bacterial transcription repressor has been reported that becomes essential under certain 
conditions. Assuming that Mpn329/Fur also acts as a repressor in M. pneumoniae, it is 
therefore more likely that this protein is required to prevent over-expression of harmful target 
genes. Different approaches have been used to identify target genes of Mpn329/Fur in this 
work. Several putative targets have been identified fulfilling the predicted phenotype of Fur-
family proteins, i.e. up-regulation during starvation on the cofactor Fe2+ required to obtain 
DNA binding ability. However, none of the putative target genes harbours a DNA binding-
motif in its promoter region resembling that of Fur-family proteins in other bacteria, making it 
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difficult to proof a direct regulatory effect by Mpn329/Fur on these genes (as will be 
discussed in chapter 4.4 below). Because no target could be identified, it is still unclear if 
Mpn329/Fur belongs to the Fur, PerR or Zur subfamily of Fur proteins. In other bacteria, Fur 
regulates the expression of genes involved in synthesis, secretion and uptake systems of 
siderophores in response to depleting Fe2+ to maintain iron homeostasis. However, human 
pathogenic bacteria have to overcome the problem that no free Fe2+ is available since it is 
bound to specialized chelator proteins like lactoferrin or transferrin, a passive defence against 
microbial colonization. Many bacteria therefore have adapted to their host by developing 
specialized transporters or binding proteins to utilize lactoferrin or transferrin as sources of 
Fe2+, like the human pathogen N. meningitidis (Mickelsen and Sparling, 1982; Schryvers and 
Morris 1988). In good agreement with its close adaption to its host, M. pneumoniae was also 
shown to specifically bind human lactoferrin, providing evidence for a specialised transport 
system (Tryon and Baseman, 1987). If such a transport system were present in                       
M. pneumoniae, it would likely be under the control of Fur. However, despite the OppB 
peptide transporter conserved among bacteria, no putative transport system or membrane 
anchored protein was up-regulated during iron starvation, suggesting that Mpn329/Fur does 
not belong to the Fur subgroup. As mentioned previously and in good agreement with these 
findings, Mpn329/Fur shows a higher degree of homology with PerR proteins from several 
Firmicutes than with Fur. The presence of a peroxide responsive transcription regulator 
makes sense in M. pneumoniae because it would allow triggering detoxification from self-
produced H2O2 with concomitant protection of the redox-state of the cell. However, no 
enzyme neutralizing H2O2 known in other bacteria such as catalase is present in the genome 
of M. pneumoniae. One of the genes up-regulated in response to iron starvation is 
mpn394/nox, a predicted NADH oxidase. Interestingly, PFAM and BLAST analyses show 
that these proteins share domain homologies with several redox-acting enzymes, among them 
NADH dependent peroxidases. However, enzymatic activity of Mpn394/Nox to oxidate 
NADH was shown previously (C. Hames, doctoral thesis). Moreover, no conserved DNA 
motif was found in the promoter region of this gene (see chapter 4.4 below). Even though a 
participation of Mpn394/Nox in H2O2 detoxification cannot be excluded, a direct regulation 
by Mpn329/Fur is very unlikely. Assuming that Mpn329/Fur indeed is a PerR orthologue in 
M. pneumoniae, one reason why no putative target could be identified by the experiments 
performed might be permanent oxidative stress by H2O2 formation under laboratory growth 
conditions, as already discussed for Mpn266/Spx. H2O2 originating from glycerol or glycerol-
3-phosphate degradation could lead to a permanent induction of Mpn329/Fur regulated genes, 
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making a further induction by iron depletion marginal or impossible. To proof this hypothesis, 
a serum-free medium would be required containing minimal amounts of sources for glycerol 
or glycerol-3-phosphate. Until this, alternative methods to characterize and to identify targets 
of Mpn329/Fur have to be developed. 
Even though almost known for 20 years, essentiality of HrcA orthologues in other bacteria 
than M. pneumoniae has not been reported to date. Essentiality of Mpn124/HrcA due to polar 
effects can be excluded due to its monocistronic transcription, leaving cytotoxic effects of its 
target genes the only logical reason to explain this phenotype. Mpn124/HrcA controls the 
transcription of chaperones and proteases in M. pneumoniae and other bacteria. However, in 
contrast to other bacteria, only three putative proteases are present in the genome of              
M. pneumoniae, two of which are under control of HrcA: Mpn332/Lon and Mpn531/ClpB 
(Chang et al., 2008). Both proteases have been characterized previously (Gur and Sauer, 
2008; Ge and Krazai, 2009; Kannan et al., 2008). The third protease, Mpn671/FtsH is 
conserved in most bacteria and involved in the proteolysis of cell division proteins 
(Schumann, 1999). Hence, deletion of HrcA would lead to an increased expression of the only 
two proteins putatively involved in protein turnover in M. pneumoniae. In B. subtilis, more 
then 30 putative proteases can be found (http://subtiwiki.uni-goettingen.de/) that could help to 
degrade HrcA-dependent proteases like Lon or ClpB, thereby compensating HrcA deletion in 
this organism. Thus, uncontrolled expression of proteases might be cytotoxic for                     
M. pneumoniae and could explain the requirement of Mpn124/HrcA for viability. The finding 
that perfect CIRCE elements are only found upstream of M. pneumoniae mpn332/lon and 
mp531/clpB and that CIRCE is even missing upstream of M. genitalium groEL/ES is 
supporting this hypothesis (Chang et al., 2008).  
mpn239/gntR is located in the middle of a large operon. Its ORF overlaps with those of its 
neighbouring genes, mpn238/gatB and mpn240/trxB, both of which are essential. Therefore it 
is tempting to speculate that essentiality of Mpn239/GntR results from the essentiality of its 
neighbouring genes. However, essentiality of this regulator might also result from a 
requirement of tight control of its target genes, either in general or only under laboratory 
growth conditions used.  
To answer the question whether a regulator is essential due to its function or due to its 
location in the genome, clean deletions or deletions that maintain the transcription start point 
of downstream genes generated by homologous recombination would be required to 
circumvent polar effects on the neighbouring genes. If the regulator is essential due to its 
function, several approaches to identify its targets can be imagined. Replacement with an 
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inducible expression system coupled with global analysis such as microarray or 2D-gels has 
been used to identify targets of the essential WalK/R two-component system or RNaseY in    
B. subtilis (Howell et al., 2003; Martin Lehnik, personal communication). Recent publications 
show that targeted knockout by homologous recombination is working in                               
M. pneumoniae, though with very low efficiency, and the development of a tetracycline 
inducible expression system functional in the Mollicutes was reported previously (Breton et 
al., 2010; Krishnakumar	   et	   al.,	   2010). Thus, the prerequisites for such an experiment are 
given. Alternatively, this experiment could also be performed in the close relative                 
M. genitalium in which homologous recombination works more efficiently. Another method 
to identify the target of an essential transcription regulator is ChIP-chip, as explained 
previously. This approach has the advantage that the experiment can be performed with native 
bacterial cells, thereby preventing construction of artificial strains that might interfere with 
the experiment.  
 
 
4.2 Evaluation and interpretation of microarray data from M. pneumoniae 
Microarray experiments have been used to study transcriptional responses towards certain 
stimuli or to identify targets of putative transcription regulators in bacteria for quite a while. 
However, strategies to normalize growth conditions of the bacteria and to interpret the data 
resulting from such experiments have to be individually defined for each bacterium. In this 
study, for the first time ever, M. pneumoniae strains with transposon insertions in genes 
putatively involved in transcription regulation have been examined by microarray analysis. 
The main difference between M. pneumoniae and other bacteria is its adherent growth that 
prevents normalisation of the growth state of a culture. Whereas the growth state of non-
adherent bacteria like B. subtilis or E. coli can be monitored by measuring the optical density 
of a culture, this is not possible with M. pneumoniae. Furthermore, shaking of cultures of non-
adherent bacteria ensures an equal distribution of nutrients and end-products of metabolism. 
In contrast, local differences in cell density of adherent M. pneumoniae cultures lead to 
differences in nutrient availability or local accumulation of metabolic end-products, and thus 
to different conditions within a single culture. In consequence, transcription signals of each 
single culture individualize along the growth curve as can be seen in Fig. 4.1. In this figure, 
scatter plots of transcription signals of wild type and GPM68 (prpC::Tn) from cultures    
grown for 6 h and 96 h are compared to visualize the decrease of conformity of      
transcription signals along the growth curve. Thus, all cultures analyzed by microarrays in 
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this work showed a high degree of conformity within the first 24 h and a decreased 
conformity within 48 h to 96 h.  
 
 
Fig. 4.1: Decrease of conformity of transcription signals along the growth curve 
Scatter plots of M. pneumoniae wild type and GPM68 transcription signals at time points 6 h and 96 h. The 
longer different strains grow, the less transcriptional signals correlate due to a lack of culture normalisation. 
 
The aim of this work was to identify genes that are directly or indirectly controlled by the 
genes knocked out in the mutant strains. To overcome the lack of culture normalisation and to 
allow differentiating between differences in transcription that are either due to the genetic 
knockout or resulting from the different growth states of two cultures compared, the following 
hypothesises have been developed: 
 
I. A gene is under direct control of the knocked out gene or influenced by a certain stimulus 
(such as iron depletion) if a regulatory effect is visible (in the mutant strain or treated culture) 
along the whole growth curve. 
 
II. The direction of regulation of the gene, i.e. up- or down-regulation of transcription, has to 
be constant along the growth curve. 
 
III. If a regulated gene is located within an operon, downstream genes should be affected by 
the regulatory event. 
 
These hypotheses were made from experiences of previous microarray experiments with      
M. pneumoniae and mainly result from observations of the HrcA regulon:  all genes of this 
regulon are constantly up-regulated along the growth curve at elevated temperatures, and 
downstream genes are affected by transcription read-through, as also observed in this work 
(Weiner et al., 2003; Güell et al., 2009). Hence, genes that are regulated in a Fe2+ dependent 
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manner or whose regulation depends on genes hprK/ prpC/ relA/ whiA would be constantly 
up- or down-regulated in cultures grown in the presence of the iron chelator 2,2´-dipyridyl or 
cultures of the corresponding mutant strains, respectively. As will be discussed below, the 
transcription pattern of GPM22 (mpn241) matches these criteria. A constant up-regulation of 
transcription of the 25 genes long mpn164/rpsJ operon is visible in this strain when compared 
to the wild type, thereby serving as a proof-of-principle for the hypotheses discussed above. 
In contrast, with the exception of polar effects by the transposon insertion, no such behaviour 
was observed for any gene in the mutant strains GPM21 (relA), GPM51 (hprK) or GPM68 
(prpC), suggesting that these genes are neither directly nor indirectly involved in transcription 
regulation under the conditions tested.  
Compared to other bacteria that have been investigated by microarray analysis, induction 
factors by mutation of the putative transcription regulator Mpn241/WhiA are somewhat low. 
Whereas fold changes of 30 and higher are observed on E. coli or B. subtilis, the highest 
induction of the mpn164/rpsJ operon observed is fold changes of about 3. However, several 
reasons could explain this phenomenon. First, the use of different microarray platforms that 
deliver different signal intensities and thus different fold change calculations. Second, 
massive data normalisation is required to compare cultures of different strains due to the fact 
that growth of the cultures themselves cannot be normalized, as discussed above. Finally, a 
comparatively low abundance of RNA polymerase has been reported for M. pneumoniae, 
leading to extremely low levels of mRNA and hence to a lower induction of transcription 
(Weiner et al., 2003; Kühner et al., 2009).  
 
 
4.3 Sequence conservation and cis-acting regulatory elements in M. pneumoniae 
A general problem in working on transcription in M. pneumoniae is the fact that DNA 
sequences involved in transcription initiation or regulation are only weakly conserved. As 
reported previously, promoter sequences lack a consensus -35 region and show a high 
variability of the central bases of the -10 region (Weiner et al., 2000; Halbedel et al., 2007; 
Güell et al., 2009). Interestingly, Mpn352/SigA shows an unusual amino acid composition in  
domain 4.2 responsible for recognition and binding to -35 regions of promoters, whereas 
domain 2.4 responsible for recognition and binding to -10 regions is highly conserved (Fig. 
4.2; Gruber and Groß, 2003). This observation results in a “hen or egg” question: are weakly 
conserved promoters a consequence of mutations in conserved domains of the sigma factor, or 
did the loss of conservation in region 4.2 result from a high sequence variability of M. 
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pneumoniae promoters? The answer to this question might be concluded from a recent 
publication on transcription in the human pathogen H. pylori (Sharma et al., 2010). As shown 
in Tab. 4.1, this bacterium has a rather small genome that harbours only very few putative 
transcription regulators just like M. pneumoniae, and transcription is initiated by only three 
different sigma factors. Thus, the equipment of H. pylori to initiate and regulate transcription 
somewhat resembles that of M. pneumoniae. Interestingly, H. pylori promoters also resemble 
those of M. pneumoniae: they only consist of a -10 region with a high sequence conservation 
of the outer bases, TANNAT. Multiple alignments of regions 2.4 and 4.2 from different 
housekeeping sigma factors show that domain 4.2 of H. pylori SigA has 8 non-conserved 
amino acids in this domain, 5 of them at the same positions as the mutations in domain 4.2 of 
SigA from M. pneumoniae (Fig. 4.2). In domain 2.4, 2 of 4 deviations from the consensus are 
located at the same positions in the sigma factor of both bacteria. Thus, even though only 
distantly related, both bacteria have developed mutations in the same positions of their 
housekeeping sigma factor, leading to a similar promoter sequence recognized by these 
proteins. 
 
Fig. 4.2: Mutations in the amino acid sequence of conserved domains in housekeeping sigma factors 
Protein structure of the E. coli [holo] RNA polymerase consisting of α (green and yellow), β (blue), β´ (rose), δ 
(grey) and σ (pink). Below: multiple alignments of regions 2.4 and 4.2 of the house-keeping sigma factor from 
Escherichia coli (Eco), Neisseria gonorrhoe (Ngo), Lactococcus casei (Lca), Bacillus subtilis (Bsu), Listeria 
monocytogenes (Lmo), Helicobacter pylori (Hpy) and Mycoplasma pneumoniae (Mpn). Deviations in the same 
amino acid residues might be responsible for similar promoter requirements of M. pneumoniae and H. pylori. 
Discussion 115	  
Both M. pneumoniae and H. pylori have in common that transcription is initiated with only 
few sigma factors. Therefore they could tolerate mutations in the amino acid composition of 
their sigma factors that lead to a loss of function in recognizing a defined -35 promoter 
sequence and, in consequence, resulting in a loss of conserved -35 sequences of promoters. In 
contrast, bacteria like B. subtilis that regulate transcription by recruiting up to 20 different 
sigma factors (http://subtiwiki.uni-goettingen.de) require highly conserved promoters to 
prevent transcriptional cross-talk or deregulation of transcription. Hence, promoter 
conservation depends on the ability of a bacterium to tolerate mutations in its sigma factor 
that itself seems to correlate with the total number of sigma factors used to initiate 
transcription. This hypothesis could therefore explain why B. subtilis is not able to recognize 
promoters from M. pneumoniae, as was shown in this work. 
The same hypothesis discussed above could also explain the weak conservation of cis-acting 
regulatory sequences in M. pneumoniae, such as CIRCE. From 5 predicted CIRCE elements, 
only 2 upstream of protease genes mpn332/lon and mp531/clpB are perfect inverted repeats 
without any mismatches. In other bacteria such as B. subtilis, genes are often targeted by 
several different transcription factors and therefore require highly conserved DNA sequences 
recognized by specific regulators. This is not the case in bacteria possessing only very few 
transcription factors, therefore these bacteria can tolerate a certain extent of mutations within 
these regulatory DNA elements. Because a weak conservation of these cis-acting elements 
results in a weak responsiveness toward its regulator, only elements upstream of genes whose 
regulation is required for viability maintain conserved, as discussed above. This lack of 
sequence conservation raises difficulties to predict new cis-acting elements recognized by the 
remaining transcription regulators. The fact that all putative transcription regulators present in 
M. pneumoniae can also be found in its close relative M. genitalium can help to overcome this 
problem: since both bacteria possess the same regulators, at least one of their target genes has 
to be present in both genomes, and thus the cis element should be found upstream of these 
genes.  
In this work, several experiments were performed to identify genes that are under control of 
Mpn329/Fur. Even though several putative target genes could be identified by their 
phenotype, i.e. up-regulation of transcription under Fe2+ depleting conditions, none of these 
genes neither harboured an inverted repeat resembling Fur- or PerR-boxes upstream of its 
start codon, nor any other sequence conserved in both M. pneumoniae and M. genitalium. 
Therefore it is unlikely that Mpn329/Fur directly controls these genes and the regulation is 
due to a so far unknown mechanism independent of a conserved cis-acting element. On the 
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other hand, in silico sequence analysis using several different databases revealed a conserved 
sequence upstream of mpn527 and its orthologe in M. genitalium that harbours a complex 
inverted repeat that strongly resembles Fur- and PerR boxes from B. subtilis. mpn527 encodes 
for a putative membrane associated oxidoreductase with orthologues in M. pneumoniae,               
M. genitalium and M. gallisepticum, hence all three Mycoplasma species with orthologues of 
Mpn329/Fur. However, no regulation of mpn527 was observed in any experiment performed 
in this work, probably due to permanent oxidative stress as discussed previously. Thus, this 
work could not provide experimental evidence that Mpn329/Fur regulates this gene. In 
addition to this putative Fur/PerR-box, in silico analysis of intergenic regions from M. 
pneumoniae using the RibEx database (Abreu-Goodger and Merino, 2005) revealed the 
presence of a novel putative cis-acting element upstream of Mpn314/MraZ. MraZ is a protein 
putatively involved in cell division and widely conserved among bacteria. Interestingly, the 
discovered motif is found upstream of mraZ in all bacteria examined, suggesting a common 
mechanism of regulation. Expression of mraZ by an artificial unregulated promoter leads to 
cell lysis in E. coli, underlining the requirement of regulation of mraZ in bacteria. Thus, 
conservation of this motif might be required to maintain viability of M. pneumoniae (Mengin-
Lecreulx et al., 1998). 
 
 
Fig. 4.3: Putative cis-acting DNA motifs in M. pneumoniae.  
A: multiple alignments reveal a conserved sequence within the intergenic region upstream of Mpn527 and 
Mge521 (red), resembling PerR and Fur boxes from B. subtilis. An inverted repeat (9-AA-9) conserved in both 
Mycoplasma species that might be the target sequence of Mpn329/Fur is underlined. B: Novel conserved DNA 
motif upstream of mraZ identified by comparisons of upstream sequences from M. pneumoniae, M. genitalium, 
B. subtilis, S. aureus, C. glutamaticum, E. coli, C. tetani, T. thermophilis, E. faecalis, P. aeroginosa, M. 
tuberculosis and Y. pestis. This motif is found in all bacteria possessing mraZ but its function is so far unknown. 
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4.4 mpn397/relA: a gene without a function? 
The stringent response and the role of (p)ppGpp in transcription regulation in M. pneumoniae 
were one of the main focuses of this work. Even though it could be shown that the 
mechanisms that lead to (p)ppGpp synthesis are conserved in M. pneumoniae, no obvious 
phenotype of an mpn397/relA mutant was observed in a variety of experiments. Moreover, 
transcriptional responses of the mpn397/relA mutant towards amino acid starvation or glucose 
downshift resembled those of the wild type, suggesting no involvement of (p)ppGpp in 
transcription regulation in M. pneumoniae. In B. subtilis and other Firmicutes, transcription 
regulation during the stringent response is a passive effect due to the inhibition of GTP 
synthesis: (p)ppGpp inhibts the activity of IMP dehydrogenase, a key enzyme of GTP 
synthesis, leading to reduced levels of intracellular GTP and a lowered synthesis of transcripts 
that initiate with GTP as start nucleotide (Krásný et al., 2008; Tojo et al., 2010). In M. 
pneumoniae, IMP dehydrogenase is absent and, according to this, preliminary results indicate 
that intracellular GTP levels were only slightly lowered when ppGpp accumulated in cells 
treated with serine hydroxamate. Hence, the missing ability to decrease amounts of 
intracellular GTP could explain the lacking transcription regulation due to ppGpp 
accumulation. This theory is supported by the fact that M. pneumoniae is not able to down-
regulate transcription of stable RNA species, neither in response to amino acid starvation nor 
to glucose starvation (Eva Yus, CRG Barcelona, personal communication). In contrast, down-
regulation of rRNA synthesis accompanied with (p)ppGpp accumulation in response to amino 
acid starvation was reported for Mycoplasma capricolum which possesses both RelA and IMP 
dehydrogenase enzymes (Glaser et al., 1981). Interestingly, the occurrence of IMP 
dehydrogenase does not correlate with the occurrence of RelA in the Mollicutes: analysis of 
the 27 available Mollicutes genomes shows that only 5 members encode an IMP 
dehydrogenase orthologue, whereas 15 (including those with IMP dehydrogenase) possess a 
RelA orthlogue. Thus, the ability to induce (p)ppGpp synthesis during nutrient starvation 
seems to be advantageous for these bacteria, even though it is unlikely to be involved in 
transcription regulation. This raises the question about alternative functions of (p)ppGpp  in 
these bacteria. Despite of being involved in transcription regulation, (p)ppGpp triggers the 
activity of a variety of enzymes by interacting with these proteins. For example, (p)ppGpp 
was shown to interact with the ribosome associated GTPase Obg,  translation initiation factor 
IF-2 and elongation factors Tu, Ts and G, thereby affecting ribosome assembly, translation 
initiation or peptide elongation in other bacteria (Buglino et al., 2002; Persky et al., 2009; 
Milon et al., 2006; Roja et al., 1984). Because these proteins are highly conserved among 
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bacteria and orthologues are also present in the genome of M. pneumoniae, it is tempting to 
speculate that (p)ppGpp can also trigger their activity in this organism. Thus, M. pneumoniae 
could down-regulate protein synthesis without further decreasing the number of ribosomes, 
whose number is already estimated to only 150 to 300 per cell. This might also explain why 
no transcription regulation is required. In addition to controlling protein synthesis, (p)ppGpp 
triggers cell division by inhibiting the enzyme primase to prevent DNA replication (Wang et 
al., 2007; Maciąg et al., 2010). It was therefore proposed previously that (p)ppGpp synthesis 
could help M. pneumoniae and other Mollicutes to persist during nutrient limitation by 
shutting down metabolic activities and replication. This hypothesis was developed from the 
finding that Mycoplasma species could be recovered from cultures containing high 
concentrations of puromycin, an antibiotic that targets protein synthesis (Algire et al., 2009). 
However, repetition of this experiment using M. pneumoniae wild type and Mpn397/RelA 
mutant strain GPM21 showed no advantage of the wild type, and both strains could be 
recovered even after 96 h incubation with the antibiotic (data not shown). Hence, there is no 
evidence that Mpn397/RelA helps M. pneumoniae to persist nutrient starvation in vitro.  
Recent findings show that (p)ppGpp is not only involved in triggering regulatory processes 
that help to overcome nutrient starvation, but also in optimizing protein costs when exposed 
to changing nutrient availabilities (Shachrai et al., 2010). Protein cost describes the penalty of 
fitness due to synthesis of unneeded proteins in bacteria: if unused proteins are synthesized, 
energy in forms of ATP or GTP and amino acids is unnecessarily consumed, leading to 
disadvantageous effects for the cell. Hence, triggering translation to prevent unnecessary 
protein synthesis is beneficial for bacteria and may be the reason why RelA is conserved in 
M. pneumoniae. Even though being surrounded by protein in its natural habitat, energy 
generation by ATP synthesis might be a limiting factor to synthesize proteins, leading to 
uncharged tRNAs (due to low levels of ATP required for aminoacetylation), and thus to 
(p)ppGpp synthesis to keep translation rates low. The hypothesis of (p)ppGpp as a general 
trigger of translation rather then as a trigger of an emergency response toward nutrient 
starvation rates is supported by the finding  that a RelA-independent transcription response 
towards amino acid starvation or glucose down-shift was observed, as already observed in         
S. pyogenes (Steiner and Malke, 2000). 
Finally, the possibility that long-term starvation leads to a decreased pool of intracellular 
GTP, due to an exhaustive conversion to (p)ppGpp in these bacteria that leads to transcription 
regulation, cannot be excluded and requires further examination.  
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4.5 A novel role of HPr phosphorylation? pH-dependent control of carbon uptake 
Even though the mechanism of HPr phosphorylation has already been extensively studied, 
only little is known about the physiological role of this conserved mechanism in                         
M. pneumoniae. This work finally confirms that the phosphorylation state of HPr is not 
involved in transcription regulation, which is in good agreement with proteome analyses of 
hprK and prpC mutants (Schmidl et al., 2010). However, this finding is not too surprising 
since no transcription regulator responsive to HPr phosphorylation such as CcpA is present in 
the genome of M. pneumoniae. In fact, CcpA orthologues are missing in all Mollicutes with 
the exception of A. laidlawii, which is more closely related to the Firmicutes. In contrast, HPr 
kinase is present in the genome of the majority of the Mycoplasmas, but absent in the 
Phytoplasma subgroup. Thus, just like RelA as discussed above, the phosphorylation state of 
HPr plays a role in the Mollicutes distinct from regulating transcription as in the Firmicutes. 
In this work, evidence is provided that HPr phosphorylation is involved in regulating the 
uptake of glucose and other PTS sugars in a pH-dependent manner: whereas the wild type 
stops to acidify the medium by metabolizing glucose at a certain pH, an hprK mutant is 
consuming all glucose available and acidifies the medium to a much lower pH. In contrast, a 
prpC mutant stops metabolizing glucose at a much higher pH compared to the wild type. The 
inability of HPr(Ser-P) to participate in phosphotransfer for glucose uptake due to 
conformational changes of the protein has been described in B. subtilis previously (Reizer et 
al., 1989). Because of the high degree of structural homology, it is tempting to speculate that 
phosphorylation of Ser46 has the same structural consequences in HPr from M. pneumoniae. 
Hence, it seems that either phosphorylation or dephosphorylation of HPr at Ser46 is regulated 
in a pH dependent manner, thereby inhibiting glucose uptake to prevent over-acidification of 
the medium. This hypothesis is in good agreement with the finding that re-buffering of M. 
pneumoniae cultures to basic pH leads to complete consumption of glucose, whereas glucose 
uptake stops at a certain pH if no buffering occurs (Judith Wodke, CRG Barcelona, personal 
communication).  
In other Gram-positive bacteria such as B. subtilis, different phosphorylated forms of HPr 
interact with proteins or are involved in phosphorylation events (other than PTS), both aiming 
to trigger enzymatic activities. However, in addition to HPr, no additional phosphorylation 
events related to HPrK were observed in M. pneumoniae in previous studies (Schmidl et al., 
2010). Moreover, no putative interaction partners despite PTS related enzyme II and HprK 
were identified in a global interactome study in M. pneumoniae (Kühner et al., 2009), 
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suggesting that pH dependent regulation of glucose uptake is the only function of HPr(Ser-P) 
in this organism. 
 
 
4.6 Transcription regulation of the rpsJ operon by WhiA: a general case? 
Among all strains investigated by microarray analysis in this work, only the mpn241/whiA 
exhibited a phenotype that met all criteria for direct transcription regulation described in 
chapter 4.2: in this strain, a constitutive up-regulation of the mpn164/rpsJ operon consisting 
of 25 genes was observed when compared to the wild type. Moreover, whereas transcription 
of this operon constantly decreased in the wild type along the growth curve as already 
described previously (Güell et al., 2009), transcription intensity in the mpn241/whiA mutant 
stayed constantly high. Because of the predicted helix-turn-helix motif of Mpn241/WhiA and 
the de facto helix-turn-helix domain of its orthologue in T. maritima (Kaiser et al., 2010) it is 
tempting to speculate that Mpn241/WhiA indeed is a DNA-binding transcription regulator, 
responsible for the down-regulation of the rpsJ operon in the stationary phase of growth.  
Previous publications show that the rpsJ operon, also referred to as S10-spc-alpha cluster, is 
highly conserved in both Gram-positive and Gram-negative bacteria (Coenye and Vandamme, 
2005). In E. coli, transcription of this operon is feedback regulated by ribosomal protein L4 
that causes premature termination at a specific site of the leader sequence (Lindahl et al., 
1983). Moreover, several other operons in E. coli that encode ribosomal proteins are feedback 
regulated by transcriptional or translational control, an important system that permits 
stoichiometric synthesis of ribosomal proteins and helps to maintain balance of ribosomal 
protein and rRNA levels (Zengel and Lindahl, 1994).  However, neither ribosomal protein L4 
nor other proteins involved in these regulatory mechanisms are encoded in the S10-spc-alpha 
cluster of Gram-positive bacteria including M. pneumoniae, making an involvement of these 
proteins in the observed regulatory effect unlikely. In general, little is known about regulation 
of ribosomal protein synthesis in Gram-positive bacteria. To date, only very few mechanisms 
have been described, among them stringent control mediated by (p)ppGpp and the feedback 
autoregulation of ribosomal protein RpsD in B. subtilis (Grundy and Henkin, 1991; Eymann 
et al., 2002). Because controlled expression of ribosomal components is required for growth 
or complex cellular processes such as sporulation in B. subtilis, it might be possible that 
WhiA proteins are regulators that control the expression of the S10-spc-alpha cluster in 
Gram-positive bacteria (Nanamiya et al., 2010; Nanamiay and Kawamura, 2010). 
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Hence, if WhiA proteins are responsible for the regulation of the rpsJ operon in all Gram-
positive bacteria by binding to an operator sequence, a common DNA motif should be found 
upstream of this operon in all these bacteria. Interestingly, comparisons of the transcriptional 
start sites of the rpsJ operon from M. pneumoniae and B. subtilis show that their promoters 
are located more then 120 bp upstream of the first start codon, leading to unusually long 
leader transcripts (Li et al., 1997; Marc Güell, CRG Barcelona, personal communication). 
Thus, a common DNA motif putatively targeted by WhiA proteins might be located within 
this region.  
 
 
Fig. 4.4: Identification of a putative binding site for WhiA proteins upstream of rpsJ 
A: Multiple alignments of the leader sequence of rpsJ from B. cereus, B. licheniformis, B. subtilis, L. innocua,    
B. pumilus, L. monocytogenes, B. clausii, L. sakei, M. gallisepticum, U. parvum, M. pulmonis, L. lactis,                    
S. coelicolor, M. pneumoniae, M. genitalium, M. arthritidis and M. mycoides (top to bottom). A long, 
asymmetric DNA motif is conserved in the Firmicutes whereas only a gapped core motif is conserved in all 
sequences aligned. The motif is always located in a similar distance to the corresponding start codon of rpsJ 
(Start). B: MAST analysis of rpsJ leader sequences from 50 different bacteria possessing WhiA orthologues 
reveals the presence of a gapped, asymmetric core motif. The 3´ sequence of this motif strongly resembles 
sequences from -35 regions of bacterial promoters recognized by sigma70 factors, TTGACA. 
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To identify putative target sequences, multiple alignments of the up-stream regions of rpsJ 
from 8 Firmicutes and 8 Mollicutes in which WhiA orthologues occur, and that of                   
S. coelicolor in which a WhiA phenotype has been described, were performed. As shown in 
Fig. 4.4, an asymmetric 47 bp long DNA sequence is conserved in a similar distance to the 
start codon of rpsJ in all Firmicutes, whereas this sequence is only weakly conserved in the 
Mollicutes. Hence, the low degree of conservation of this sequence could explain the 
relatively weak induction of transcription in strain GPM22 due to a lowered affinity of 
Mpn241/WhiA to this region. MAST analysis (http://meme.sdsc.edu) of sequences upstream 
of rpsJ from 50 different Gram-positive bacteria that harbour WhiA orthologues reveals the 
presence of an asymmetric, gapped core motif present in all sequences. Interestingly, the 3´ 
part of this motif strongly resembles DNA sequences of -35 regions of bacterial promoters 
recognized by sigma70 factors. Structural analysis of a WhiA orthologue from T. maritima 
demonstrated that WhiA proteins possesses a bipartite structure, consisting of two putative 
DNA binding domains: an N-terminal domain showing a LAGLIDADG homing 
endonuclease (LHE) scaffold and a helix-turn-helix domain that strongly resembles related 
regions of bacterial sigma70 factors responsible for the recognition of -35 regions of 
promoters (Kaiser et al., 2009). Thus, it is tempting to speculate that this helix-turn-helix 
domain binds to the 3´ sequence of the discovered motif upstream of rpsJ. On the other hand, 
members of the LHE family bind to long, asymmetric DNA sequences that can be extremely 
degenerated by mutation (Gimble and Wang, 1996; Argast et al., 1998). Thus, the LHE-like 
domain could be involved in binding the 5´ sequence of this motif. However, despite RecA 
proteins in Mycobacteria that have been shown to maintain their endoculease activity, no 
protein of this family has been described in bacteria so far and nothing is known about DNA 
sequences recognized by these proteins (Singh et al., 2009). Therefore, further experiments 
are required to determine the prerequisites for DNA binding of WhiA proteins and the role of 
this DNA motif in the regulation of the S10-spc-alpha cluster in Gram-positive bacteria. 
Moreover, if WhiA proteins are acting as repressors, the mechanism by which the DNA 
binding activity of WhiA proteins is regulated requires further inestigations. Only very few 
possible protein interaction partners of Mpn241/WhiA have been discovered in a recent 
interactome study that could be involved in this mechanism. Among them were components 
of sugar transporters, enzymes of central metabolic pathways, translation elongation factor 
Tuf and DnaB involved in replication initiation, making several different mechanisms of 
regulation thinkable (Kühner et al., 2009).   
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The name WhiA is derived from the phenotype in S. coelicolor that forms white colonies if 
the orthologous gene is disrupted. Therefore, if further experiments indeed show that WhiA 
proteins are conserved regulators of the S10-spc-alpha cluster in Gram-positive bacteria, an 
alternative name is proposed for these proteins: transcriptional regulator of ribosomal 
proteins, TrrP. 
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5. Outlook 
 
Two of the main questions addressed in this work were (I) what is the minimal requirement of 
regulation of gene expression in a minimal organism, and (II) how does M. pneumoniae 
accomplish the massive transcription regulations observed previously (Güell et al., 2009) with 
such a little set of transcription regulators? This work shed some light at least on the first 
question by proofing the essentiality of some genes putatively involved in transcription 
regulation and by verifying the involvement of other genes in regulatory processes. However, 
several further questions result from this work. Because target genes of the putative, essential 
transcription regulators could not be identified in this work, their precise implication in 
transcription regulation is still not clear. Thus, alternative approaches such as ChIP-chip need 
to be developed for M. pneumoniae to identify targeted genes. Moreover, even though it could 
be shown that the mechanism leading to (p)ppGpp formation is conserved in M. pneumoniae, 
no phenotype could be observed, suggesting that M. pneumoniae lacks a stringent response 
known in other bacteria. RelA proteins are conserved in all facultative intracellular pathogens, 
but not in obligate intracellular pathogens. Furthermore, all relA mutants of pathogenic 
bacteria published to date are impaired in infection or host adaption. Hence, a proper infection 
model needs to be developed to proof an involvement of M. pneumoniae RelA in host 
adaptation. 
A participation of HPr(Ser-P) in transcription regulation could be excluded by the results of 
this work. However, evidence for a pH dependent feedback mechanism of HPr(Ser46) 
phosphorylation was provided leading to a stop of glucose uptake. To verify this mechanism, 
native blots using cell extracts have to be performed to proof a pH dependent phosphorylation 
state of HPr in M. pneumoniae in vivo. Moreover, in vitro phosphorylation experiments could 
be performed to study if the activity of HPrK is directly triggered by the pH or by an 
alternative mechanism including additional factors, such as proteins. 
Finally, experiments are required that proof that TrrP proteins (formerly WhiA) are conserved 
regulators of the S10-spc-alpha cluster in other Gram-positive bacteria. Therefore, trrP 
deletion mutants of other bacteria need to be constructed and the effect on transcription of the 
S10-spc-alpha cluster has to be studied. Such experiments are currently ongoing in the 
Firmicute B. subtilis. Moreover, experiments have to be performed to proof that TrrP binds to 
the conserved motif upstream of rpsJ. To achieve this, EMSA experiments using TrrP and 
DNA fragments containing rpsJ leader sequences from different bacteria could be performed. 
Mutational analysis of the conserved core motif and DNase foot-printing experiments would 
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then provide final evidence for a specific interaction of TrrP with this motif. However, all 
these proposed experiments only shed little light on transcription regulation in                       
M. pneumoniae. To get a much deeper insight into regulation of gene expression, the role of 
small non-coding RNAs needs to be studied, as well as RNA turnover and RNA processing 
since nothing is known about these regulatory events in M. pneumoniae.  
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6. Summary 
 
Mycoplasma pneumoniae has maintained only a small repertoire of genes putatively involved 
in transcription regulation. This reflects its adaption to a nutrient rich and rather constant 
habitat, the human lung epithelium. To date, the heat shock response regulator HrcA is the 
only characterized protein involved in transcription regulation in this organism. However, 
several transcription regulation events have been described, leading to the question which 
mechanisms or which regulators are responsible for these events. This work aimed to study 
the implication of the putative, so far uncharacterized regulators in transcription in                
M. pneumoniae. Screening of a mutant library showed that the majority of the genes encoding 
these regulators are essential for viability. Only mutants affected in genes relA and whiA, both 
widely distributed and highly conserved in bacteria, could be isolated from the library. In 
addition, interaction of protein Mpn266 with RpoA could be shown, providing evidence that 
this protein is an orthologue of transcription regulator Spx in the Firmicutes. However, this 
regulator is essential, too. Several experiments have been performed to characterize the role 
of RelA and the alarmone (p)ppGpp in M. pneumoniae. Whereas it could be shown that 
mechanisms leading to (p)ppGpp formation in this organism are conserved, no additional 
phenotype could be identified in a relA mutant despite an inability to synthesize these 
alarmones. An effect on transcription regulation could not be shown by microarray analysis. 
However, evidence was provided that (p)ppGpp formation is not involved in short-term 
regulation of transcription in M. pneumoniae. Experimental data indicate that the 
phosphorylation state of HPr is involved in regulating the uptake of glucose and other PTS 
sugars in a pH dependent manner, rather then in transcription regulation. Microarray analysis 
of a whiA mutant showed that a large operon consisting mainly of genes encoding ribosomal 
proteins is constitutively up-regulated in this strain. Both the regulator and the operon co-
occur in Gram-positive bacteria, suggesting a similar function of this regulator in other 
bacteria. The finding of a conserved DNA sequence upstream of this operon supports this 
hypothesis. In summary, this work provides the first microarray analyses of M. pneumoniae 
mutants. Furthermore, the first M. pneumoniae mutant impaired in transcription regulation 
and a novel putative role of HPr phosphorylation were described. Thus, this work provides a 
basis for future experiments that could help to understand regulatory mechanisms in this 
minimal organism. 
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Michael Lalk, mit dem ich die MS Experimente durchgeführt habe. Außerdem danke ich 
Prof. Luis Serrano vom CRG in Barcelona dafür dass ich mehr als 3 Monate in seinem 
Labor arbeiten durfte. Eva Yus und Marc Güell haben mich dabei nicht nur mit ihrem 
Know-how unterstützt.  
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Ohne Moos nix los? Es soll deswegen nicht unerwähnt bleiben dass die GGNB (nicht nur) 
meinen Forschungsaufenthalt in Barcelona finanziell unterstützt hat.  
In Forscherkreisen trifft man immer wieder auf das Stereotyp des irren Wissenschaftlers. Um 
zu verhindern dass man sich in einen eben solchen verwandelt braucht man eine gute 
Verankerung im Leben außerhalb des Labors. Solche Anker sind für mich unter anderem 
„meine Mädels“ Claudia Wrzos, Eva Wagner und Christina Heemann die mich bereits 
durch das gesamte Studium hinweg begleitet haben. Außerdem zu nennen wäre mein guter 
Freund Tobias Soffner. Einen Abend lang Musik auflegen im Eldorado brachte so manches 
wieder ins Lot. 
 
„Doktor Hinnerk Eilers, das klänge doch sehr gut.“ war ein Satz den mein während meines 
Studiums verstorbener Vater in meiner Kindheit einige Male angebracht hatte. Sowohl er als 
auch meine Mutter haben mich bis heute immer in allem was ich gemacht habe 
uneingeschränkt unterstützt. Aus diesem Grunde ist ihnen beiden diese Arbeit gewidmet. 
 
Kerstin. Am schwierigsten fällt es mir zu schreiben wie sehr ich Dir danke. Nicht, weil ich 
nicht weiß was ich schreiben soll, sondern weil kein Blatt Papier groß genug wäre um dies 
alles zu fassen. Ohne Dich gäbe es diese Arbeit nicht. Ich liebe Dich. 
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9. Appendix 
 
9.1 Materials 
 
9.1.1 Chemicals 
Chemical Source 
2,2'-dipyridyl Fluka, Buchs, Switzerland 
3-(N-morpholino)propanesulfonic acid (MOPS) Fluka, Buchs, Switzerland 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
(HEPES) 
Roth, Karlsruhe 
 
5-Brom-4-chlor-3-indoxyl-β-D-galactopyranosid 
(X-Gal) 
PeqLab, Erlangen 
 
8-Bromoadenosine 5′-triphosphate sodium salt Sigma-Aldrich, München 
Acrylamide Roth, Karlsruhe 
Agar Roth, Karlsruhe 
Agarose PeqLab, Erlangen 
Ammonium iron (III) citrate Sigma-Aldrich, München 
Ammonium Peroxydisulfate (APS) Roth, Karlsruhe 
Antibiotics Applichem, Darmstadt 
Blocking reagent Roche Diagnostics, Mannheim 
Bowine serum albumine MBI Fermentas, St. Leon-Rot 
Bromphenol blue Roth, Karlsruhe 
CDP* Roche Diagnostics, Mannheim 
Coomassie blue, G250 Roth, Karlsruhe 
D-Glucose Roth, Karlsruhe 
Desthiobiotin IBA, Göttingen 
Diethylpyrocarbonate (DEPC) Roth, Karlsruhe 
DL-Dithiotreitol Sigma-Aldrich, München 
DL-serine hydroxamate Sigma-Aldrich, München 
dNTPs Fermentas, Lithuania 
Ethidium bromide Roth, Karlsruhe 
Ethylenediaminetetraacetic acid (EDTA) Sigma-Aldrich, München 
Glycerol Merck, Damstadt 
Immidazole Sigma-Aldrich, München 
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Chemical Source 
Immidazole Sigma-Aldrich, München 
Isopropyl-ß-D-1-thiogalactopyranoside (IPTG) Sigma-Aldrich, München 
Ni2+-nitrilotriacetic acid superflow Qiagen, Hilden 
Nutrient Broth Roth, Karlsruhe 
Paraformaldehyde Roth, Karlsruhe 
Phenol red Roth, Karlsruhe 
Piperazine-N,N′-bis(2-ethanesulfonic acid) (PIPES) Roth, Karlsruhe 
Potassium acetate Merck, Damstadt 
Potassium glutamate Roth, Karlsruhe 
PPLO broth 
 
Becton, Dickinson & Company, 
France 
Skim milk powder Oxoid, Hampshire, UK 
Sodium citrate Roth, Karlsruhe 
Sodium Dodecyl Sulfate Roth, Karlsruhe 
Sodium hydroxide Roth, Karlsruhe 
Sodium succinate Fluka, Buchs, Switzerland 
ß-Mercaptoethanol Roth, Karlsruhe 
Starch Sigma-Aldrich, München 
Strep-Tactin Sepharose IBA, Göttingen 
Sucrose Sigma-Aldrich, München 
Tetramethylethylenediamine (TEMED) Roth, Karlsruhe 
Tris(hydroxymethyl)aminomethane (Tris) Roth, Karlsruhe 
Tryptone Oxoid, Hampshire, UK 
Tween 20 Sigma-Aldrich, München 
Xylencyanol Merck, Damstadt 
Yeast extract Oxoid, Hampshire, UK 
Tab. 9.1: Chemicals used in this study  
 
Other chemicals were purchased from Fluka, Merck, Roth, Oxoid, Serva or Sigma-Aldrich. 
Compounds for the preparation of M. pneumoniae defined media (chapter 2.1.2) were 
provided by the CRG, Barcelona. 
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9.1.2 Auxiliary material and consumables 
Material Source 
Cell culture flasks (75 cm2, 150 cm2, 300 cm2)  Renner GmbH, Dannstadt 
Cell culture plates (6 wells, 24 wells) TPP AG, Switzerland 
Cell scraper (240 mm) Renner GmbH, Dannstadt 
Centrifuge cups Beckmann, Munich 
Cuvettes (microlitre, plastic) Greiner, Nürtingen 
Dialysis tube Roth, Karlsruhe 
Electroporation cuvettes Bio-Rad, Munich 
Falcon tubes (15 ml, 50 ml) Sarstedt, Nümbrecht 
Gene amp reaction tubes Applied Biosystems, USA 
Glas pipettes Ochs, Bovenden 
Microlitre pipettes (2 µl, 200 µl, 1000 µl) Gilson, Düsseldorf 
Microtiter plates TPP AG, Switzerland 
Syringes, non-returnable  Becton Dickinson, Heidelberg 
Nylon membrane, positively charged Roche Diagnostics, Mannheim 
Petri dishes Greiner, Nürtingen 
Pipette tips 
 
 
Greiner, Nürtingen 
Eppendorf, Hamburg 
Sarstedt, Nümbrecht 
Pipettes (2 µl, 20 µl, 200 µl, 1000 µl) Eppendorf, Hamburg 
Poly-Prep Chromatography columns Bio-Rad, Munich 
Polyvinylidendifluoride membrane (PVDF) Bio-Rad, Munich 
Serological pipettes TPP AG, Switzerland 
Tab. 9.2:  Auxiliary material and consumables used in this study 
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9.1.3 Instrumentation 
Device Source 
Biofuge fresco Heraeus Christ, Osterode 
Blotting device VacuGeneTMXI Amersham, Feiburg 
Chemiluminescence system ChemiSmart PeqLab, Erlangen 
CO2 incubator C42 Labotect, Göttingen 
Frensh pressure cell press SLM Aminco, Lorch 
Gel electrophoresis apparatus PeqLab, Erlangen 
Heatblock Waasetec, Göttingen 
HERA Safe Work Bench HS12 Heraeus Christ, Osterode 
Hoefer TE 70 Semi Dry Blotting Device Amersham, Feiburg 
Horizontal shaker VXR basic IKA, Staufen 
Hydro tech vacuum pump Bio-Rad, Munich 
Ice maschine Ziegra, Isernhagen 
Image eraser Molecular Dynamics, USA 
Magnetic Stirer Reo basci C IKA, Staufen 
Mini-Protean III System Bio-Rad, Munich 
ND-1000 Spectrophotometer Nanodrop Technologies, USA 
OneShot Cell Disruptor Constant Systems, UK 
Orbital shaker G10 New Brunswick (Eppendorf), USA 
OV2 Incubation oven Biometra, Göttingen 
pH meter Knick Calimatic, Berlin 
Refrigerated centrifuge Kendro, Hanau 
Special accuracy weighing machine Sartorius, Göttingen 
Spectral photometer Amersham, Feiburg 
Speedvac Univapo 150H Zirbus technology, Bad Grund 
Standard power pack Bio-Rad, Munich 
Steam autoclave Zirbus technology, Bad Grund 
Thermocycler iCycler Bio-Rad, Munich 
Thermocycler LabCycler Sensoquest, Göttingen 
Thermocycler Tpersonal Biometra, Göttingen 
Ultra centrifuge, Sorvall Ultra Pro 80 Thermo scientific, USA 
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Device Source 
Ultrasonic device UP200S Dr. Hielscher, Teltow 
UV Transilluminator Gel Doc 2000 Bio-Rad, Munich 
Vibrax VXR basic IKA, Staufen 
Vortex Bender & Hobein, Bruchsal 
Water desalination plant Millepore, Schwalbach 
Water-bath incubation system GFL, Burgwedel 
Tab. 9.3: Technical equipment and instrumentation used in this study 
 
9.1.4 Commercial systems  
System Source 
Cy5TM Mono-Reactive Dye module  Amersham Biosciences 
DNeasy Tissue Kit (50) Qiagen, Hilden 
iScriptTM One-Step-RT-PCR Bio-Rad, Munich 
Merckoquant peroxide test Merck, Darmstadt 
Nucleospin Plasmid Machery-Nagel, Düren 
Qiaquick PCR Purification Kit Qiagen, Hilden 
RNeasy® Midi Kit Qiagen, Hilden 
RNeasy® Plus Mini Kit Qiagen, Hilden 
S.N.A.P.TM Purification module Invitrogen 
SuperScriptTM Indirect cDNA Labeling System Invitrogen 
Tab. 9.4: Commercialized test systems and kits used in this study 
 
9.1.5 Software  
Name Source Description 
ChemiCapt Version 11.07 Bio-Rad Chemiluminescence analysis 
FreeMind Open source Mind mapping 
Microsoft Office 2007 Microsoft Data processing 
Nanodrop software Nanodrop Technologies Photometric measurements 
Quantity One 4.1.0 Bio-Rad Imaging of luminescence  
R Open source Data processing 
SeqManTM II 5.07 DNASTAR Analysis of DNA sequencing files 
Vector NTI Invitrogen DNA/protein sequence analysis 
Tab. 9.5: Hard drive-based computer software used in this study 
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9.1.6 Internet based software, websites and databases 
Name Source Description 
http://www.subtiwiki.uni-goettingen.de/ 
 
Flórez et al., 
2009 
Data base of  
B. subtilis 
http://www.ncbi.nlm.nih.gov/pubmed 
  
Literature research, 
general data base 
http://www.genome.jp/kegg/kegg2.html 
 
Ogata et al., 
1999 
Data base of genes 
and genomes 
http://cbi.labri.fr/outils/molligen/ 
 
Barré et al., 
2004 
Data base of 
Mollicutes  
http://genolist.pasteur.fr/Colibri/ 
 
Médigue et 
al., 1993 
Data base of 
 E. coli 
http://genolist.pasteur.fr/SubtiList/ 
 
Moszer et al., 
2002 
Data base of  
B. subtilis 
http://cmr.jcvi.org/cgi-
bin/CMR/CmrHomePage.cgi 
JCVI 
 
Data base of genes 
and genomes 
http://bips.u-strasbg.fr/EMBOSS/ 
 
EMBOSS 
 
Molecular biology 
tools 
http://multalin.toulouse.inra.fr/multalin/ 
multalin.html 
Corpet, 1988 
 
Multiple alignment 
tool 
http://www.chemie.fu-
berlin.de/chemistry/general/units.html 
FU Berlin 
 
Unit calculations 
 
http://expasy.org/ 
 
# 
 
Data base of proteins 
families 
http://rna.lundberg.gu.se/cutter2/ 
  
DNA restriction 
analysis 
http://transterm.cbcb.umd.edu/query.php 
 
 
Kingsford et 
al., 2007 
 
Prediction of Rho-
independent 
terminators 
http://prodoric.tu-bs.de/ 
 
Grote et al., 
2009 
Regulon prediction 
 
http://pfam.sanger.ac.uk/ 
 
Finn et al., 
2009 
Data base of proteins 
families 
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Name Source Description 
http://www.cellbiol.com/scripts/complement/ 
reverse_complement_sequence.html  
DNA reverse-
complement tool 
http://www.basic.northwestern.edu/biotools/ 
oligocalc.html 
 
Kibbe, 2007 
 
 
Calculator for 
oligonucliotide 
properties 
http://meme.nbcr.net/meme4_4_0/intro.html 
 
# 
 
DNA motif prediction 
tools 
http://molbiol-tools.ca/Promoters.htm 
 
# 
 
Tools to predict 
bacterial promoters 
http://132.248.32.45:8080/cgi-bin/ribex.cgi 
 
 
Abreu-
Goodger and 
Merino, 2005 
Riboswitch prediction 
tool 
 
http://www.transcriptionfactor.org 
 
Wilson et al., 
2008 
Data base of 
transcription factors 
http://string.embl.de/ 
 
Snel et al., 
2000 
Protein association 
network tool 
Tab. 9.6: Internet-based software and databases used in this study 
# Several related publications could be found on the respective websites. 
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9.2 Oligonucleotides 
 
9.2.1 Available oligonucleotides used in this study  
 Sequence# Description* 
SH29 ATGAGTGAGCTAACTCACAG Sreening for M. pneumoniae mutants 
SH30 CAATACGCAAACCGCCTC Sreening for M. pneumoniae mutants 
IW01 
 
AAAGAATTCGATCAGCGGCTTC
TGAAACGTG 
Fwrd. Primer: amplification of PgltAB 
from B. subtilis 
IW02 
 
AAAGGATCCTGAGCTTTTGGCAT
TTGATTGTACGC 
Rev. Primer: amplification of PgltAB 
from B. subtilis 
mls-fwd 
(kan) 
 
CAGCGAACCATTTGAGGTGATA
GGGATCCTTTAACTCTGGCAACC
CTC 
Construction B. subtilis mutants by 
LFH-PCR 
 
mls-
rev(kan) 
 
CGATACAAATTCCTCGTAGGCG
GGCCGACTGCGCAAAAGACATA
AGCTCTCG 
Construction B. subtilis mutants by 
LFH-PCR 
 
Tab. 9.7: Oligonucleotides designed in previous works used in this study 
# restriction sites are underlined, introduced mutations are bold, promoters are italic, P indicates 5’-
phosphorylation 
* LFH-PCR: long flanking homology PCR 
 
 
9.2.2 Oligonucleotides designed in this work 
Name Sequence# Description* 
HE167 
 
 
AAAAGATCTATGATTGAAGCTAG
TACAAAAAAGACAATGATTAAGG
TCTTATCATTAC 
Fwrd. primer: Amplification of BglII-
PackA-STREP-MCS aus pGP1012 
HE168 
 
 
TTTTCTAGAATTCCCGGGATCCTT
TTTCGAACTGCGGGTGGCTCCAC
CGCGGCATT 
Rev. primer: Amplifikation of BglII-
PackA-STREP-MCS from pGP1012; 
mutagenesis PstI SacII 
HE169 
 
CACGCACATTAATAAGTTAGTGC Fwrd. primer: Screening for 
Mpn317/ftsZ mutant 
HE170 
 
GCTTATTCTAAAGAAGAAAGACC Rev. primer: Screening for 
Mpn317/ftsZ mutant 
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Name Sequence# Description* 
HE171 
 
AAAAAGCTTATGATTGAAGCTAG
TACAAAAAAGAC 
Fwrd. primer: Amplification of PackA-
STREP from pGP1012 
HE172 
 
AAAGAATTCTTTTTCGAACTGCGG
GTGGC 
Rev. Primer:  Amplification of PackA-
STREP from pGP1012 
HE173 
 
AAATGATCAATGATTGAAGCTAG
TACAAAAAAGAC 
Fwrd. Primer:  Amplification of PackA-
STREP from pGP193  
HE174 
 
AAATCTAGAACTAGTGGATCCCC Rev. Primer: Amplification of PackA-
STREP from pGP193  
HE175 
 
AAAGAATTCATGAAGAAGATTCA
AGTAGTCGTTAAAG 
Fwrd. Primer: Amplification of 
Mpn053/ptsH 
HE176 
 
TTTGGATCCCTTAAATAACTTGGT
GTTTTTCTAAAAC 
Rev. Primer: Amplification of 
Mpn053/ptsH 
HE179 
 
CATTCCGGGATAATTTTCCCG Fwrd. Primer: Screening for Mpn626 
mutants 
HE180 
 
CAAGAAGAAGGATATCTTCATCT
AG 
Rev. Primer: Screening for Mpn626 
mutants 
HE181 
 
GACAAGCATAATTATCCCGCTG Fwrd. Primer: Screening for Mpn329 
mutants 
HE182 
 
GCACTTAAGTGGTTGACAAACTG Rev. Primer: Screening for Mpn329 
mutants 
HE183 
 
AAAGGATCCGGCGTTAATAATGA
TGATTGAAGC 
Fwrd. Primer: Amplification of PackA 
from M. pneumoniae 
HE184 
 
TTTTGAATTCTTTTATCTAATAGG
TAACAATAATAAAATATTAG 
Rev. Primer: Amplification of PackA 
from M. pneumoniae 
HE185 
 
 
AAAGAATTCATGACAAAGCGTAA
TAAAAAGAACAACAAGCTGTACA
AG 
Fwrd. Primer: Amplification of rpoC 
from M. pneumoniae 
HE186 
 
 
TTTCTAGATTAGTGATGGTGATGG
TGATGATACTCCTCTTGAACCGTT
TTGGCACCGAG 
Rev. Primer: Amplification of rpoC 
from M. pneumoniae 
HE187 
 
CAATTGACGCAAGATCTTTTTAAC
C 
Rev. Primer: rpoC Sequencing 
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Name Sequence# Description* 
HE188 GGTTACATCTTCCGGAACCTG Fwrd. Primer: rpoC Sequencing 
HE189 CCAGATCAGGTCGTCCTG Rev. Primer: rpoC Sequencing 
HE190 CCTTTTAGGTAAACGGGTGG Fwrd. Primer: rpoC Sequencing 
HE191 CTTGGAGATGACCTTCTTACC Rev. Primer: rpoC Sequencing 
HE192 GCATACGAAGCGGGCAAG Fwrd. Primer: rpoC Sequencing 
HE193 GTCATGTAACCAGACTTAGCC Rev. Primer: rpoC Sequencing 
HE194 GTGTCGAGTGAGATCCAGG Fwrd. Primer: rpoC Sequencing 
HE195 CTTCCTGCGCGTTTTGGG Rev. Primer: rpoC Sequencing 
HE196 CCCAGTTAACGATGCGTACC Fwrd. Primer: rpoC Sequencing 
HE203 
 
TTTTGGATCCATGGCAAAGGA
ATTAGTATTTGGC 
Fwrd. Primer: Amplification of groEL  
HE204 
 
TTTTCTGCAGCTATTCTTGGA
AGCTACCTTCC 
Rev. Primer: Amplification of groEL  
HE205 
 
 
TTTTGGATCCATGAAAAATTT
AACTACCCGACAAGCCCAAA
TTC 
Fwrd. Primer: Amplification of HrcA 
HE206 
 
TTTTCTGCAGTTAAGTGGAGC
TAGTGGTTTTACCACCG 
Rev. Primer: Amplification of HrcA 
HE207 
 
 
P-CTTACTGGAAGATACT 
AGTGTCTGGCAACAAATGGC
CTTTATGAACCAAAACAACC 
CCR mutagenesis primer for hrcA ,  5´-
phosphorylated 
HE215 
 
CCCATAGCTTTGGACACAC pMT85/pGP194 sequencing;  
Fwrd. anneals upstream of SpeI 
HE217 
 
AAAGAATTCATGGTGCTGAA
ATCGAAAGGATCC 
Fwrd. Primer: Amplification of 
Mpn329 
HE218 
 
TTTTCTAGATTATTGATCATCT
TCAAGTGTACCGC 
Rev. Primer: Amplification of Mpn329 
HE219 
 
AAAGAATTCATGATTTCAGCG
AAAGAGCAAGC 
Fwrd. Primer: Amplification of 
Mpn239 
HE220 
 
TTTGCGGCCGCTTAAGCATTA
ATAATTTTGATGCGGGG 
Rev. Primer: Amplification of Mpn239 
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Name Sequence# Description* 
HE221 
 
AAAGGATCCATGATTTCAGCG
AAAGAGCAAGC 
Fwrd. Primer: Amplification of 
Mpn239 
HE222 
 
AAACTGCAGTTAAGCATTAAT
AATTTTGATGCGGGG 
Rev. Primer: Amplification of Mpn239 
HE223 
 
AAAGTCGACATGGTGCTGAA
ATCGAAAGGATCCGTG 
Fwrd. Primer: Amplification of 
Mpn329 
HE224 
 
AAACTGCAGTTATTGATCATC
TTCAAGTGTACCGCTAGCGAC 
Rev. Primer: Amplification of Mpn329 
HE225 
 
CTGATGAAAAACAACTAACG
CAAATC 
Fwrd. Primer: Promoter region of 
Mpn239  
HE226 
 
CCTAAGAGGGTATTGAGGAT
AG 
Rev. Primer:  Promoter region of 
Mpn239 
HE227 
 
AGGTCATCCACTTAAACGAGT
CC 
Fwrd. Primer: Promoter region of 
Mpn329  
HE228 
 
CAAGTGGTGTTTGAGCTCAGC 
 
Rev. Primer:  Promoter region of 
Mpn329 
HE229 
 
P-CCAGGACAACAAATTGCCC 
AAGTGGGCTAAGCTCTCAACC 
Mutagenesis primer for MMR of 
Mpn239; 5´-phosphorylated 
HE230 
 
CTAATAGCGCGTTTAGGTAGT
C 
Fwrd. Primer: Promoter region of nox 
 
HE231 
 
CCAAAAAGGAGATGTTGGTA
TTGC 
Rev. Primer: Promoter region of nox 
 
HE232 
 
CCAAAAATTCAATTAACCGGA
AGTTTGC 
Fwrd. Primer: Mpn517 probe 
 
HE233 
 
 
CTAATACGACTCACTATAGGGA
GACGTCAGTGATAAATGGCTG
AAAATCAAAGCC 
Rev. Primer: Mpn517 probe, contains 
T7-Promotor 
 
HE234 
 
AAAGGATCCATGAGTACCAA
ACCGTTAATCTTATTG 
Fwrd. Primer: Amplification of 
Mpn517 
HE235 
 
AAAGTCGACTTATATCAATTT
TTGTACGTCAGTGATAAATGG 
Rev. Primer: Amplification of Mpn517 
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Name Sequence# Description* 
HE236 
 
GCTGTTAGAAGAGCTACTGAT
GAG 
Fwrd Primer: Primer:  Promoter region 
of  Mpn517 
HE237 
 
CAGCATTGAGTTGTTGTTCCA
AAGC 
Rev. Primer: Primer:  Promoter region 
of Mpn517 
HE238 
 
GGCGTGCGTGTATACGCGTGC
GC 
Fwrd. Primer: Screening for Mpn352 
(sigA) mutants 
HE239 
 
GGGTTTTTGCTGTAAGACTAA
ATTAGCAATTGTGC 
Rev. Primer: Screening for Mpn352 
(sigA) mutants 
HE240 
 
 
CCTATCACCTCAAATGGTTCG
CTGCGTAAGTTTATAGCTGGA
TGAGTGCAGTTG 
Rev. Primer: Upstream of B. subtilis 
fur; Kan-extension for LFH-PCR 
HE241 
 
GAGGCAGCACACCATCTTTCA
GCAC 
Fwrd. Primer: Upstream of B. subtilis 
fur; for LFH-PCR 
HE242 
 
GAAAAAGAAGCGGGGGCATC
GATTG 
Sequencing of upstream LFH fragment:  
fur from B. subtilis 
HE243 
 
 
CGAGCGCCTACGAGGAATTTG
TATCGGGAAATTTAAGATTAA
AGATCATAGATTGACG 
Fwrd. Primer: downstream of B. 
subtilis fur; Kan-extension for LFH-
PCR 
HE244 
 
CAGGTTCTTCCAAAATCCCTG
GCGG 
Rev. Primer: downstream of                 
B. subtilis fur; for LFH-PCR 
HE245 
 
GGAGTCAGCTCTTTCTTAATG
CCGGC 
Sequencing of downstream LFH 
fragment:  fur from B. subtilis 
HE246 
 
 
AAACCCGGGAAAGGAGGAAA
CAATCATGGTGCTGAAATCGA
AAGGATCCGTGCTTGATT 
Fwrd. Primer: Amplification of 
Mpn329 for expression in B. subtilis 
HE247 
 
TTTTCTAGATTATTGATCATCT
TCAAGTGTACCGC 
Rev. Primer: Amplification of Mpn329 
for expression in B. subtilis 
HE248 
 
AAAGAATTCCCACCTTTGATC
ACGATAAAAGAGAAT 
Fwrd. Primer: Amplification and 
cloning of PMpn517 
HE249 
 
AAAGGATCCAGTTAGCTAAC
AATAAGATTAACGGTTTG 
Rev. Primer: Amplification and cloning 
of PMpn517 
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Name Sequence# Description* 
HE250 
 
 
P-GCTACTGATGAGTTTTATA 
AGGAAAATTGACAAGCAAAA
ATCAATGAACTTATTAAGTTG 
Mutagenesis of PMpn517 (agcttg, 
optimized -35 region) 
HE251 CTCCTTACGCATCTGTGCGG Sequencing of pGlt-Kan derivates  
HE252 GGCAGACATGGCCTGCCC Sequencing of pGlt-Kan derivates  
HE253 
 
AAAGAATTCTTTGGCTTCCAA
AACCAAACTACCC 
Fwrd. Primer: Amplification of Pnox  
HE254 
 
AAAGGATCCGGTATTGCGATC
ATAAGCGTTGAC 
Rev. Primer: Amplification of Pnox   
HE255 
 
 
P-GGTAAAGCAAAGCTACAA 
CCAAATTTGACAACCAAGATC
TTGCTCCACTATTAAATAAAT 
Mutagenesis of Pnox  (gtggcattgaca), 
optimized -35 Region  
HE256 
 
 
AAACCCGGGAAAGGAGGAAA
CAATCATGTCATCGCCAAAGA
AAAATTTCAAAAAACCTC 
Fwrd. Primer: Amplification of 
Mpn352/sigA  
HE257 
 
AAATCTAGACTAATCCTTCTT
TTCATTTCCCCTC 
Rev. Primer: Amplification of 
Mpn352/sigA  
HE258 
 
 
AAACCCGGGAAAGGAGGAAA
CAATCATGGCTGATAAACAA
ACCCACGAGACAGAATTAAC 
Fwrd. Primer: Amplification of  
B. subtilis sigA  
HE259 
 
 
AAATCTAGATTATTCAAGGAA
ATCTTTCAAACGTTTACTTCT
GC 
Rev. Fwrd. Primer: Amplification of  
B. subtilis sigA  
HE260 
 
GTCAGAGTTGCAATGATTCCT
GACGGATTGG 
Fwrd. Primer: Upstream of B. subtilis 
sigA;  for LFH-PCR 
HE261 
 
 
CCTATCACCTCAAATGGTTCG
CTGCCAGACTCTGTTAATTGC
TCTTTTACTTGGTCG 
Rev. Primer: Upstream of B. subtilis 
sigA; Kan-extension for LFH-PCR 
HE262 
 
GCTATGACTCTGATAAAGCCG
GTTATG 
Sequencing of upstream LFH fragment:  
sigA from B. subtilis 
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Name Sequence# Description* 
HE263 
 
 
CGAGCGCCTACGAGGAATTTG
TATCGCGTATTCGACAAATCG
AAGCCAAAGCGTTGC 
Fwrd. Primer: downstream of B. 
subtilis sigA; Kan-extension for LFH-
PCR 
HE264 
 
GCACCGCATAACAAGGAAGG
TAGGCGTGG 
Rev. Primer: Upstream of B. subtilis 
sigA; Kan-extension for LFH-PCR 
HE265 
 
GCAGACAAAAATGGGCCGTC
TGTTATTTCTCCG 
Sequencing of downstream LFH 
fragment:  sigA from B. subtilis 
HE266 
 
TTTTCTAGAGCAAAGCGCACA
CTGCTATTATTG 
Fwrd. Primer: Upstream of 
Mpn053/ptsH 
HE267 
 
 
AAAGGATCCTTATTTTTCGAA
CTGCGGGTGGCTCCAAATAAC
TTGGTGTTTTTCTAAAACTGC 
Rev. Primer: Mpn053/ptsH with 
STREP-tag. 
HE268 
 
CAGTGAATTGTTTGAGTTTGT
ACTGGAACAAATGG 
Fwrd. Primer: Mpn395 probe 
HE269 
 
 
CTAATACGACTCACTATAGGG
AGACAATAACCCACAGTTTGA
CTACCTAAACGC 
Rev. Primer: Mpn395 probe, contains 
T7 Promoter 
HE270 
 
CGCTTTTTACCTCATGAATCTT
TCCCGAATCATG 
Fwrd. Primer: Mpn393/pdhA probe 
HE271 
 
 
CTAATACGACTCACTATAGGG
AGACTCGCAATTAAGTCATTA
CCGTCAACGCG 
Rev. Primer: Mpn393/pdhA probe 
contains T7 Promoter 
HE272 
 
GCTTGGGGTTGAAAATCAACG
GTAATTG 
Fwrd. Primer: Screening for Mpn266 
mutants 
HE273 
 
CCTTTTCATTAAACGATGTGT
AAAAACCTAG 
Rev. Primer: Screening for Mpn266 
mutants 
HE274 
 
AAATCTAGAGATGGTTACACT
ATACACATCACCAAGC 
Fwrd. Primer: spx from B. subtilis for 
B2H 
HE275 
 
AAAGGTACCCGGTTTGCCAAA
CGCTGTGCTTCTC 
Rev. Primer: spx from B. subtilis for 
B2H 
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Name Sequence# Description* 
HE276 
 
 
AAATCTAGAGATGATCGAGA
TTGAAAAACCAAAAATCGAA
AC 
Fwrd. Primer: rpoA from B. subtilis for 
B2H 
HE277 
 
AAAGGTACCCGATCGTCTTTG
CGAAGTCCGAGTC 
Rev. Primer: rpoA from B. subtilis for 
B2H 
HE278 
 
 
AAATCTAGAGATGCTTAAGA
AAAAAGTTAATAATGATGCTG
G 
Fwrd. Primer: Mpn266/spx for B2H 
HE279 
 
AAAGGTACCCGCTTCTTTACT
GTACGCACTTTAGG 
Rev. Primer: Mpn266/spx for B2H 
HE280 
 
AAATCTAGAGATGGAAAAGT
TTTTAAAGTACGAAATAAAGG 
Fwrd. Primer: Mpn191/rpoA for B2H 
HE281 
 
AAAGGTACCCGAGATCTTAAT
TTGAGTCCTAATTCGTG 
Rev. Primer: Mpn191/rpoA for B2H 
HE282 
 
 
P-CGAACCACCACTAGAACGT 
TGGCCATTGTTAACGGTAACA
GCTG 
CCR primer: mutation of  
Mpn191/rpoA (TGATGG);  
HE283 
 
 
AAAGGATCCAAAGGAGGAAA
CAATCATGCTTAAGAAAAAA
GTTAATAATGATGCTGG 
Fwrd. Primer: Amplification of 
Mpn266/spx  
HE284 
 
AAAAAGCTTCTTCTTTACTGT
ACGCACTTTAGGTTCC 
Rev. Primer: Amplification of 
Mpn266/spx  
HE285 
 
GATCTAACTCCTTGTTAGCGT
C 
Fwrd. Primer: Screening for 
Mpn397relA mutants 
HE286 
 
 
GGCTATTGAAGAAACACTTAG
TG 
 
Rev. Primer: Screening for 
Mpn397relA mutants 
HE287 
 
 
AAAGCGGCCGCATGAAAAAT
TTAACTACCCGACAAGCCC 
Fwrd. Primer: Amplification of 
Mpn124/hrcA with C-terminal STREP-
tag 
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Name Sequence# Description* 
HE289 
 
 
AAAGCGGCCGCATGATTTCAG
CGAAAGAGCAAGCTAAAAAA
GG 
Fwrd. Primer: Amplification of 
Mpn239/gntR with C-terminal STREP-
tag 
HE291 
 
 
AAAGCGGCCGCATGGTGCTG
AAATCGAAAGGATCCG 
Fwrd. Primer: Amplification of 
Mpn329/perR with C-terminal STREP-
tag 
HE293 
 
 
AAAGCGGCCGCATGTCCTTTA
GTGTTCAGATTAAGCACGAG 
 
Fwrd. Primer: Amplification of 
Mpn241/whiA with C-terminal STREP-
tag 
HE295 
 
AAAGGATCCGTGTACCAAGA
AGAAAGATTAGTAGCG 
Fwrd. Primer: Amplification of glcR 
from B. subtilis 
HE296 
 
TTTAAGCTTTCAGTCCTTTCCT
TCATCCTGCTCTG 
Rev. Primer: Amplification of glcR 
from B. subtilis 
HE297 
 
 
AAAGGATCCAAAGGAGGAAA
CAATCGTGTACCAAGAAGAA
AGATTAGTAGCG 
Fwrd. Primer: Amplification of glcR 
from B. subtilis 
HE298 
 
TTTAAGCTTGTCCTTTCCTTCA
TCCTGCTCTGTC 
Rev. Primer: Amplification of glcR 
from B. subtilis 
HE299 
 
 
 
TTTGAGCTCCTATTATTTTTCG
AACTGCGGGTGGCTCCAAGTG
GAGCTAGTGGTTTTACCACCG
TG 
Rev. Primer: Amplification of  
Mpn124/hrcA with C-terminal STREP-
Tag  
HE300 
 
 
 
TTTGAATTCCTATTATTTTTCG
AACTGCGGGTGGCTCCAAGC
ATTAATAATTTTGATGCGGGG
GTTTA 
Rev. Primer: Amplification of  
Mpn239/gntR with C-terminal STREP-
Tag  
HE301 
 
 
 
TTTGAATTCCTATTATTTTTCG
AACTGCGGGTGGCTCCATTGA
TCATCTTCAAGTGTACCGCTA
GC 
Rev. Primer: Amplification of  
Mpn329/perR with C-terminal STREP-
Tag  
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Name Sequence# Description* 
HE302 
 
 
 
TTTGAGCTCCTATTATTTTTCG
AACTGCGGGTGGCTCCAATTT
TGGTTTAGTTTTTTTAACTTAG
CGTTGAG 
Rev. Primer: Amplification of  
Mpn241/whiA with C-terminal STREP-
Tag  
HE303 
 
 
GTAAACGGTTACATAAACAA
GGAGGAGCTG 
Frwd. Primer: qPCR for the promoter 
region of the rbsR-Operon from           
B. subtilis (cre site)  
HE304 
 
 
TCGCCGCTATGACACGCGTTC
G 
Rev. Primer: qPCR for the promoter 
region of the rbsR-Operon from            
B. subtilis (cre site)  
HE305 
 
 
GCAGTGAGAAAACGCTTATA
AAACGAATGGAAG 
Frwd. Primer: qPCR for the promoter 
region of the purA-Operon from          
B. subtilis (cre site)  
HE306 
 
 
GCACCTCCGTTAACCTTTCAA
AACGATTC 
Rev. Primer: qPCR for the promoter 
region of the purA-Operon from          
B. subtilis (cre site)  
HE307 
 
 
AAAAGATCTAAGCTTGCATGC
CTGCAGGTCGAC 
Rev. Primer: Amplification of P[degQ36]-
SD-STREP-MCS from pGP380 (with 
M13_puc_Fwrd) 
HE308 
 
 
AAAAGATCTTTATCATTTTTC
GAACTGCGGGTGCTC 
Rev. Primer zur Amplifikation 
P[degQ36]–MCS-STREP-STOPSTOP  
from pGP382 (with M13_puc_Fwrd) 
HE309 
 
CTCAATTGGGAACAGTAAATG
ATTGGTGG 
Frwd. Primer: qPCR for the promoter 
region of Mpn674/ldh  
HE310 
 
ACCACGGCTCATGGCAGCGTA
G 
Rev. Primer: qPCR for the promoter 
region of Mpn674/ldh  
HE311 
 
ACAGCTGTCGAAACAGCAGC
CAC 
Frwd. Primer: qPCR for the promoter 
region of Mpn533/ackA  
HE312 
 
CCAGCATTGACTACTAAAATT
TTGTTGTCGTTC 
Rev. Primer: qPCR for the promoter 
region of Mpn533/ackA  
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Name Sequence# Description* 
HE313 
 
CAGTTAACTTGATTAACCACC
ACTTTTGGAAC 
Frwd. Primer: qPCR for the promoter 
region of Mpn434/dnaK (incl. CIRCE) 
HE314 
 
ACCAAGGTCAATGCCGATAAT
TAAGCCG 
Rev. Primer: qPCR for the promoter 
region of Mpn434/dnaK (incl. CIRCE) 
HE315 
 
GGACTTTGTGGAATCGATAAT
TTTGAACCG 
Frwd. Primer: qPCR for the promoter 
region of Mpn332/lon (incl. CIRCE) 
HE316 
 
CAGCTGGCATAGTTATTAAGA
TAAGAGGTTG 
Rev. Primer: qPCR for the promoter 
region of Mpn332/lon (incl. CIRCE) 
HE317 
 
AAAGAATTCGCAAAACTTATT
AGTTAATCAACAG 
Fwrd. Primer: Amplifcation of 16S 
rRNA promoters from M. pneumoniae 
HE318 
 
AAAGGATCCGACAGATTGCA
TCCAGTTTTG 
Rev. Primer: Amplifcation of 16S 
rRNA promoters from M. pneumoniae 
HE319 
 
 
P-CTGTATAATCTTCAGACT 
GTTGACAACTCTGTC 
CCR primer: mutagenesis of the 16S 
rRNA promoter from M. pneumoniae 
(+1G+1A) 
HE320 
 
CGACCGACTCGACAACATCTC
CTC 
Fwrd. Primer: Mpn397/relA probe 
HE321 
 
 
CTAATACGACTCACTATAGGG
AGAGACATAACCTCAACCCAT
CGAGTTTG 
Rev. Primer: Mpn397/relA probe, 
contains T7-Promotor 
HE322 
 
ATATATCATATGATTTCAGCG
AAAGAGCAAGC 
Amplification of Mpn239  (with 
HE300) 
HE323 
 
ATATATCATATGGTGCTGAAA
TCGAAAGGATC 
Amplification ofMpn329  (with 
HE301) 
HE324 
 
GGGTAACAATACCCTAAACG
GCATAG 
Fwrd. Primer: Screening for Mpn241 
mutants 
HE325 
 
CAATTCCGCGGTCTTTGGTTT
TGCG 
Rev. Primer: Screening for Mpn241 
mutants 
HE326 
 
CAGCTCAACGCCGAGCTAGA
AC 
Fwrd. Primer: Screening for Mpn244 
mutants 
HE327 
 
CCCAAGATTATCAACTTAAGT
GCCAAC 
Rev. Primer: Screening for Mpn244 
mutants 
 
Appendix 170	  
Name Sequence# Description* 
HE328 
 
CATTTGCGCAGCTGTTTCTCC
ACG 
Fwrd. Primer: Screening for Mpn273 
mutants 
HE329 
 
CCAGTTATGAACCGTCCTACT
CCC 
Rev. Primer: Screening for Mpn273 
mutants 
HE330 
 
TTTGAGAATTCAGCTCACACC
CCG 
Fwrd. Primer: Promoter region of rpsJ 
from B. subtilis 
HE331 
 
AAAGGATCCCGAATTTTTTGT
TTTGCCATTATTTTCCC 
Rev. Primer: Promoter region of rpsJ 
from B. subtilis 
Tab. 9.8: Oligonucleotides designed and used in this study 
# restriction sites are underlined, introduced mutations are bold, promoters are italic, P indicates 5’-
phosphorylation 
* LFH-PCR: long flanking homology PCR 
 
 
9.3 Plasmids 
 
9.3.1 Available plasmids used in this study 
Name Resistance Description* Publication 
p25-N KanR N-terminal fusions T25 domain, 
BACTH 
EUROMEDEX# 
pAC5 AmpR/ 
CmR 
Probing of translational lacZ-fusions 
in B. subtilis 
Martin-Verstraete 
et al., 1992 
pAC6 AmpR/ 
CmR 
Probing of transcriptional lacZ-fusions 
in B. subtilis 
Stülke et al., 1997 
pAC7 AmpR/ 
KanR 
Probing of translational lacZ-fusions 
in B. subtilis 
Weinrauch et al., 
1991 
pBGM31 AmpR/CatR Mutation of B. subtilis Görke et al., 2004 
pBGM67 AmpR/ 
CmR 
Construction of a B. subtilis yvcL 
mutant 
Görke et al., 2005 
pBlueskript AmpR Cloning vector STRATAGENE# 
pBQ200 AmpR/ 
ErmR 
Overexpression of proteins in B. 
subtilis under control of a strong 
degQ36 promoter 
Martin-Verstraete 
et al., 1994 
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Name Resistance Description* Publication 
pClpB-TAP KanR/ 
GenR 
Expression of TAP-tagged proteins in                  
M. pneumoniae 
Kühner et al., 
2009 
pET3c AmpR Inducible over-expression vector for 
E. coli 
NOVAGEN# 
pGlt-Kan AmpR/ 
KanR 
Shuttle vector that integrates in gltA of 
B. subtilis 
Middleton and 
Hofmeister, 2004 
pGP172 AmpR Inducible over-expression of proteins 
in E. coli; allows fusion to a Strep-tag 
at the N-terminus of the protein 
Merzbacher et al., 
2004 
pGP380 AmpR/ 
ErmR 
Expression of proteins in B. subtilis 
allows fusion to a Strep-tag at the N-
terminus of the protein 
Herzberg et al., 
2007 
pGP382 AmpR/ 
ErmR 
Expression of proteins in B. subtilis 
allows fusion to a Strep-tag at the C-
terminus of the protein 
Herzberg et al., 
2007 
pKT25 KanR C-terminal fusions to the T25 domain, 
BACTH 
EUROMEDEX# 
pKT25-zip KanR Positive control for the BACTH EUROMEDEX# 
pMT85 KanR/ 
GenR 
Transposon for the manipulation of                        
M. pneumoniae 
Zimmerman and 
Herrmann, 2005 
pUT18 AmpR N-terminal fusions to the T18 domain, 
BACTH 
EUROMEDEX# 
pUT18C AmpR C-terminal fusions to the T18 domain, 
BACTH 
EUROMEDEX# 
pUT18C-zip AmpR Positive control for the BACTH EUROMEDEX# 
pWH844 AmpR Inducible over-expression of proteins 
in E. coli; allows fusion to a N-
terminal His-tag 
Schirmer et al., 
1997 
Tab. 9.9: Plasmids constructed in previous studies used in this work 
* AmpR: ampicilin; KanR: kanamycin; ErmR: erythromycin; CmR: chloramphenicol; GenR: gentamycin 
# Information about the plasmids related publications can be found on the website of the respective suppliers. 
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9.3.2 Plasmids constructed in this work 
Name Backbone Description 
pGP193 pBluSkP 
HindIII/EcoRI 
PackA-His6 from pGP1012,  
HE171/HE172  
pGP194 
 
pMT85 
SpeI/XbaI 
PackA-His6from pGP1012 with MCS from pGP193, 
HE173/174  
pGP195 
 
pMT85 
BamHI/EcoRI 
PPackA(-227 to -1) from M. pneumoniae,  
HE183/HE184b  
pGP196 
 
pGP195 
EcoRI/XbaI 
rpoC-His6 from M. pneumoniae,  
HE185/HE186  
pGP197 
 
pBluSkP 
EcoRI/XbaI 
rpoC-His6 from M. pneumoniae,  
HE185/HE186 
pGP198 
 
pWH844 
BamHI/PstI 
 groEL from M. pneumoniae,  
HE203/HE204  
pGP199 
 
pBluSkP 
BamHI/PstI 
hrcA from M. pneumoniae,  
HE205/HE206 
pGP199 
 
pBluSkP 
BamHI/PstI 
hrcA from M. pneumoniae,  
HE205/HE206 
pGP272 pWH844 
BamHI/PstI 
Mutated hrcA from M. pneumoniae, 
HE205/HE206/HE207] 
pGP273 pGP194 
EcoRI/BamHI 
ptsH from M. pneumoniae,  
HE175/HE176  
pGP274 pBluSkP 
BamHI/PstI 
Mpn239,  
HE221/HE222 
pGP275 pWH844 
BamHI/PstI 
Mutated Mpn239,   
HE221/HE222/HE229  
pGP276 pWH844 
BamHI/PstI 
Mpn329,  
HE223/HE224 
pGP277 pBQ200 
XmaI/XbaI 
Mpn329 with RBS from pGP380  
pGP278 pGlt-Kan, 
EcoRI/XbaI 
PDegU-RBS-Mpn329 from pGP277,  
pGP279 pAC6 
EcoRI/BamHI 
PMpn517(nat), native promoter region from Mpn517, 
HE248/HE249   
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Name Backbone Description 
pGP280 pAC6 
EcoRI/BamHI 
PMpn517(mut), modified promoter region from Mpn517, 
HE248/HE249/HE250 
pGP281 pAC6 
EcoRI/BamHI 
Pnox(nat), native promoter region from Mpn394/nox, 
HE253/HE254 
pGP282 pAC6 
EcoRI/BamHI 
Pnox(mut), modified promoter region from Mpn394/nox, 
HE253/HE254/HE255 
pGP283 pBQ200 
XmaI/XbaI 
Mpn352/sigA with RBS from pGP380,  
HE256/HE257 
pGP284 pBQ200 
XmaI/XbaI 
sigA from B. subtilis with RBS from pGP380, 
HE258/HE259 
pGP285 pMT85 
BamHI/XbaI 
Mpn053/ptsH with ~1kb upstream and 3´-STREP, 
HE266/HE267  
pGP286 pAC6 
EcoRI/BamHI 
ldh promoter from M. pneumoniae,  
SH46/SH47 
pGP287 pUT18,  
XbaI, KpnI 
spx from B. subtilis,  
HE274/HE275 
pGP288 pUT18C, 
XbaI, KpnI 
spx from B. subtilis,  
HE274/HE275 
pGP289 pKNT25, 
XbaI, KpnI 
spx from B. subtilis,  
HE274/HE275 
pGP290 pKT25,  
XbaI, KpnI 
spx from B. subtilis,  
HE274/HE275 
pGP291 pUT18,  
XbaI, KpnI 
rpoA from B. subtilis,  
H276/HE277 
pGP292 pUT18C, 
XbaI, KpnI 
rpoA from B. subtilis,  
H276/HE277 
pGP293 pKNT25, 
XbaI, KpnI 
rpoA from B. subtilis,  
H276/HE277 
pGP294 pKT25, XbaI, 
KpnI 
rpoA from B. subtilis,  
H276/HE277 
pGP295 pUT18,  
XbaI, KpnI 
Mpn266 from M. pneumoniae,  
H278/HE279 
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pGP296 pUT18C, 
XbaI, KpnI 
Mpn266 from M. pneumoniae,  
H278/HE279 
pGP297 pKNT25, 
XbaI, KpnI 
Mpn266 from M. pneumoniae,  
H278/HE279 
pGP298 pKT25,  
XbaI, KpnI 
Mpn266 from M. pneumoniae,  
H278/HE279 
pGP299 pUT18,  
XbaI, KpnI 
rpoA from M. pneumoniae, native,  
HE280/HE281 
pGP300 pUT18, 
 XbaI, KpnI 
rpoA from M. pneumoniae, mutated (tgatgg), 
HE280/HE281/HE282 
pGP1451 pUT18C, 
XbaI, KpnI 
rpoA from M. pneumoniae, mutated (tgatgg) , 
HE280/HE281/HE282 
pGP1452 pKNT25, 
XbaI, KpnI 
rpoA from M. pneumoniae, mutated (tgatgg) , 
HE280/HE281/HE282 
pGP1453 pKT25, , 
XbaI, KpnI 
rpoA from M. pneumoniae, mutated (tgatgg) , 
HE280/HE281/HE282 
pGP1454 pGP382, 
BamHI, 
HindIII 
Mpn266 from M. pneumoniae, with SD from pGP380; 
HE283/HE284 
pGP1455 pClpB-TAP, 
SacI, NotI 
Mpn124/hrcA-STREP from M. pneumoniae, 
HE287/HE299  
pGP1456 pClpB-TAP, 
EcoRI, NotI 
Mpn239-STREP from M. pneumoniae,  
HE289/HE300 
pGP1457 pClpB-TAP, 
EcoRI, NotI 
Mpn329-STREP from M. pneumoniae,  
HE291/HE301 
pGP1458 pClpB-TAP, 
SacI, NotI 
Mpn241-STREP from M. pneumoniae,  
HE292/HE302 
pGP1459 pGP882, 
BamHI, SmaI 
aphA3 (EcoRI/SmaI) and P[degQ36]-SD-STREP-MCS 
(EcoRI/BglII); shuttle vector analogous to pGP380; 
integrates in lacA of B. subtilis 
pGP1460 pGP882 
BamHI, SmaI 
aphA3 (EcoRI/SmaI) und P[degQ36] –MCS-STREP-
STOPSTOP (EcoRI/BglII); shuttle vector analogous to 
pGP382; integrates in lacA of B. subtilis 
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pGP1461 pAC6 
EcoRI/BamHI 
Promoter of 16S rRNA from M. pneumoniae; 
HE317/HE318 
pGP1462 pAC6 
EcoRI/BamHI 
Mutated Promoter of 16S rRNA from M. pneumoniae; 
HE317/HE318/ HE319 
pGP1463 pMT85  
BcuI / EcoRI 
16S rRNA promoter-lacZ fusion,  
HE317/SH45 
pGP1464 pMT85  
BcuI /EcoRI 
mutated 16S rRNA promoter-lacZ fusion,  
HE317/SH45 
pGP1465 pET3c  
NdeI/EcoRI 
Mpn239 with C-terminal STREP-tag,  
HE322/HE300 
pGP1466 pET3c  
NdeI/EcoRI 
Mpn329 with C-terminal STREP-tag;  
HE323/HE301 
pGP1467 pAC7 
EcoRI/BamHI 
rpsJ promoter fragment from B. subtilis,  
HE330/HE331 
pGP1468 pBGM31 
SacI/BamHI, 
ApaI/KpnI 
Contains flanking regions from B. subtilis yvcL derived 
from pBGM67, either SacI/BamHI or ApaI/KpnI digested 
Tab. 9.10: Plasmids constructed in this work 
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9.4 Proteins, antibodies and enzymes 
Tab. 9.11: Enzymes, antibodies and other proteins used in this work 
AB: antibody, AK: alkaline phosphatase 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Description* Source/Supplier 
Anti-Digoxigenin-AP, Fab Fragments Roche Diagnostics, Mannheim 
DNase I Sigma, München 
Lysozyme from chicken egg protein (178000 U/mg) Merck, Darmstadt 
Phusion DNA Polymerase Finnzymes, Finnland 
Polyclonal AB against M. pneumoniae GlpK-STREP, 
(Hames et al., 2005) 
Seqlab, Göttingen 
 
Restriction enzymes 
 
NEB Biolabs, Frankfurt am Main 
MBI Fermentas, St. Leon-Rot 
RNaseA Roche Diagnostics, Mannheim 
Secondary AB Anti-rabbit, coupled to IgG-AP 
gekoppelt 
Promega, Mannheim 
 
T4-DNA-Ligase Roche Diagnostics, Mannheim 
Taq polymerase, recombinant; purified from  
E. coli stock 147; purified by Julia Busse 
Nadicom, Karlsruhe 
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9.5 Bacterial strains 
 
9.5.1 Available strains used in this study 
Tab. 9.12: E. coli strains used in this study  
 
 
Tab. 9.13: B. subtilis strains used in this study 
 
 
Tab. 9.14: M. pneumoniae strains used in this study 
 
Strain Genotype Reference 
BL21 F-,lon ompT rBmB hsdS gal (cIts857 ind1 Sam7 nin5 
lacUV5-T7 gene1) 
Sambrook et al., 
1989 
BTH101 F-, cya-99, araD139, galE15, galK16, rpsL1 (StrR), 
hsdR2, mcrA1, mcrB1 
EUROMEDEX 
DH5α recA1 endA1 gyrA96 thi hsdR17rK- mK+relA1 
supE44 '80#lacZ#M15 #(lacZYA-argF)U169 
Sambrook et al., 
1989 
XL1-Blue endA1, gyrA96(nalR), thi-1, recA1, lac, glnV44, 
F´[::Tn10, proAB+, lacIq, ∆(lacZ)M15] hsdR17 (rK- 
mK+) 
STRATAGENE 
Strain Genotype Reference 
168 trpC2 Laboratory collection 
HB0509 HB1000 perR::spx Bsat et al., 1998 
HB6543 HB1000 fur::kan Bsat et al., 1998 
GP278 trpC2 amyE::(xynP-lacZ cat) xylR::ErmR Singh et al., 2007 
ORB6781 trpC2, pheA, spx::SpcR P. Zuber, unpublished 
Strain Genotype Reference 
M129 Wild type (ATCC 29342) Laboratory collection 
GPM51 hprK::Tn  Halbedel et al., 2006 
GPM52 glpD::Tn Hames et al., 2009 
GPM68 prpC::Tn Halbedel et al., 2006 
GPM70 mpn474::Tn Hegermann et al., 2008 
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9.5.2 Strains constructed in this work 
Tab. 9.15: B. subtilis strains constructed in this study 
 
 
 
Strain Genotype Construction 
GP868 perR: :spc, fur:mls chrom. DNA 
HB0509GP879 
GP869 perR::spc, fur:mls, gltA::PdegQ-mpn329  pGP278GP868 
GP870 perR::spc, fur:mls, gltA::pGltA-Kan pGlt-KanGP868 
GP871 perR::spc, fur:mls, gltA::PdegQ-mpn329, 
amyE ::PMpn517(nat)-lacZ 
pGP279GP869 
GP872 perR::spc, fur::mls, gltA::pGlt-Kan,  
amyE ::PMpn517(nat)-lacZ 
pGP279GP870 
GP873 perR::spc, fur::mls, gltA::PdegQ-
mpn329,amyE ::Pnox(nat)-lacZ 
pGP281GP869 
GP874 perR::spc, fur:mls, gltA::pGlt-Kan,  
amyE ::Pnox(nat)-lacZ 
pGP281GP870 
GP875 perR::spc, fur:mls, gltA::PdegQ-mpn329, 
amyE ::PMpn517(mut)-lacZ 
pGP280GP869 
GP876 perR::spc, fur::mls, gltA::pGlt-Kan,  
amyE ::PMpn517(mut)-lacZ 
pGP280GP870 
GP877 perR::spc, fur::mls, gltA::PdegQ-
mpn329,amyE ::Pnox(mut)-lacZ 
pGP282GP869 
GP878 perR::spc, fur:mls, gltA::pGlt-Kan,  
amyE ::Pnox(mut)-lacZ 
pGP282GP870 
GP879 fur ::mls LFHWT168 
GP880 amyE ::P517(nat)-lacZ pGP279WT168 
GP881 amyE ::Pnox(nat)-lacZ pGP281WT168 
GP882 amyE ::Pldh(nat)-lacZ pGP286WT168 
GP883 spx ::spc chrom. DNA ORB6781 
WT168 
GP230 amyE ::ProsJ-lacZ pGP1467WT168 
GP231 amyE ::ProsJ-lacZ, yvcL::cat pGP1468GP230 
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Tab. 9.16: M. pneumoniae strains constructed or isolated in this study 
 
 
9.6 Microarray data 
The microarray data from all experiments are available upon request. If required, please 
contact: 
 
Name   Email   Phone 
Prof. Jörg Stülke jstuelk@gwdg.de +49-551-39-3781 
Hinnerk Eilers heilers@gwdg.de  +49-551-39-8727 
 
 
 
9.7 Abbreviations 
Abbreviation Full text 
% (v/v) % (volume/volume) 
% (w/v) % (weight/volume) 
°C Degrees Celsius 
A Ampere 
ADP Adenosine diphosphate 
 
Strain Genotype Construction 
GPM13 Tn[PclpB-hrcA-STREP]::??  pGP1455Wild type 
GPM14 Tn[PclpB-hrcA-STREP]::?? pGP1455Wild type 
GPM15 Tn[PclpB-Mpn239-STREP]::?? pGP1456Wild type 
GPM16 Tn[PclpB-Mpn239-STREP]::?? pGP1456Wild type 
GPM17 Tn[PclpB-Mpn329-STREP]::?? pGP1457Wild type 
GPM18 Tn[PclpB-Mpn329-STREP]::?? pGP1457Wild type 
GPM19 Tn[PclpB-Mpn241-STREP]::?? pGP1458Wild type 
GPM20 Tn[PclpB-Mpn241-STREP]::?? pGP1458Wild type 
GPM21 Tn::Mpn397/relA Isolated by Haystack 
mutagenesis 
GPM22 Tn::Mpn241/whiA Isolated by Haystack 
mutagenesis 
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Abbreviation Full text 
AMP Adenosine monophosphate 
AP Alkaline phosphatase 
APS Ammonium persulfate 
ATP Adenosine triphosphate 
BACTH Bacterial adenylate cyclase based two-hybrid system 
bp Base pairs 
CAA Casamino acids 
cAMP Cyclic adenosine monophosphate 
CAP Cyclase associated protein 
CCR Combined chain reaction 
CDP* 
 
 
2-Chlor-5-(4-Methoxyspiro{1,2-Dioxetan-3,2‘-(5‘-
Chlor)Tricyclo[3.3.1.13,7]Decan}-4-yl)-1-Phenylphosphate, 
sodium salt 
ChAP Chromatin affinity purification 
ChIP Chromatin immuno precipitation 
Da Dalton 
DBD DNA binding domain 
DEPC Diethylpyrocarbonate 
DHAP Dihydroxyacetone phosphate 
Dig Digoxigenin 
DMF Dimethylformamide 
DMSO Dimethyl sulfoxide 
dNTP Deoxyribonucleotide 
DTT Dithiothreitol 
EDTA Ethylenediaminetetraacetic acid 
EI  Enzyme I (of PTS) 
EII  Enzyme II (of PTS) 
et al. et alia (and others) 
FBP Fructose-1,6-bisphosphate 
Fig. Figure 
g Gram 
GDP Guanosine diphosphate 
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Abbreviation Full text 
GMP Guanosine monophosphate 
GTP Guanosine triphosphate 
h Hour(s) 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
His Histidine 
HPLC High-performance liquid chromatography 
IMP (dehydrogenase) Inosine monophosphate (dehydrogenase) 
IPTG Isopropyl β-D-1-thiogalactopyranoside 
l Litre 
LB Luria Bertani (medium) 
LC-M/S Liquid chromatographie- mass spectrometry 
LFH-PCR Long flanking homology PCR 
M molar (mol/l) 
min Minute 
mM milimolar 
MMR Multiple mutation reaction 
MOPS 3-(N-morpholino)propanesulfonic acid 
mRNA Messenger RNA 
NADH Nicotinamide adenine dinucleotide (reduced) 
OD Optical density 
ORF Open reading frame 
PAA Poly acryl amide 
PAGE Polyacrylamide gel electrophoresis 
PBS Phosphate buffered saline 
PCR Polymerase chain reaction 
PEP Phosphoenolpyruvic acid 
pH Power of hydrogen 
PNPase Polynucleotide phosphorylase 
PPLO Pleuropneumonia-Like organisms 
PTS Phosphotransferase system 
qPCR Quantitative PCR 
PTS Phosphotransferase system 
 
Appendix 182	  
Abbreviation Full text 
qPCR Quantitative PCR 
RNA Ribonucleic acid 
Rnase Ribonuclease 
rpm Rounds per minute 
rRNA Ribosomal RNA 
RT Room temperature 
SDS Sodium dodecyl sulfate 
sec Seconds 
Ser Serine  
SHX Serine hydroxamate 
sRNA Small (non-coding) RNA 
Tab. Table 
TBS Tris buffered saline 
TEMED Tetramethylethylenediamine 
tRNA Transfer RNA 
U Units 
UV Ultra violett (light) 
V Volt 
WT Wild type 
X-Gal Bromo-chloro-indolyl-galactopyranoside 
Tab. 9.17: List of abbreviations used in this publication, in alphabetical order. 
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